WO2019086474A1 - Pesticidally active mesoionics heterocyclic compounds - Google Patents

Pesticidally active mesoionics heterocyclic compounds Download PDF

Info

Publication number
WO2019086474A1
WO2019086474A1 PCT/EP2018/079743 EP2018079743W WO2019086474A1 WO 2019086474 A1 WO2019086474 A1 WO 2019086474A1 EP 2018079743 W EP2018079743 W EP 2018079743W WO 2019086474 A1 WO2019086474 A1 WO 2019086474A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
group
spp
formula
compound
Prior art date
Application number
PCT/EP2018/079743
Other languages
French (fr)
Inventor
André Stoller
Aurelien BIGOT
Pierre Joseph Marcel Jung
Julien Daniel Henri GAGNEPAIN
Stefano RENDINE
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of WO2019086474A1 publication Critical patent/WO2019086474A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Definitions

  • the present invention relates to pesticidally active, in particular insecticidally active mesoionics heterocyclic compounds, to compositions comprising those compounds, and to their use for controlling animal pests (including arthropods and in particular insects or representatives of the order lepidoptera and coleoptera).
  • Mesoionics heterocyclic compounds with pesticidal action are known and described, for example, in WO09099929, W01 1017334, W01 1017347, W01 1017342, WO120921 15, WO12106495, W012136724, WO14033244, WO14202582, WO14167084, W016055431 , W016171053 and WO17093214.
  • the present invention accordingly, in a first aspect, relates to compounds of formula I,
  • V is S or O
  • Ria, Rib, Ri c and Rid are independently selected from hydrogen, halogen, amino, hydroxyl, C1-C6 alkyl, C1-C6 haloalkyi, C1-C6 haloalkoxy, Ci-C6 alkoxy, C3-C6 cycloalkyl, C3-C6 halocycloalkyl and cyano;
  • R2 is hydrogen, halogen, hydroxyl, amino, cyano, C1-C6 alkyl, mono- or poly-substituted C1-C6 alkyl (where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, Ci-C6 alkoxy, Ci-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, Ci-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and Ci-C6 haloalkylsulfonyl), C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, triazole, pyrazole, imidazole, or te
  • R3 is hydrogen or C1-C6 alkyl
  • R4 is hydrogen or a 5 or 6 membered heteroaromatic ring Y, optionally independently substituted with a substituent from the group U, wherein Y is a ring selected from Y1 to Y29
  • Z is hydrogen, cyano, nitro, hydroxyl, Ci-C4alkyl, C1-C4 haloalkyi, Ci-C4alkoxy, C1-C4 haloalkoxy, C1-C4 haloalkoxy-Ci-C4alkyl or Ci-C4alkoxy-Ci-C4alkyl;
  • n 0, 1, 2, or 3;
  • U is independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, amino, Ci-C4alkyl, C1-C4 haloalkyi, Ci-C4alkoxy, C1-C4 haloalkoxy, C1-C4 haloalkoxy-Ci-C4alkyl, Ci-C4alkoxy- Ci-C4alkyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, Ci-C4 aloalkylsulfonyl, formyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C1-C6 alkylcarbonyl and C3-C6 cycloalkylcarbonyl; and
  • R 5 is hydrogen, -OR 6 , -NR 8 R/, -N(R 8 )N(R 8 R7); or
  • R5 is a 5 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can be mono- or polysubstituted by substituents independently selected from the group U2; or
  • R5 is a 3 to 12 membered heteroaromatic ring, or a 3 to 12 membered saturated or partially saturated heterocyclic ring, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said 3 to 12-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2; or
  • R5 is C3-C6 cycloalkyl, which can be mono- or poly-substituted by substituents independently selected from the group U3; or
  • R5 is C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or
  • R5 is C2-C4 alkenyl which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or
  • R5 is C2-C4 alkynyl which can optionally be mono- or poly-substituted by substituents independently selected from the group U3;
  • U2 is selected from the group consisting of halogen, nitro, cyano, amino, hydroxyl, -SCN, -CO2H,
  • U3 is selected from the group consisting of halogen, nitro, cyano, amino, hydroxyl, -SCN, -CO2H, C1-C6 alkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkyl-Ci-C4 alkyl, C3-C6 halocycloalkyl- C1-C4 alkyl,C1-C6 haloalkyl, Ci-C6 alkoxy, Ci-C4 alkoxy-Ci-C4 alkyl, Ci-C4 alkoxy-Ci-C4 alkoxy, cyano- C1-C4 alkyl, cyano-Ci-C4 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 haloalk
  • U3 is a 5 to 6 membered aromatic ring, 5 to 6 membered heteroaromatic ring, or 5 to 6 membered saturated or partially saturated carbocyclic or heterocyclic ring system, wherein heteroaromatic or heterocyclic ring can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen substituted or not, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, said 5 to 6-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2;
  • R6 is selected from the group consisting of hydrogen, amino, Ci-C6 alkyl, Ci-C6 haloalkyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, Ci-C4 alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C6 cycloalkyl, cyano-Ci-C4 alkyl, cyano-C
  • Re is selected from the group consisting of hydrogen, hydroxyl, cyano, Ci-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, Ci-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, C1-C4
  • alkylsulfanyl Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl, pyridyl and pyrimidyl, wherein said phenyl, pyridyl or pyrimidyl ring system can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, C
  • R7 is selected from the group consisting of hydrogen, cyano, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, C1-C4 alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 halo
  • Compounds of formula I which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as Ci-C4alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid , or with organic sulfonic acids, such as Ci-C4-alkane- or arylsulfonic acids which are
  • halogen for example methane- or p-toluenesulfonic acid.
  • Compounds of formula I which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.
  • bases for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts
  • salts with ammonia or an organic amine such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethy
  • the compounds of formula I are mesoionic compounds (also known as inner salts or zwitterions), which are understood to be compounds that are neutral but carry a formal positive and a negative charge on different atoms within the compounds.
  • mesoionic compounds also known as inner salts or zwitterions
  • compounds according to the present invention can be represented by any one of the charge distribution above.
  • alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, hexyl, nonyl, decyl and their branched isomers.
  • Alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned.
  • the alkenyl and alkynyl groups can be mono- or polyunsaturated.
  • Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl.
  • a haloalkyl group is an alkyl group having one or more independently selected halogen atoms on the alkyl group.
  • Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 , 1 - difluoro-2,2,2-trichloroethyl, 2,2,3, 3-tetrafluoroethyl and 2,2,2-trichloroethyl.
  • Alkoxy group is an alkyl group connected to an oxygen atom, wherein the alkoxy group is connected to the rest of the compound via the oxygen atom.
  • Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert-butoxy and also the isomeric pentyloxy and hexyloxy radicals.
  • a cycloalkyl group has at least three carbon atoms in a ring, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl, preferably cyclopropyl.
  • a haloalkoxy group is an alkoxy group having one or more independently selected halogen atoms on the alkyl group of the alkoxy group.
  • Haloalkoxy is, for example, difluoromethoxy, trifluoromethoxy or 2,2,2-trifluoroethoxy.
  • An alkoxyalkyl group has one or more alkoxy groups and an alkyl group, wherein the alkoxy groups are in a chain with one of the oxygen atoms of the alkoxy chain connected to the alkyl group, which alkoxyalkyl group is connected to the rest of the compound via a carbon atom of the alkyl group.
  • Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n- propoxymethyl, n-propoxyethyl, isopropoxymethyl, isopropoxyethyl or a dialkoxyalkyi group such as for example CH30CH2CH20CH2-.
  • a haloalkoxyalkyl group is an alkoxyalkyl group having one or more independently selected halogen atoms on the alkoxyalkyl group (for example the halogenation can be on the carbon atoms forming part of the alkyl and/or any one of the alkoxy group).
  • haloalkoxyalkyl are, trifluoromethyloxymethyl, trifluoromethyloxyethyl, methoxyfluromethyl, trifluoroethyloxymethyl or a dihaloalkoxyalkyl group such as for example CF30CH2CH20CH2-, CH30CH2CF20CH2-,
  • alkylcarbonyl group is an alkyl group connected to a carbonyl group, which alkylcarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl moiety. Examples are CH3C(0)-, and (CH3)2CHC(0)-.
  • a cycloalkylcarbonyl group is a cycloalkyl group connected to a carbonyl group, which
  • cycloalkylcarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl moiety. Examples are cyclopropylC(O)-, and cyclobutylC(O)-.
  • a cycloalkylalkyl group is a cycloalkyl group connected to an alkyl group, which cycloalkylalkyl group is connected to the rest of the compound via a carbon atom of the alkyl group.
  • Examples are - CyclopropylCH2-, and Cyclopropyl(CH3)CH-.
  • a haloalkylcarbonyl group is an alkylcarbonyl group, wherein the alkyl group has one or more halogen atoms, which haloalkylcarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl moiety.
  • An example of such is CF3C(0)-.
  • An alkoxycarbonyl group is an alkoxy group connected to the carbon atom of a carbonyl group via the oxygen of the alkoxy group, which alkoxycarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl group.
  • An example is CH30C(0)-.
  • An haloalkoxycarbonyl group is an alkoxycarbonyl group wherein the alkoxy group is halogenated by one or more independently selected halogen atoms, for example, CF30C(0)-.
  • An alkylcarbonylamino group is an alkylcarbonyl group connected to the nitogen atom of an amino group via the carbon atom of the carbonyl group, which alkylcarbonylamino group is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example CH3C(0)NH-.
  • a cycloalkylcarbonylamino group is a cycloalkylcarbonyl group connected to the nitogen atom of an amino group via the carbon atom of the carbonyl group, which cycloalkylcarbonylamino is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example, cyclopropylC(0)NH-.
  • An alkylaminocarbonyl group has an alkyl group, an amino group and a carbonyl group, wherein a carbon atom of the the alkyl group is connected to a nitrogen atom of the amino group and then a nitrogen atom of the amino group is connected to the carbon atom of the carbonyl group, which alkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example, CH3NHC(0) -.
  • a cycloalkylaminocarbonyl group has a cycloalkyi group, an amino group and a carbonyl group, wherein a carbon atom of the cycloalkyi group is connected to a nitrogen atom of the amino group and then a nitrogen atom of the amino group is connected to the carbon atom of the carbonyl group, which cycloalkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example, cyclopropylNHC(O) -.
  • a haloalkylcarbonylamino group is an alkylcarbonylamino group having one or more independently selected halogen atoms on the alkyl group, which haloalkylcarbonylamino group is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example, CFH2C(0)NH-.
  • a halocycloalkylcarbonylamino group is an cycloalkylcarbonylamino group having one or more independently selected halogen atoms on the cycloalkyi group, which halocycloalkylcarbonylamino group is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example, 2-fluoro-cyclopropylC(0)NH-.
  • a haloalkylaminocarbonyl group is an alkylaminocarbonyl group having one or more independently selected halogen atoms on the alkyl group, which haloalkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example, CFH2NHC(0) -.
  • a halocycloalkylaminocarbonyl group is a cycloalkylaminocarbonyl group having one or more independently selected halogen atoms on the cycloalkyi group, which halocycloalkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example 2-fluorocyclopropylNHC(0) -.
  • mono- to poly-substituted in the definition of the substituents, means typically, depending on the chemical structure of the substituents, generally mono-substituted to seven-times substituted, preferably mono-substituted to five-times substituted, more preferably mono-, di- or tri-substituted.
  • C2-C6 alkynyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • C2-C4alkynyl and C2-C3alkynyl are to be construed accordingly.
  • Examples of C2-C6 alkynyl include, but are not limited to, ethynyl, prop-1-ynyl, but-1-ynyl and but-2-ynyl.
  • C2-C6 alkenyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • C2-C4alkenyl and “C2-C3alkenyl” are to be defined accordingly.
  • Examples of C2-C6 alkenyl include, but are not limited to prop-1-enyl, but-1-enyl and but-2-enyl.
  • Alkylsulfanyl is for example methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, pentylsulfanyl and hexylsulfanyl.
  • Alkylsulfinyl is for example methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, a butylsulfinyl, pentylsulfinyl or hexylsulfinyl.
  • Alkylsulfonyl is for example methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, pentylsulfonyl or hexylsulfonyl.
  • Haloalkylsulfanyl is for example difluoromethylsulfanyl, trifluoromethylsulfanyl, 2,2,2- trifluoroethylsulfanyl or pentafluoroethylsulfanyl.
  • Haloalkylsulfinyl is for example difluoromethylsulfinyl, trifluoromethylsulfinyl, 2,2,2- trifluoroethylsulfinyl or pentafluoroethylsulfinyl.
  • Haloalkylsulfonyl is for example difluoromethylsulfonyl, trifluoromethylsulfonyl, 2,2,2- trifluoroethylsulfonyl or pentafluoroethylsulfonyl.
  • Examples of a 5 to 12 membered aromatic ring system which can be monocyclic or polycyclic, include phenyl, naphthyl, anthracenyl and biphenyl; preferred are phenyl, naphthyl, and biphenyl.
  • Examples of a 3 to 12 membered heteroaromatic ring system which can be monocyclic or polycyclic, include pyridyl, pyrimidyl, pyrrolyl, pyrazolyl, furyl, thienyl, imidazolyl, isoxazolyl, oxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyrazinyl, pyridazinyl, triazinyl, pyranyl, quinazolinyl, isoquinolinyl, indolizinyl, isobenzofuranylnaphthyridinyl, quinoxalinyl, isochinolinyl, cinnolinyl, phthalazinyl, benzothiazolyl, benzoxazolyl, benzotriazolyl, indazolyl, indolyl
  • Examples of a 3 to 12 membered saturated or partially saturated heterocyclic ring system which can be monocyclic or polycyclic, include dihydropyranyl, tetrahydrofuryl, tetrahydrofuranyl, tetrahydrothienyl, pyrrolidinyl, pyrrolidinyl, isoxazolidinyl, isothiazolidinyl, pyrazolidinyl, oxazolidinyl, thiazolidinyl, imidazolidinyl, oxadiazolidinyl,thiadiazolidinyl, dihydrofuryl, dihydrothienyl, pyrrolinyl, isoxazolinyl, dihydropyrazolyl, dihydrooxazolyl, piperidinyl, dioxanyl, tetrahydropyranyl,
  • tetrahydrothienyl hexahydropyridazinyl, hexahydropyrimidinyl, oxiranyl, and piperazinyl; preferred is tetrahydrofuryl.
  • Example of a 5 to 6 membered aromatic ring system includes phenyl.
  • Examples of a 5 to 6 membered heteroaromatic ring system include pyridyl, pyrimidyl, pyrrolyl, pyrazolyl, furyl, thienyl, imidazolyl, isoxazolyl, oxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyrazinyl, pyridazinyl, triazinyl, and pyranyl; preferred are pyridyl, pyrimidyl, and thienyl.
  • Examples of a 5 to 6 membered saturated or partially saturated carbocyclic or heterocyclic ring system include dihydropyranyl, tetrahydrofuryl, tetrahydrofuranyl, tetrahydrothienyl, pyrrolidinyl, pyrrolidinyl, isoxazolidinyl, isothiazolidinyl, pyrazolidinyl, oxazolidinyl, thiazolidinyl, imidazolidinyl, oxadiazolidinyl,thiadiazolidinyl, dihydrofuryl, dihydrothienyl, pyrrolinyl, isoxazolinyl, dihydropyrazolyl, dihydrooxazolyl, piperidinyl, dioxanyl, tetrahydropyranyl, tetrahydrothienyl, hexahydropyridazinyl, hexahydropyrimidinyl,
  • Polycyclic as used herein refers to fused cyclic rings, and substituted cyclic rings, in which the substituent is another cyclic ring (such as an aryl or heteroaryl ring).
  • An example of a fused ring is naphthyl or benzisoxazolyl or benzoxazolyl, whereas an example of a substituted ring is biphenyl or 2- phenylpyridyl or 2-pyridylphenyl.
  • a “ring system” as used herein refers in entirety to the ring substitutent whether monocyclic or polycyclic.
  • Rs being a 3 to 12 membered heteroaromatic ring, which ring system can contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said 3 to 12-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2", the ring sytem refers to the fact that only 1 to 4 heteroatoms can be present in total and not per ring.
  • the compounds of formula I according to the invention also include hydrates which may be formed during the salt formation.
  • V is O.
  • U is halogen, cyano, Ci-
  • n is 0 or 1.
  • U2 is halogen, cyano, Ci- Ce alkyl, Ci-C6 alkoxy, or Ci-C6 haloalkyl; preferably U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or Ci-C4 alkoxy.
  • U2 is chloro, fluoro, cyano, methyl, cyclopropyl, trifluoromethyl or methoxy.
  • U3 is halogen, nitro, cyano, Ci-C6 alkyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, Ci-C6 alkoxy,or a phenyl, optionally mono- or polysubstituted by substituents independently selected from the group U2; more preferably U3 is halogen or phenyl; especially U3 is fluoro or phenyl
  • Z is cyano, Ci-C4 alkyl, C1-C4 haloalkyl, Ci-C4 alkoxy, or C1-C4 haloalkoxy; preferably Z is Ci-C4 alkyl; more preferably Z is methyl.
  • Ri a , Rib, Ric and Rid are independently selected from hydrogen, Ci-C6alkyl, Ci-C6 alkoxy, and Ci-C6 haloalkyl.
  • Rib, Ri c and Rid are each hydrogen and Ri a is hydrogen, Ci-C6alkyl, Ci-C6 alkoxy or C1-C6 haloalkyl; more preferably Rib, Ric and Rid are each hydrogen and Ria is hydrogen, Ci-C4alkyl, Ci-C4 alkoxy or C1-C4 haloalkyl; and especially Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl.
  • R2 is hydrogen, C1-C6 alkyl, or mono- or poly-substituted Ci-C6 alkyl, where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, Ci-C6 haloalkoxy, Ci-C6 alkoxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and C1-C6 haloalkylsulfonyl; preferably R2 is hydrogen, C1-C6 alkyl, or mono- or poly- substituted C1-C6 alkyl, where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano,
  • R3 is hydrogen or C1-C4 alkyl; preferably R3 is hydrogen, methyl, ethyl, or propyl; more preferably R3 is hydrogen, methyl, or ethyl; especially R3 is hydrogen, or methyl.
  • R4 is a heteroaromatic ring Y selected from Y1 to Y29 independently substituted with a substituent from the group U, wherein n, Z and U are as defined in the first aspect; preferably R4 is heteroaromatic ring Y selected from selected from Y1 , Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined herein; more preferably R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined herein.
  • R5 is a 5 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 as defined herein; preferably R5 is 6 to 12, more preferably 6, 10 and 12 membered aromatic rings, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 as defined herein; more preferably R5 is phenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2 as defined herein.
  • R5 is a 3 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein.
  • R5 is a 5 to 12, more preferably 5, 6, 10 or 12, membered heteroaromatic ring, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein.
  • R5 is a thiophenyl, pyridyl, or pyridylphenyl, and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein U2 is as defined herein.
  • R5 is a 3 to 12 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein.
  • R5 is a 3 to 6, more preferably 3, 5 and 6, membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein. More preferably R5 is a tetrahydrofuryl.
  • R5 is C3-C6 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is defined herein.
  • R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is as defined herein.
  • R5 is C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is as defined herein.
  • R5 is C1-C4 alkyl, which can optionally be mono- or poly- substituted by substituents independently selected from the group U3 wherein U3 is as defined herein.
  • R5 is C1-C4 alkyl, C1-C4 haloalkyl or phenyl-Ci-C4 alkyl.
  • R5 is methyl, trifluoromethyl, heptafluoropropyl or benzyl.
  • V is oxygen
  • Ri a , Rib, Ric and Rid are independently selected from hydrogen, Ci-C6alkyl, Ci-C6 alkoxy, or C1-C6 haloalkyl
  • R2 is hydrogen, C1-C6 alkyl, or mono- or poly-substituted C1-C6 alkyl, where the substiuents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, Ci-C6 haloalkoxy, Ci-C6 alkoxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and C1-C6 haloalkylsulfonyl; R3 is hydrogen or C1-C4 alkyl
  • V is oxygen; Rib, Ri c and Rid are each hydrogen and Ria is hydrogen, Ci-C6alkyl, C1-C6 alkoxy or C1-C6 haloalkyl; R2 is hydrogen, C1-C6 alkyl, or mono- or poly- substituted C1-C6 alkyl, where the substiuents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, and C1-C6 alkoxy; R3 is hydrogen, methyl, ethyl, or propyl; R4 is heteroaromatic ring Y selected from selected from Y1 , Y4, Y9 and Y12; and R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a
  • Preferred compounds of formula I are where V is oxygen; Ri b, Ri c and Rid are each hydrogen and Ria is hydrogen, Ci-C4alkyl, Ci-C4 alkoxy or C1-C4 haloalkyi; R2 is hydrogen, Ci-C4 alkyl or mono- substituted Ci-C4 alkyl, where the substiuents are selected from the group consisting of halogen, hydroxyl, amino, and cyano; R3 is hydrogen, or methyl, or ethyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms
  • Preferred compounds of formula I are where V is oxygen; Ri b, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5 to 12 membered heteroaromatic ring system, or 5 to 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen
  • V is oxygen; Rib, Ri c and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6, 10 or 12 membered aromatic ring, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5, 6, 10 or 12 membered heteroaromatic ring system, or 5, 6, 10 or 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said
  • V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, biphenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is pyridyl, pyrimidyl, phenylpyridyl, pyridylphenyl, thienyl or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3;
  • V is each oxygen; Rib, Ri c and Rid are each hydrogen and Ri a is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is Cs cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; U is halogen; U2 is halogen, cyano, C1-C4 alkyl, C3-C6 cycloal
  • V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6, 10 or 12 membered aromatic ring, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5, 6, 10 or 12 membered heteroaromatic ring system, or 5, 6, 10 or 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system
  • V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6, 10 or 12 membered aromatic ring, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5, 6, 10 or 12 membered heteroaromatic ring system, or 5, 6, 10 or 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be
  • Preferred compounds of formula I are where V is oxygen; Rib, Ri c and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, biphenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is pyridyl, pyrimidyl, phenylpyridyl, pyridylphenyl, thienyl or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n
  • V is each oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; U is halogen; U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy ; and U3 is halogen or phenyl.
  • V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is biphenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is pyrimidyl, phenylpyridyl, pyridylphenyl, or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; wherein n is 0 or 1 ; U is halogen; and U2 is halogen, cyano, C1-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or
  • Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is selected from the groups (i) to (iii): (i) benzyl, 3-CI-Phenyl, 3,5-diCI-Phenyl, 2-CI-Phenyl, 2-F-Phenyl, 4-F- Phenyl, 3-l-Phenyl, 2-methyl-Phenyl, 3,5-diBr-Phenyl, ,3-Br-5-CF 3 -Phenyl, 3-Br-5-OCF 3 -Phenyl, 3- OCF 3 -Phenyl, 3-SCH 3 -Phenyl, 4-methoxy-Phenyl, 3-methoxy-Phen
  • a substiutent list (e.g. Z or Lh or U3) is used in more than one substiuent in the compound
  • the substituent list is independently selected for each substituent (e..g in the instance of Z, it can be used on the nitrogen atom of the ring Y29, and also on atom of the heteroatomic ring F3 ⁇ 4; or in the instance of U2, it can be a substituent on the 5 to 12 membered aromatic ring Rs and also on a 5 or 6 membered aromatic ring R5; or in the instance of U3, it can be a substiuent on C3-C6 cycloalkyl R5 or Ci-Ce alkyl R 5 , etc),
  • the compounds according to the invention can be prepared by methods known to those skilled in the art, in particular, for example, see Canadian Journal of Chemistry (1971 ), 49(4), 668-71 or Journal of the Chemical Society (1959), 2865-71.
  • the compounds of formula III wherein Ria, Rib, Ric and Rid as described under formula I above and wherein R is a C1-C4 alkyl, can be prepared from compounds of formula 111 wherein Ria, Rib, Ric and Rid are as described in formula I, via alkylation of compound 111 with compound of formula IV1 wherein R is a C1-C4 alkyl, in presence of a base, such as lithium amide, in a appropriate solvent such as for example toluene, to generate a compound of formula III at temperatures between -20 and 150°C, preferably between 20°C and 130°C. .
  • a base such as lithium amide
  • a appropriate solvent such as for example toluene
  • the compound of formula III wherein Ria, Rib, Ric, Rid are as described under formula I above and wherein R is a C1-C4 alkyl
  • R is a C1-C4 alkyl
  • the compound of formula III can be prepared from compounds of formula II2 via palladium coupling (Buchwald-Hartwig cross coupling), which involves for example, reacting compounds of formula II2, wherein Ria, Rib, Ric and Rid are as described in formula I and wherein X is a leaving group, for example, chlorine, bromine or iodine with, for example, compounds of formula IV2 wherein R is a C1-C4 alkyl.
  • the reaction can be catalyzed by a palladium based catalyst, for example palladium acetate, in presence of a base, like cesium carbonate or sodium tert-butoxide, in a solvent or a solvent mixture, like, for example toluene, preferably under inert atmosphere and in presence of chelating phosphine such as BINAP or Xamtphos.
  • a palladium based catalyst for example palladium acetate
  • a base like cesium carbonate or sodium tert-butoxide
  • a solvent or a solvent mixture like, for example toluene
  • BINAP chelating phosphine
  • Xamtphos chelating phosphine
  • compounds of formula III wherein Ria, Rib, Ric and Rid are as defined in formula I above, and R is a C1-C4 alkyl
  • R is a C1-C4 alkyl
  • nucleophile substitution which involves for example, reaction of compounds of formula II2, wherein X is a leaving group, for example, fluorine with compounds of formula IV2 wherein R is a C1-C4 alkyl, under basic condition or not, with or without solvent, via heating or under microwave irradiation (see for example WO2016029146 or Journal of the Chemical Society, Perkin T 1 Organic and Bio-Organic Chemistry 1980, p 132).
  • the preparation of compounds of formula IV, wherein Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above and R is C1-C4 alkyl from compounds of formula III wherein Ria, Rib, Ric and Rid are as described under formula I above and R is C1-C4 alkyl, may involve (scheme 2) alkylation of compound III with R2R3R4C-XLG wherein R2, R3 and R4 are as described under formula I above and wherein XLG is a leaving group, such as a halogen, preferably iodine, bromine or chlorine, in presence of a base, such as butyllithium or sodium hydride, in a appropriate solvent such as for example tetrahydrofuran, N,N-dimethylformamide, ⁇ , ⁇ -dimethylacetamide or acetonitrile, at temperatures between -78°C and 150°C, preferably between -78°C and 50°C.
  • the reactants can be reacted in the presence of a base.
  • suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines.
  • sodium hydroxide sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert- butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine,
  • the reactants can be reacted with each other as such, i.e. without adding a solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture of these. If the reaction is carried out in the presence of a base, bases which are employed in excess, such as triethylamine, pyridine, N-methylmorpholine or ⁇ , ⁇ -diethylaniline, may also act as solvents or diluents.
  • the reaction is advantageously carried out in a temperature range from approximately -80°C to approximately +140°C, preferably from approximately -30°C to approximately +100°C, in many cases in the range between ambient temperature and approximately +80°C.
  • a compound of formula I can be converted in a manner known per se into another compound of formula I by replacing one or more substituents of the starting compound of formula I in the customary manner by (an)other substituent(s) according to the invention.
  • Salts of compounds of formula I can be prepared in a manner known per se.
  • acid addition salts of compounds of formula I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
  • Salts of compounds of formula I can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.
  • Salts of compounds of formula I can be converted in a manner known per se into other salts of compounds of formula I, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
  • a salt of inorganic acid such as hydrochloride
  • a suitable metal salt such as a sodium, barium or silver salt
  • the compounds of formula I which have salt-forming properties, can be obtained in free form or in the form of salts.
  • the compounds of formula I and, where appropriate, the tautomer's thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule, the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.
  • Diastereomer mixtures or racemate mixtures of compounds of formula I, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
  • Enantiomer mixtures such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl cellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the di
  • Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.
  • V is S
  • a suitable agent for example the Lawesson reagent or diphosphorus pentasulfide in presence of a solvent or not such as dimethylformamide.
  • Such reactions are known to the person skilled in the art and are described, for example, Tetrahedron, 63(48), 1 1862-1 1877, 2007, Inorganic Chemistry, 43(21), 6534-6536, 2004 or Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, Fourth Edition by Jerry March, 1992 (Publisher Wiley New York, N. Y.) pages 1 184-1 185.
  • the compounds of formula I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
  • the present invention provides a compound of formula IV
  • Ri a , Rib, Ric, Rid, R2, and R3 are as defined in formula l ⁇ and R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined in formula I; and R is Ci-C4 alkyl; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula IV.
  • R is methyl or ethyl.
  • the present invention provides a compound of formula V
  • Ri a , Rib, Ric, Rid, R2, and R3 are as defined in formula I; and R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12, substituted with a substituent from the group U, wherein n and U are as defined in formula I; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula V.
  • the present invention provides a compound of formula VI
  • R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined in formula I; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula VI.
  • the present invention makes available a process for preparing a compound of formula la, wherein (1 ) a compound of formula III is prepared from compound of formula 111 via alkylation with a compound of formula IV1 , in presence of a base to generate a compound of formula III; or the compound of formula III is prepared from a compound of formula II2 via palladium coupling with a compound of formula IV2; or a compound of formula III is prepared by nucleophile substitution, in presence of a base, with a compound of formula IV2;
  • a compound of formula IV is prepared from a compound of formula III by alkylation with R2R3R4C-
  • a compound of formula V is prepared from a compound of formula IV by cleavage of the acetal group to aldehyde in presence of an acid;
  • a compound of formula la is prepared from a compound of formula VI by cyclisation and acylation in presence of an anhydride of formula Vila or acid halide of formula Vllb,
  • R is C1-C4 alkyl
  • XLG and X are independently of each other a leaving group
  • Ri a , Ri b, Ric and Rid, R2, R3, R4 and R5 are as described for formula I herein.
  • Table 1 This table discloses 139 com ounds of the formula I:
  • the compounds of formula I (including compounds of formula la and lb) according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warmblooded species, fish and plants.
  • the compounds of formula I are safe towards non-target species, such as bees, and accordingly have a good toxicity profile.
  • the active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina.
  • the insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e.
  • Hyalomma spp. Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp, Polyphagotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.,
  • Haematopinus spp. Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp., from the order Coleoptera, for example, Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp, Astylus atromaculatus, Ataenius spp, Atomaria linearis, Chaetocnema tibialis, Cerotoma spp, Conoderus spp, Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp, Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, La
  • Acyrthosium pisum Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicoryne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp, Cofana spec
  • Macrosiphum spp. Mahanarva spp, Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria
  • Coptotermes spp Coptotermes spp, Corniternes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp., Solenopsis geminate
  • Siphonaptera for example, Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis
  • Thysanoptera for example
  • Thysanura for example, Lepisma saccharina.
  • the active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests.
  • Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum, beet, such as sugar or fodder beet, fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries, leguminous crops, such as beans, lentils, peas or soya, oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts, cucurbits, such as pumpkins, cucumbers or melons, fibre plants, such as cotton, flax, hemp or jute, citrus fruit, such as oranges, lemons, grapefruit or tangerines, vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers, Lauraceae, such as avocado, Cinnamonium or camphor, and also tobacco, nuts,
  • the active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Thrips tabaci, Euschistus heros, Heliothis virescens, Myzus persicae, Plutella xylostella and Spodoptera littoralis in cotton, vegetable, maize, rice and soya crops.
  • the active ingredients according to the invention are further especially suitable for controlling Mamestra
  • Cydia pomonella preferably in apples
  • Empoasca preferably in vegetables, vineyards
  • Leptinotarsa preferably in potatos
  • Chilo supressalis preferably in rice
  • the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species, cyst-forming nematodes, Globodera rostochiensis and other Globodera species, Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species, Seed gall nematodes, Anguina species, Stem and foliar nematodes, Aphelenchoides species, Sting nematodes, Belonolai
  • Pratylenchus species Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans,
  • the compounds of the invention may also have activity against the molluscs.
  • examples of which include, for example, Ampullariidae, Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus),
  • Bradybaenidae (Bradybaena fruticum), Cepaea (C. hortensis, C. Nemoralis), ochlodina, Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum), Discus (D. rotundatus), Euomphalia, Galba (G. trunculata), Helicelia (H. itala, H. obvia), Helicidae Helicigona arbustorum), Helicodiscus, Helix (H. aperta), Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L.
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from Bacillus cereus or Bacillus popilliae, or insecticidal proteins from Bacillus thuringiensis, such as ⁇ -endotoxins, e.g. CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A, or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus, toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins, toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins, agglutinins, proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors, ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin, steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdy
  • ⁇ -endotoxins for example CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins.
  • Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ).
  • Truncated toxins for example a truncated CrylAb, are known.
  • modified toxins one or more amino acids of the naturally occurring toxin are replaced.
  • amino acid replacements preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
  • Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
  • Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.
  • the toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects.
  • insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).
  • Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin), YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin), YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin), Starlink® (maize variety that expresses a Cry9C toxin), Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium), NuCOTN 33B® (cotton variety that expresses a Cry1 Ac toxin), Bollgard I® (cotton variety that expresses a
  • transgenic crops are:
  • Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated CrylAb toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
  • MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
  • NK603 * MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810.
  • NK603 * MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain
  • Lepidoptera include the European corn borer.
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225).
  • PRPs pathogenesis-related proteins
  • Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818 and EP-A-0 353 191.
  • the methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • Crops may also be modified for enhanced resistance to fungal (for example Fusarium,
  • Anthracnose, or Phytophthora bacterial (for example Pseudomonas) or viral (for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus) pathogens.
  • bacterial for example Pseudomonas
  • viral for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus
  • Crops also include those that have enhanced resistance to nematodes, such as the soybean cyst nematode. Crops that are tolerance to abiotic stress include those that have enhanced tolerance to drought, high salt, high temperature, chill, frost, or light radiation, for example through expression of NF-YB or other proteins known in the art.
  • Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1 , KP4 or KP6 toxins, stilbene synthases, bibenzyl synthases, chitinases, glucanases, the so- called “pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225), antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called "plant disease resistance genes", as described in WO 03/000906).
  • ion channel blockers such as blockers for sodium and calcium channels
  • PRPs the so- called "pathogenesis-related proteins”
  • antipathogenic substances produced by microorganisms for example peptide antibiotics or heterocyclic antibiotics (see e.g
  • compositions according to the invention are the protection of stored goods and store ambients and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.
  • the present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors, see also https://www.who.int/malaria/vector_control/irs/en/).
  • the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping.
  • an IRS indoor residual spraying
  • a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention.
  • compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.
  • a substrate selected from nonwoven and fabric material comprising a composition which contains a compound of formula I.
  • the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate.
  • a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate.
  • Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention.
  • an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface.
  • it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.
  • Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like.
  • the polyesters are particularly suitable.
  • the methods of textile treatment are known, e.g. WO 2008/151984, WO 03/034823, US 5631072, WO 2005/64072, WO 2006/128870, EP 1724392, WO 20051 13886 or WO 2007/090739.
  • Further areas of use of the compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.
  • the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following tables A and B:
  • Agrilus sayi Bayberry, Sweetfern
  • Rhododendron Rhadodendron, Azalea, Laurel, Poplar, Willow, Mulberry
  • Phloeotribus liminaris Peach, Cherry, Plum, Black
  • the present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs.
  • the present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults.
  • the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as Cyclocephala spp. (e.g. masked chafer, C. lurida),
  • white grubs such as Cyclocephala spp. (e.g. masked chafer, C. lurida)
  • Rhizotrogus spp. e.g. European chafer, R. majalis
  • Cotinus spp. e.g. Green June beetle, C. nitida
  • Popillia spp. e.g. Japanese beetle, P. japonica
  • Phyllophaga spp. e.g. May/June beetle
  • Ataenius spp. e.g. Black turfgrass ataenius, A. spretulus
  • Maladera spp. e.g. Asiatic garden beetle, M.
  • the present invention may also be used to control insect pests of turfgrass that are thatch dwelling, including armyworms (such as fall armyworm Spodoptera frugiperda, and common armyworm
  • the present invention may also be used to control insect pests of turfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), rhodesgrass mealybug (Antonina graminis), two-lined spittlebug (Propsapia bicincta), leafhoppers, cutworms (Noctuidae family), and greenbugs.
  • chinch bugs such as southern chinch bugs, Blissus insularis
  • Bermudagrass mite Eriophyes cynodoniensis
  • rhodesgrass mealybug Antonina graminis
  • two-lined spittlebug Propsapia bicincta
  • the present invention may also be used to control other pests of turfgrass such as red imported fire ants (Solenopsis invicta) that create ant mounds in turf.
  • red imported fire ants Solenopsis invicta
  • the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
  • Anoplurida Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.,
  • Nematocerina and Brachycerina for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysom
  • Siphonaptrida for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.,
  • Heteropterida for example Cimex spp., Triatoma spp., Rhodnius spp.,
  • Actinedida Prostigmata
  • Acaridida Acaridida
  • Acarapis spp. Cheyletiella spp., Ornitrocheyletia spp., Myobia spp., Psorergatesspp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp.
  • compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings.
  • compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium
  • rufovillosum Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec.,Tryptodendron spec, Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec, and Dinoderus minutus, and also hymenopterans such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus and Urocerus augur, and termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes,
  • Reticulitermes santonensis Reticulitermes lucifugus
  • Mastotermes darwiniensis Zootermopsis nevadensis and Coptotermes formosanus
  • bristletails such as Lepisma saccharina.
  • the compounds according to the invention can be used as pesticidal agents in unmodified form, but they are generally formulated into compositions in various ways using formulation adjuvants or addditives, such as carriers, solvents and surface-active substances.
  • formulation adjuvants or addditives such as carriers, solvents and surface-active substances.
  • the formulations can be in various physical forms, e.g.
  • Such formulations can either be used directly or diluted prior to use.
  • the dilutions can be made, for example, with water, liquid fertilisers,
  • micronutrients biological organisms, oil or solvents.
  • the formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions.
  • the active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.
  • the active ingredients can also be contained in very fine microcapsules.
  • Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release).
  • Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95 % by weight of the capsule weight.
  • the active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution.
  • the encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art.
  • very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the
  • microcapsules are not themselves encapsulated.
  • liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1 ,2-dichloropropane, diethanolamine, p- diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, A/,A/-dimethylformamide, dimethyl sulfoxide, 1 ,4- dioxane, di
  • Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances.
  • a large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use.
  • Surface- active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes.
  • Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate, salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate, alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate, alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate, soaps, such as sodium stearate, salts of alkylnaphthalenesulfonat.es, such as sodium dibutylnaphthalenesulfonate, dialkyl esters of sulfosuccinate salts, such as sodium di(2- ethylhexyl)sulfosuccinate, sorbitol esters, such as sorbitol oleate, quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol est
  • compositions according to the invention can include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives.
  • the amount of oil additive in the composition according to the invention is generally from 0.01 to 10 %, based on the mixture to be applied.
  • the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared.
  • Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow.
  • Preferred oil additives comprise alkyl esters of C8-C22 fatty acids, especially the methyl derivatives of C12-C18 fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively).
  • Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10 th Edition, Southern Illinois University, 2010.
  • inventive compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to
  • a formula- tion adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance.
  • the rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop.
  • a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to
  • Preferred formulations can have the following compositions (weight %):
  • Emulsifiable concentrates are:
  • active ingredient 1 to 95 %, preferably 60 to 90 %
  • surface-active agent 1 to 30 %, preferably 5 to 20 %
  • liquid carrier 1 to 80 %, preferably 1 to 35 %
  • active ingredient 0.1 to 10 %, preferably 0.1 to 5 %
  • solid carrier 99.9 to 90 %, preferably 99.9 to 99 %
  • active ingredient 5 to 75 %, preferably 10 to 50 %
  • surface-active agent 1 to 40 %, preferably 2 to 30 %
  • active ingredient 0.5 to 90 %, preferably 1 to 80 % surface-active agent: 0.5 to 20 %, preferably 1 to 15 %
  • solid carrier 5 to 95 %, preferably 15 to 90 %
  • active ingredient 0.1 to 30 %, preferably 0.1 to 15 %
  • solid carrier 99.5 to 70 %, preferably 97 to 85 %
  • the combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
  • the combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
  • Emulsions of any required dilution which can be used in plant protection, can be obtained from this concentrate by dilution with water.
  • Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
  • the combination is mixed and ground with the adjuvants, and the mixture is moistened with water.
  • the mixture is extruded and then dried in a stream of air.
  • the finely ground combination is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol.
  • Non-dusty coated granules are obtained in this manner.
  • the finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • the finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • 28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8: 1 ).
  • This mixture is emulsified in a mixture of 1 .2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51 .6 parts of water until the desired particle size is achieved.
  • To this emulsion a mixture of 2.8 parts 1 ,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.
  • the obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent.
  • the capsule suspension formulation contains 28% of the active ingredients.
  • the medium capsule diameter is 8-15 microns.
  • the resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
  • Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo- emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.
  • EC emulsion concentrate
  • SC suspension concentrate
  • SE suspo- emulsion
  • CS capsule suspension
  • WG water dispersible granule
  • the present invention makes available a pesticidal composition
  • a pesticidal composition comprising a compound of the first aspect, one or more formulation additives and a carrier.
  • compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/or fungicidally active ingredients.
  • mixtures of the compounds of formula I with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use.
  • Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.
  • TX means "one compound selected from the group consisting of the compounds described in Tables 1 and A of the present invention
  • an adjuvant selected from the group of substances consisting of petroleum oils (628) + TX
  • an acaricide selected from the group of substances consisting of 1 , 1-bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cy
  • an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hyd rated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,
  • an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin [CCN] + TX, ivermectin [CCN] + TX, milbemycin oxime [CCN] + TX, moxidectin [CCN] + TX, piperazine [CCN] + TX, selamectin [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,
  • an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1-hydroxy-1 /- -pyridine-2-thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + T
  • streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal [CCN] + TX, a biological agent selected from the group of substances consisting of Adoxophyes orana GV (12) + TX, Agrobacterium radiobacter (13) + TX, Amblyseius spp.
  • Steinernema spp. (742) + TX, Trichogramma spp. (826) + TX, Typhlodromus occidentalis (844) and Verticillium lecanii (848) + TX, a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,
  • a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir [CCN] + TX, busulfan [CCN] + TX, diflubenzuron (250) + TX, dimatif [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron [CCN] + TX, tepa [CCN] + TX, thiohempa [CCN] + TX, thiotepa [CCN] + TX, tretamine [CCN] and uredepa [CCN] + TX,
  • an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (lUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (lUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (lUPAC name) (541 ) + TX, (E,Z)-tetradeca-4, 10-dien-1-yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (lUPAC name) (285) + TX, (Z)-hexadec-l 1- enal (lUPAC name) (436) + TX, (Z)-hexadec-l 1-en-1-yl acetate (lUPAC name) (437) + TX, (Z)- hexade
  • an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (lUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX, an insecticide
  • a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913)
  • a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2- dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3- dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4- dichlorotetrahydrothiophene 1 ,1-dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4- chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3- ylacetic acid (lUPAC name) (1286
  • a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,
  • a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (720) + TX, a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione
  • a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (lUPAC name) (903) + TX, farnesol with nerolidol (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,
  • an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,
  • a virucide selected from the group of substances consisting of imanin [CCN] and ribavirin
  • a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX, and biologically active compounds selected from the group consisting of azaconazole (60207-31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [1 16255-48-2] + TX, cyproconazole [94361-06- 5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-24-3] + TX, epoxiconazole
  • Acinetobacter Iwoffii + TX Acremonium alternatum + TX + TX, Acremonium cephalosporium + TX + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter strain K84 (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX,
  • Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp.
  • Bacillus subtilis strain AQ178 + TX Bacillus subtilis strain QST 713 (CEASE® + TX, Serenade® + TX, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis var.
  • amyloliquefaciens strain FZB24 (Taegro® + TX, Rhizopro®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis CrylAb + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis israelensis (BMP123® + TX, Aquabac® + TX, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin® + TX, Deliver® + TX, CryMax® + TX, Bonide® + TX, Scutella WP® + TX, Turilav WP ® + TX, Astuto® + TX, Dipel WP® + TX, Biobit® + TX, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®
  • aizawai (XenTari® + TX, DiPel®) + TX, bacteria spp. (GROWMEND® + TX, GROWSWEET® + TX, Shootup®) + TX, bacteriophage of Clavipacter michiganensis (AgriPhage®) + TX, Bakflor® + TX, Beauveria bassiana (Beaugenic® + TX, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES® + TX, Mycotrol O® + TX, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz® + TX, Schweizer Beauveria® + TX, Melocont®) + TX, Beauveria spp. + TX, Botrytis cineria + TX, Bradyrhizobium japonicum
  • Chromobacterium subtsugae strain PRAA4-1T (Grandevo®) + TX, Cladosporium cladosporioides + TX, Cladosporium oxysporum + TX, Cladosporium chlorocephalum + TX, Cladosporium spp. + TX, Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp. + TX, Cryptococcus albidus (YIELDPLUS®) + TX, Cryptococcus humicola + TX, Cryptococcus infirmo-miniatus + TX,
  • Cryptococcus laurentii + TX TX
  • Cupriavidus campinensis + TX Cydia pomonella granulovirus (CYD-X®) + TX
  • Drechslera hawaiinensis + TX Enterobacter cloacae + TX
  • Enterobacteriaceae + TX Entomophtora virulenta (Vektor®) + TX
  • Epicoccum nigrum + TX Epicoccum purpurascens + TX, Epicoccum
  • TX Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean® / Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop® + TX, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp. (SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus
  • Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp.
  • TX Scytalidium uredinicola + TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X® + TX, Spexit®) + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, Spodoptera littoralis nucleopolyhedrovirus (Littovir®) + TX,
  • Trichoderma asperellum T34 Biocontrol®
  • Trichoderma gamsii TX
  • Trichoderma atroviride Plantmate®
  • Trichoderma harzianum rifai Mycostar®
  • Trichoderma harzianum T-22 Trianum- P® + TX, PlantShield HC® + TX, RootShield® + TX, Trianum-G®) + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma spp.
  • LC 52 (Sentinel®) + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma taxi + TX, Trichoderma virens + TX, Trichoderma virens (formerly Gliocladium virens GL-21 ) (SoilGuard®) + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX,
  • Plant extracts including: pine oil (Retenol®) + TX, azadirachtin (Plasma Neem Oil® + TX,
  • pheromones including: blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Codling Moth Pheromone (Paramount dispenser-(CM)/ Isomate C-Plus®) + TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Leafroller pheromone (3M MEC - LR Sprayable Pheromone®) + TX, Muscamone (Snip7 Fly Bait® + TX, Starbar Premium Fly Bait®) + TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable pheromone®) + TX, Peachtree Borer Pheromone (Isomate-P®) + TX, Tomato Pinworm Pheromone (3M Sprayable pheromone®) + TX, Entostat powder (extract from palm tree) (Exosex CM®) + TX, Tetradecatrienyl a
  • Macrobials including: Aphelinus abdominalis + TX, Aphidius ervi (Aphelinus-System®) + TX,
  • Acerophagus papaya + TX Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline® + TX, Andersoni-System®) + TX, Amblyseius californicus
  • TX Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug® + TX, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica + TX, Dacnusa sibirica
  • Diglyphus isaea (Diminex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea + TX, Diglyphus isaea (Miglyphus® + TX, Digline®) + TX, Dacnusa sibirica (DacDigline® + TX, Minex®) + TX, Diversinervus spp.
  • TX Psyttalia concolor (complex) + TX, Quadrastichus spp. + TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinemema carpocapsae (Nematac C® + TX, Millenium® + TX, BioNem C® + TX, NemAttack® + TX, Nemastar® + TX, Capsanem®) + TX, Steinemema feltiae (NemaShield® + TX, Nemasys F® + TX, BioNem F® + TX, Steinernema-System® + TX, NemAttack® + TX, Nemaplus® + TX, Exhibitline sf® + TX, Scia-
  • TX Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator, and
  • Pheromone trap Thripline ams® + TX, potassium bicarbonate (MilStop®) + TX, potassium salts of fatty acids (Sanova®) + TX, potassium silicate solution (Sil-Matrix®) + TX, potassium iodide + potassiumthiocyanate (Enzicur®) + TX, SuffOil-X® + TX, Spider venom + TX, Nosema locustae (Semaspore Organic Grasshopper Control®) + TX, Sticky traps (Trapline YF® + TX, Rebell Amarillo®) + TX and Traps (Takitrapline y + b®) + TX.
  • the ratio (by weight) of active ingredient mixture of the compounds of formula I selected from Tables 1 and A with active ingredients described above is from 100: 1 to 1 :6000, especially from 50: 1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10: 1 to 1 : 10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2: 1 to 1 :2, and a ratio of from 4: 1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 : 150, or 1 :35, or 2:35, or 4
  • the mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
  • the mixtures comprising a compound of formula I selected from Tables 1 and A and one or more active ingredients as described above can be applied, for example, in a single "ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days.
  • the order of applying the compounds of formula I selected from Tables 1 and A and the active ingredients as described above is not essential for working the present invention.
  • the present invention provides a combination of active ingredients comprising a compound defined in the first aspect, and one or more further active ingredients (whether chemical or biological).
  • compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
  • auxiliaries such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides
  • compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • compositions that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention.
  • Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient.
  • the rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha.
  • a preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question.
  • the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.
  • the compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type.
  • the propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing.
  • the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling.
  • These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention.
  • Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.
  • seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.
  • the present invention also comprises seeds coated or treated with or containing a compound of formula I.
  • coated or treated with and/or containing generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application.
  • the said seed product When the said seed product is (re)planted, it may absorb the active ingredient.
  • the present invention makes available a plant propagation material adhered thereto with a compound of formula I . Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound of formula I .
  • Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting.
  • the seed treatment application of the compound formula I can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds.
  • the compounds of the invention can be distinguished from other similar compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples below, using lower concentrations if necessary, for example 10 ppm, 5 ppm, 2 ppm, 1 ppm or 0.2 ppm; or lower application rates, such as 300, 200 or 100, mg of Al per m 2 .
  • An aspect of the present invention is a method of controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula I defined the first aspect, or a composition containing a compound of formula I defined the first aspect, to a pest, a locus of pest, preferably a plant, to a plant susceptible to attack by a pest or to plant propagation material thereof, such as a seed, provided if the the control were on a human or animal body, then it is non-therapeutical.
  • a further aspect is a plant propagation material comprising by way of treatment or coating one or more compounds of formula I defined the first aspect, optionally also comprising a colour pigment.
  • Mp means melting point in °C. Free radicals represent methyl groups. H and 9 F NMR measurements were recorded on Brucker 400MHz or 300MHz spectrometers, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated. Either one of the LCMS methods below was used to characterize the compounds. The characteristic LCMS values obtained for each compound were the retention time ("Rt", recorded in minutes) and the measured molecular ion (M+H) + and/or (M-H) ⁇ .
  • Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150°C, Desolvation Temperature: 350°C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector.
  • Step 11 -A Synthesis of N-(2,2-dimethoxyethyl)pyridin-2-amine
  • Step 11-B Synthesis of N-[(2-chlorothiazol-5-yl)methyll-N-(2,2-dimethoxyethyl)pyridin-2-amine (compound B5 in table B)
  • reaction mixture was stirred at 0°C for 4 hours, then the cooling bath was removed and the reaction mixture was stirred at 20°C for 1 1 hours. Water (a few drops) was added carefully and the reaction mixture was evaporated. The residue was submitted to flash chromatography over silica gel, eluting with a mixture of ethyl acetate and cyclohexane.
  • Step 11-C Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)aminolacetaldehyde (compound B1 in table B)
  • Step 11-D Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)aminolacetic acid (compound B2 in table B)
  • Step I2-A Synthesis of N-(2,2-dimethoxyethyl)-3-methyl-pyridin-2-amine
  • Step I2-B Synthesis of N-[(2-chlorothiazol-5-yl)methyll-N-(2,2-dimethoxyethyl)-3-methyl-pyridin-2- amine
  • Step I2-C Synthesis of 2-[(2-chlorothiazol-5-vnmethyl-(3-methyl-2-pyridvnaminolacetaldehyde (compound B3 in table B)
  • Step I2-D Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-(3-methyl-2-pyridyl)aminolacetic acid (compound B4 in table B
  • Step I3-A Synthesi -[(2-chlorothiazol-5-vnmethyll-3- trifluoromethvnpyridin-2-amine
  • Step I3-B Synthesis of N-allyl-N-[(2-chlorothiazol-5-vnmethyll-3-(trifluoromethyl)pyridin-2-amine (compound B8 in table B)
  • Step I3-C Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2- pyridyllaminolacetaldehyde (compound B9 in table B)
  • Step I3-D Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2-pyridyllaminolacetic
  • Step I3-B Synthesis of tert-butyl N-(2-pyridyl Carbamate
  • Step I3-C Synthesis of tert-butyl N-(2-pyridyl)-N-(pyrimidin-5-ylmethyl)carbamate
  • Step I3-E Synthesis of tert-butyl 2-[2-pyridyl(pyrimidin-5-ylmethyl)aminolacetate
  • Example I Preparation of 2-benzoyl-1-[(2-chlorothiazol-5-yl)methyllimidazo[1 ,2-alpyridin-1-ium-3- olate (example A1 in table A)
  • Example 2 1-[(2-chlorothiazol-5-yl)methyll-8-methyl-2-(2,2,2-trifluoroacetyl)imidazo[1 ,2-alpyridin-1- ium-3-olate (example A2 in table A)
  • Example 3 1-[(2-chlorothiazol-5-vnmethyll-2-(2,2,2-trifluoroacetvn-8-(trifluoromethvnimidazo[1 ,2- alpyridin-1-ium-3-olate (example A16 in table A)
  • Example 4 2-benzoyl-1-(pyrimidin-5-ylmethyl)imidazo[1 ,2-alpyridin-1-ium-3-olate (example A18 in table A)
  • Example 5 2-benzoyl-1-(pyrimidin-5-ylmethyl)imidazo[1 ,2-alpyridin-1-ium-3-olate (example A17 in table A)
  • Example I6 Preparation of 1-[(2-chlorothiazol-5-yl)methyl1-8-methyl-2-(2,2,2- trifluoroethylcarbamoyl)imidazo[1 ,2-a1pyridin-1-ium-3-olate (example A92 in table A)
  • Example 7 1-[(2-chlorothiazol-5-yl)methyll-8-methyl-2-[methyl(2,2,2-trifluoroethyl)carbamoyll- imidazo[1 ,2-alpyridin-1-ium-3-olate (example A91 in table A)
  • Example 8 Preparation of 2-[[3,5-bis(trifluoromethyl)phenyllcarbamothioyll-1-[(2-chlorothiazol-5- yl)methyllimidazo[1 ,2-alpyridin-1-ium-3-olate (example A123 in table A3)
  • Table A3 This table discloses compounds of the formula Id :
  • Ri a , Rib, Ric, and Rid are each Hydrogen, V is S and: .
  • Rib, Ri c , id, R3, R 4 are each Hydrogen, V is O, and:
  • Diabrotica balteata (Corn root worm)
  • Maize sprouts placed onto an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation.
  • Soybean leaves on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying the leaves were infested with N2 nymphs. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
  • Sunflower leaf discs were placed onto agar in a 24-well microtiter plate and sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying, the leaf discs were infested with an aphid population of mixed ages. The samples were assessed for mortality 6 days after infestation.
  • 24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
  • Spodoptera littoral is (Egyptian cotton leaf worm)
  • Cotton leaf discs were placed onto agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying the leaf discs were infested with five L1 larvae. The samples were assessed for mortality, anti-feeding effect, and growth inhibition in comparison to untreated samples 3 days after infestation. Control of Spodoptera littoralis by a test sample is given when at least one of the categories of mortality, anti-feedant effect, and growth inhibition is higher than the untreated sample.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.

Description

PESTICIDALLY ACTIVE MESOIONICS HETEROCYCLIC COMPOUNDS
The present invention relates to pesticidally active, in particular insecticidally active mesoionics heterocyclic compounds, to compositions comprising those compounds, and to their use for controlling animal pests (including arthropods and in particular insects or representatives of the order lepidoptera and coleoptera).
Mesoionics heterocyclic compounds with pesticidal action are known and described, for example, in WO09099929, W01 1017334, W01 1017347, W01 1017342, WO120921 15, WO12106495, W012136724, WO14033244, WO14202582, WO14167084, W016055431 , W016171053 and WO17093214.
There have now been found novel pesticidally active mesoionics heterocyclic compounds.
The present invention accordingly, in a first aspect, relates to compounds of formula I,
Figure imgf000002_0001
wherein
V is S or O;
Ria, Rib, Ric and Rid are independently selected from hydrogen, halogen, amino, hydroxyl, C1-C6 alkyl, C1-C6 haloalkyi, C1-C6 haloalkoxy, Ci-C6 alkoxy, C3-C6 cycloalkyl, C3-C6 halocycloalkyl and cyano;
R2 is hydrogen, halogen, hydroxyl, amino, cyano, C1-C6 alkyl, mono- or poly-substituted C1-C6 alkyl (where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, Ci-C6 alkoxy, Ci-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, Ci-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and Ci-C6 haloalkylsulfonyl), C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, triazole, pyrazole, imidazole, or tetrazole, wherein said triazole, pyrazole, imidazole and tetrazole can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, C1-C4 alkyl, Ci-C4 alkoxy, C1-C4 haloalkyi and cyano;
R3 is hydrogen or C1-C6 alkyl;
R4 is hydrogen or a 5 or 6 membered heteroaromatic ring Y, optionally independently substituted with a substituent from the group U, wherein Y is a ring selected from Y1 to Y29
Figure imgf000003_0001
wherein Z is hydrogen, cyano, nitro, hydroxyl, Ci-C4alkyl, C1-C4 haloalkyi, Ci-C4alkoxy, C1-C4 haloalkoxy, C1-C4 haloalkoxy-Ci-C4alkyl or Ci-C4alkoxy-Ci-C4alkyl;
n is 0, 1, 2, or 3;
U is independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, amino, Ci-C4alkyl, C1-C4 haloalkyi, Ci-C4alkoxy, C1-C4 haloalkoxy, C1-C4 haloalkoxy-Ci-C4alkyl, Ci-C4alkoxy- Ci-C4alkyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, Ci-C4 aloalkylsulfonyl, formyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C1-C6 alkylcarbonyl and C3-C6 cycloalkylcarbonyl; and
R5 is hydrogen, -OR6, -NR8R/, -N(R8)N(R8R7); or
R5 is a 5 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can be mono- or polysubstituted by substituents independently selected from the group U2; or
R5 is a 3 to 12 membered heteroaromatic ring, or a 3 to 12 membered saturated or partially saturated heterocyclic ring, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said 3 to 12-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2; or
R5 is C3-C6 cycloalkyl, which can be mono- or poly-substituted by substituents independently selected from the group U3; or
R5 is C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or
R5 is C2-C4 alkenyl which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or
R5 is C2-C4 alkynyl which can optionally be mono- or poly-substituted by substituents independently selected from the group U3;
U2 is selected from the group consisting of halogen, nitro, cyano, amino, hydroxyl, -SCN, -CO2H,
C1-C6 alkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkyl-Ci-C4 alkyl, C3-C6 halocycloalkyl- C1-C4 alkyl,Ci-C6 haloalkyl, Ci-C6 alkoxy, Ci-C4 alkoxy-Ci-C4 alkyl, Ci-C4 alkoxy-Ci-C4 alkoxy, cyano- C1-C4 alkyl, cyano-Ci-C4 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 haloalkoxy, Ci-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, Ci-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylcarbonyl, Ci-C6 alkoxycarbonyl, C1-C6 haloalkylcarbonyl, Ci-C6 haloalkoxycarbonyl, (C1-C6 alkyl)NH, (Ci-C6 alkyl)2N, (C3-C6 cycloalkyl)NH, (C3-C6 cycloalkyl)2N, Ci-Cealkylcarbonylamino, C3-C6 cycloalkylcarbonylamino, C1-C6 haloalkylcarbonylamino, C3-C6 halocycloalkylcarbonylamino, C1-C6 alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, C1-C6 haloalkylaminocarbonyl, C3-C6
halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs and - C(0)NH2;
U3 is selected from the group consisting of halogen, nitro, cyano, amino, hydroxyl, -SCN, -CO2H, C1-C6 alkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkyl-Ci-C4 alkyl, C3-C6 halocycloalkyl- C1-C4 alkyl,C1-C6 haloalkyl, Ci-C6 alkoxy, Ci-C4 alkoxy-Ci-C4 alkyl, Ci-C4 alkoxy-Ci-C4 alkoxy, cyano- C1-C4 alkyl, cyano-Ci-C4 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 haloalkoxy, Ci-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, Ci-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylcarbonyl, Ci-C6 alkoxycarbonyl, C1-C6 haloalkylcarbonyl, Ci-C6 haloalkoxycarbonyl, (C1-C6 alkyl)NH, (Ci-C6 alkyl)2N, (C3-C6 cycloalkyl)NH, (C3-C6 cycloalkyl)2N, Ci-Cealkylcarbonylamino, C3-C6 cycloalkylcarbonylamino, C1-C6 haloalkylcarbonylamino, C3-C6 halocycloalkylcarbonylamino, C1-C6 alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, C1-C6 haloalkylaminocarbonyl, C3-C6
halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs and - C(0)NH2; or
U3 is a 5 to 6 membered aromatic ring, 5 to 6 membered heteroaromatic ring, or 5 to 6 membered saturated or partially saturated carbocyclic or heterocyclic ring system, wherein heteroaromatic or heterocyclic ring can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen substituted or not, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, said 5 to 6-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2;
R6 is selected from the group consisting of hydrogen, amino, Ci-C6 alkyl, Ci-C6 haloalkyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, Ci-C4 alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C6 cycloalkyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl and C3-C6 halocycloalkyl;
Re is selected from the group consisting of hydrogen, hydroxyl, cyano, Ci-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, Ci-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, C1-C4
alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl, pyridyl and pyrimidyl, wherein said phenyl, pyridyl or pyrimidyl ring system can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, and Ci-C4 alkoxy; and
R7 is selected from the group consisting of hydrogen, cyano, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, C1-C4 alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl, pyridyl and pyrimidyl, wherein said phenyl, pyridyl or pyrimidyl ring system can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, and Ci-C4 alkoxy; and agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula I, wherein in the instance the moiety -NCR2R3R4 is -NCH2CH3, R5 is not phenyl, methyl or ethyl.
Compounds of formula I which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as Ci-C4alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid , or with organic sulfonic acids, such as Ci-C4-alkane- or arylsulfonic acids which are
unsubstituted or substituted, for example by halogen, for example methane- or p-toluenesulfonic acid.
Compounds of formula I which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.
The compounds of formula I are mesoionic compounds (also known as inner salts or zwitterions), which are understood to be compounds that are neutral but carry a formal positive and a negative charge on different atoms within the compounds. There are literature papers that have described these types of compounds, such as, for example Tetrahedron (1985), 41 (12), 2239-329 or
Tetrahedron 69 (2013) 4146-4159. Examples of mesoionics of formula I could be described by the followin structures:
Figure imgf000006_0001
Accordingly, compounds according to the present invention can be represented by any one of the charge distribution above.
The alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, hexyl, nonyl, decyl and their branched isomers. Alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned. The alkenyl and alkynyl groups can be mono- or polyunsaturated.
Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl.
A haloalkyl group is an alkyl group having one or more independently selected halogen atoms on the alkyl group. Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 , 1 - difluoro-2,2,2-trichloroethyl, 2,2,3, 3-tetrafluoroethyl and 2,2,2-trichloroethyl. An alkoxy group is an alkyl group connected to an oxygen atom, wherein the alkoxy group is connected to the rest of the compound via the oxygen atom. Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert-butoxy and also the isomeric pentyloxy and hexyloxy radicals.
A cycloalkyl group has at least three carbon atoms in a ring, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl, preferably cyclopropyl.
A haloalkoxy group is an alkoxy group having one or more independently selected halogen atoms on the alkyl group of the alkoxy group. Haloalkoxy is, for example, difluoromethoxy, trifluoromethoxy or 2,2,2-trifluoroethoxy.
An alkoxyalkyl group has one or more alkoxy groups and an alkyl group, wherein the alkoxy groups are in a chain with one of the oxygen atoms of the alkoxy chain connected to the alkyl group, which alkoxyalkyl group is connected to the rest of the compound via a carbon atom of the alkyl group. Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n- propoxymethyl, n-propoxyethyl, isopropoxymethyl, isopropoxyethyl or a dialkoxyalkyi group such as for example CH30CH2CH20CH2-.
A haloalkoxyalkyl group is an alkoxyalkyl group having one or more independently selected halogen atoms on the alkoxyalkyl group (for example the halogenation can be on the carbon atoms forming part of the alkyl and/or any one of the alkoxy group). Examples of haloalkoxyalkyl are, trifluoromethyloxymethyl, trifluoromethyloxyethyl, methoxyfluromethyl, trifluoroethyloxymethyl or a dihaloalkoxyalkyl group such as for example CF30CH2CH20CH2-, CH30CH2CF20CH2-,
C(CI)F20CH2CH20CH2-, and CH30CH2C(CI)20CH2-.
An alkylcarbonyl group is an alkyl group connected to a carbonyl group, which alkylcarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl moiety. Examples are CH3C(0)-, and (CH3)2CHC(0)-.
A cycloalkylcarbonyl group is a cycloalkyl group connected to a carbonyl group, which
cycloalkylcarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl moiety. Examples are cyclopropylC(O)-, and cyclobutylC(O)-.
A cycloalkylalkyl group is a cycloalkyl group connected to an alkyl group, which cycloalkylalkyl group is connected to the rest of the compound via a carbon atom of the alkyl group. Examples are - CyclopropylCH2-, and Cyclopropyl(CH3)CH-.
A haloalkylcarbonyl group is an alkylcarbonyl group, wherein the alkyl group has one or more halogen atoms, which haloalkylcarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl moiety. An example of such is CF3C(0)-.
An alkoxycarbonyl group is an alkoxy group connected to the carbon atom of a carbonyl group via the oxygen of the alkoxy group, which alkoxycarbonyl group is connected to the rest of the compound via the carbon atom of the carbonyl group. An example is CH30C(0)-.
An haloalkoxycarbonyl group is an alkoxycarbonyl group wherein the alkoxy group is halogenated by one or more independently selected halogen atoms, for example, CF30C(0)-. An alkylcarbonylamino group is an alkylcarbonyl group connected to the nitogen atom of an amino group via the carbon atom of the carbonyl group, which alkylcarbonylamino group is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example CH3C(0)NH-.
A cycloalkylcarbonylamino group is a cycloalkylcarbonyl group connected to the nitogen atom of an amino group via the carbon atom of the carbonyl group, which cycloalkylcarbonylamino is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example, cyclopropylC(0)NH-.
An alkylaminocarbonyl group has an alkyl group, an amino group and a carbonyl group, wherein a carbon atom of the the alkyl group is connected to a nitrogen atom of the amino group and then a nitrogen atom of the amino group is connected to the carbon atom of the carbonyl group, which alkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example, CH3NHC(0) -.
A cycloalkylaminocarbonyl group has a cycloalkyi group, an amino group and a carbonyl group, wherein a carbon atom of the cycloalkyi group is connected to a nitrogen atom of the amino group and then a nitrogen atom of the amino group is connected to the carbon atom of the carbonyl group, which cycloalkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example, cyclopropylNHC(O) -.
A haloalkylcarbonylamino group is an alkylcarbonylamino group having one or more independently selected halogen atoms on the alkyl group, which haloalkylcarbonylamino group is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example, CFH2C(0)NH-. A halocycloalkylcarbonylamino group is an cycloalkylcarbonylamino group having one or more independently selected halogen atoms on the cycloalkyi group, which halocycloalkylcarbonylamino group is connected to the rest of the compound via the nitrogen atom of the amino group, such as for example, 2-fluoro-cyclopropylC(0)NH-.
A haloalkylaminocarbonyl group is an alkylaminocarbonyl group having one or more independently selected halogen atoms on the alkyl group, which haloalkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example, CFH2NHC(0) -.
A halocycloalkylaminocarbonyl group is a cycloalkylaminocarbonyl group having one or more independently selected halogen atoms on the cycloalkyi group, which halocycloalkylaminocarbonyl is connected to the rest of the compound via the carbon atom of the carbonyl group, such as for example 2-fluorocyclopropylNHC(0) -.
In the context of this invention "mono- to poly-substituted" in the definition of the substituents, means typically, depending on the chemical structure of the substituents, generally mono-substituted to seven-times substituted, preferably mono-substituted to five-times substituted, more preferably mono-, di- or tri-substituted.
As used herein, the term "C2-C6 alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond. The term "C2-C4alkynyl" and "C2-C3alkynyl" are to be construed accordingly. Examples of C2-C6 alkynyl include, but are not limited to, ethynyl, prop-1-ynyl, but-1-ynyl and but-2-ynyl.
As used herein, the term "C2-C6 alkenyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond. The term "C2-C4alkenyl" and "C2-C3alkenyl" are to be defined accordingly. Examples of C2-C6 alkenyl include, but are not limited to prop-1-enyl, but-1-enyl and but-2-enyl.
Alkylsulfanyl is for example methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, pentylsulfanyl and hexylsulfanyl.
Alkylsulfinyl is for example methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, a butylsulfinyl, pentylsulfinyl or hexylsulfinyl.
Alkylsulfonyl is for example methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, pentylsulfonyl or hexylsulfonyl.
Haloalkylsulfanyl is for example difluoromethylsulfanyl, trifluoromethylsulfanyl, 2,2,2- trifluoroethylsulfanyl or pentafluoroethylsulfanyl.
Haloalkylsulfinyl is for example difluoromethylsulfinyl, trifluoromethylsulfinyl, 2,2,2- trifluoroethylsulfinyl or pentafluoroethylsulfinyl.
Haloalkylsulfonyl is for example difluoromethylsulfonyl, trifluoromethylsulfonyl, 2,2,2- trifluoroethylsulfonyl or pentafluoroethylsulfonyl.
Examples of a 5 to 12 membered aromatic ring system, which can be monocyclic or polycyclic, include phenyl, naphthyl, anthracenyl and biphenyl; preferred are phenyl, naphthyl, and biphenyl.
Examples of a 3 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, include pyridyl, pyrimidyl, pyrrolyl, pyrazolyl, furyl, thienyl, imidazolyl, isoxazolyl, oxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyrazinyl, pyridazinyl, triazinyl, pyranyl, quinazolinyl, isoquinolinyl, indolizinyl, isobenzofuranylnaphthyridinyl, quinoxalinyl, isochinolinyl, cinnolinyl, phthalazinyl, benzothiazolyl, benzoxazolyl, benzotriazolyl, indazolyl, indolyl, tetrahydroquinolynyl, benzofuryl, benzisofuryl, benzothienyl, benzisothienyl, isoindolyl, naphthyridinyl, benzisothiazolyl, benzisoxazolyl, benzoxazolyl, benzotriazinyl, purinyl, chinazolinyl, chinoxalinyl, teridinyl, Indolizinyl, phenylpyridyl, and pyridylphenyl; preferred are pyridyl, pyrimidyl, phenylpyridyl, pyridylphenyl, and thienyl.
Examples of a 3 to 12 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, include dihydropyranyl, tetrahydrofuryl, tetrahydrofuranyl, tetrahydrothienyl, pyrrolidinyl, pyrrolidinyl, isoxazolidinyl, isothiazolidinyl, pyrazolidinyl, oxazolidinyl, thiazolidinyl, imidazolidinyl, oxadiazolidinyl,thiadiazolidinyl, dihydrofuryl, dihydrothienyl, pyrrolinyl, isoxazolinyl, dihydropyrazolyl, dihydrooxazolyl, piperidinyl, dioxanyl, tetrahydropyranyl,
tetrahydrothienyl, hexahydropyridazinyl, hexahydropyrimidinyl, oxiranyl, and piperazinyl; preferred is tetrahydrofuryl.
Example of a 5 to 6 membered aromatic ring system includes phenyl. Examples of a 5 to 6 membered heteroaromatic ring system include pyridyl, pyrimidyl, pyrrolyl, pyrazolyl, furyl, thienyl, imidazolyl, isoxazolyl, oxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyrazinyl, pyridazinyl, triazinyl, and pyranyl; preferred are pyridyl, pyrimidyl, and thienyl.
Examples of a 5 to 6 membered saturated or partially saturated carbocyclic or heterocyclic ring system include dihydropyranyl, tetrahydrofuryl, tetrahydrofuranyl, tetrahydrothienyl, pyrrolidinyl, pyrrolidinyl, isoxazolidinyl, isothiazolidinyl, pyrazolidinyl, oxazolidinyl, thiazolidinyl, imidazolidinyl, oxadiazolidinyl,thiadiazolidinyl, dihydrofuryl, dihydrothienyl, pyrrolinyl, isoxazolinyl, dihydropyrazolyl, dihydrooxazolyl, piperidinyl, dioxanyl, tetrahydropyranyl, tetrahydrothienyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl; prefererd is tetrahydrofuryl.
Polycyclic as used herein refers to fused cyclic rings, and substituted cyclic rings, in which the substituent is another cyclic ring (such as an aryl or heteroaryl ring). An example of a fused ring is naphthyl or benzisoxazolyl or benzoxazolyl, whereas an example of a substituted ring is biphenyl or 2- phenylpyridyl or 2-pyridylphenyl.
A "ring system" as used herein refers in entirety to the ring substitutent whether monocyclic or polycyclic. For example, in the instance of "Rs being a 3 to 12 membered heteroaromatic ring, which ring system can contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said 3 to 12-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2", the ring sytem refers to the fact that only 1 to 4 heteroatoms can be present in total and not per ring.
The compounds of formula I according to the invention also include hydrates which may be formed during the salt formation.
In an embodiment, independent of the different aspects or embodiments, V is O.
In an embodiment, independent of the different aspects or embodiments, U is halogen, cyano, Ci-
C4 alkyl, C1-C4 haloalky, Ci-C4 alkoxy, or C1-C4 haloalkoxy; preferably U is halogen; more preferably chloro, or fluoro.
In an embodiment, independent of the different aspects or embodiments, n is 0 or 1.
In an embodiment, independent of the different aspects or embodiments, U2 is halogen, cyano, Ci- Ce alkyl, Ci-C6 alkoxy, or Ci-C6 haloalkyl; preferably U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or Ci-C4 alkoxy. Especially U2 is chloro, fluoro, cyano, methyl, cyclopropyl, trifluoromethyl or methoxy.
In an embodiment, independent of the different aspects or embodiments, U3 is halogen, nitro, cyano, Ci-C6 alkyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, Ci-C6 alkoxy,or a phenyl, optionally mono- or polysubstituted by substituents independently selected from the group U2; more preferably U3 is halogen or phenyl; especially U3 is fluoro or phenyl
In an embodiment, independent of the different aspects or embodiments, Z is cyano, Ci-C4 alkyl, C1-C4 haloalkyl, Ci-C4 alkoxy, or C1-C4 haloalkoxy; preferably Z is Ci-C4 alkyl; more preferably Z is methyl. ln an embodiment, independent of the different aspects or embodiments, Ria, Rib, Ric and Rid are independently selected from hydrogen, Ci-C6alkyl, Ci-C6 alkoxy, and Ci-C6 haloalkyl. Preferably Rib, Ric and Rid are each hydrogen and Ria is hydrogen, Ci-C6alkyl, Ci-C6 alkoxy or C1-C6 haloalkyl; more preferably Rib, Ric and Rid are each hydrogen and Ria is hydrogen, Ci-C4alkyl, Ci-C4 alkoxy or C1-C4 haloalkyl; and especially Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl.
In an embodiment, independent of the different aspects or embodiments, R2 is hydrogen, C1-C6 alkyl, or mono- or poly-substituted Ci-C6 alkyl, where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, Ci-C6 haloalkoxy, Ci-C6 alkoxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and C1-C6 haloalkylsulfonyl; preferably R2 is hydrogen, C1-C6 alkyl, or mono- or poly- substituted C1-C6 alkyl, where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, and Ci-C6 alkoxy; more preferably R2 is hydrogen, Ci- C4 alkyl or mono-substituted is C1-C4 alkyl whee the substiuent is selected from the group consisting of halogen, hydroxyl, amino, and cyano; especially R2 is hydrogen, methyl or cyanomethyl.
In an embodiment, independent of the different aspects or embodiments, R3 is hydrogen or C1-C4 alkyl; preferably R3 is hydrogen, methyl, ethyl, or propyl; more preferably R3 is hydrogen, methyl, or ethyl; especially R3 is hydrogen, or methyl.
In an embodiment, independent of the different aspects or embodiments, R4 is a heteroaromatic ring Y selected from Y1 to Y29 independently substituted with a substituent from the group U, wherein n, Z and U are as defined in the first aspect; preferably R4 is heteroaromatic ring Y selected from selected from Y1 , Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined herein; more preferably R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined herein.
In an embodiment, independent of the different aspects or embodiments, R5 is a 5 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 as defined herein; preferably R5 is 6 to 12, more preferably 6, 10 and 12 membered aromatic rings, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 as defined herein; more preferably R5 is phenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2 as defined herein.
In an embodiment, independent of the different aspects or embodiments, R5 is a 3 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein. Preferably R5 is a 5 to 12, more preferably 5, 6, 10 or 12, membered heteroaromatic ring, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein. More preferably R5 is a thiophenyl, pyridyl, or pyridylphenyl, and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein U2 is as defined herein.
In an embodiment, independent of the different aspects or embodiments, R5 is a 3 to 12 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein. Preferably R5 is a 3 to 6, more preferably 3, 5 and 6, membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2 wherein Z and U2 are as defined herein. More preferably R5 is a tetrahydrofuryl.
In an embodiment, independent of the different aspects or embodiments, R5 is C3-C6 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is defined herein. Preferably R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is as defined herein.
In an embodiment, independent of the different aspects or embodiments, R5 is C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is as defined herein. Preferably R5 is C1-C4 alkyl, which can optionally be mono- or poly- substituted by substituents independently selected from the group U3 wherein U3 is as defined herein. More preferably R5 is C1-C4 alkyl, C1-C4 haloalkyl or phenyl-Ci-C4 alkyl. Especially R5 is methyl, trifluoromethyl, heptafluoropropyl or benzyl.
Preferred compounds of formula I are where V is oxygen; Ria, Rib, Ric and Rid are independently selected from hydrogen, Ci-C6alkyl, Ci-C6 alkoxy, or C1-C6 haloalkyl; R2 is hydrogen, C1-C6 alkyl, or mono- or poly-substituted C1-C6 alkyl, where the substiuents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, Ci-C6 haloalkoxy, Ci-C6 alkoxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and C1-C6 haloalkylsulfonyl; R3 is hydrogen or C1-C4 alkyl; R4 is a heteroaromatic ring Y selected from Y1 to Y29; and R5 is a 5 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3 to 12 membered heteroaromatic ring system or 3 to 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3-C6 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein n is 0 or 1 ; Z is cyano, C1-C4 alkyl, Ci- C4 haloalkyl, Ci-C4 alkoxy, or C1-C4 haloalkoxy; U is halogen, cyano, C1-C4 alkyl, C1-C4 haloalky, C1-C4 alkoxy, or C1-C4 haloalkoxy; U2 is halogen, cyano, C1-C6 alkyl, Ci-C6 alkoxy, or Ci-C6 haloalkyl; and U3 is halogen, nitro, cyano, Ci-C6 alkyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, Ci-C6 alkoxy,or a phenyl, which phenyl is optionally mono- or polysubstituted by substituents independently selected from the group
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, Ci-C6alkyl, C1-C6 alkoxy or C1-C6 haloalkyl; R2 is hydrogen, C1-C6 alkyl, or mono- or poly- substituted C1-C6 alkyl, where the substiuents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, and C1-C6 alkoxy; R3 is hydrogen, methyl, ethyl, or propyl; R4 is heteroaromatic ring Y selected from selected from Y1 , Y4, Y9 and Y12; and R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3 to 6 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; Z is cyano, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy; U is halogen, cyano, C1-C4 alkyl, C1-C4 haloalky, C1-C4 alkoxy, or C1-C4 haloalkoxy; U2 is halogen, cyano, C1-C6 alkyl, C1-C6 alkoxy, or C1-C6 haloalkyl; and U3 is halogen, nitro, cyano, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, Ci-C6 alkoxy,or a phenyl, which phenyl is optionally mono- or polysubstituted by substituents independently selected from the group U2.
Preferred compounds of formula I are where V is oxygen; Ri b, Ric and Rid are each hydrogen and Ria is hydrogen, Ci-C4alkyl, Ci-C4 alkoxy or C1-C4 haloalkyi; R2 is hydrogen, Ci-C4 alkyl or mono- substituted Ci-C4 alkyl, where the substiuents are selected from the group consisting of halogen, hydroxyl, amino, and cyano; R3 is hydrogen, or methyl, or ethyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3 to 6 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; Z is cyano, C1-C4 alkyl, C1-C4 haloalkyi, Ci-C4 alkoxy, or C1-C4 haloalkoxy; U is halogen, cyano, C1-C4 alkyl, C1-C4 haloalky, Ci-C4 alkoxy, or Ci-C4 haloalkoxy; U2 is halogen, cyano, C1-C6 alkyl, Ci-C6 alkoxy, or C1-C6 haloalkyi; and U3 is halogen, nitro, cyano, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 haloalkyi, Ci-C6 alkoxy,or a phenyl, which phenyl is optionally mono- or polysubstituted by substituents independently selected from the group U2
Preferred compounds of formula I are where V is oxygen; Ri b, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5 to 12 membered heteroaromatic ring system, or 5 to 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3 to 6 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; Z is cyano, C1-C4 alkyl, C1-C4 haloalkyi, Ci-C4 alkoxy, C1-C4 haloalkoxy; U is halogen, cyano, C1-C4 alkyl, C1-C4 haloalky, Ci-C4 alkoxy, or C1-C4 haloalkoxy; U2 is halogen, cyano, C1-C6 alkyl, Ci-C6 alkoxy, or C1-C6 haloalkyi; and U3 is halogen, nitro, cyano, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 haloalkyi, Ci-C6 alkoxy,or a phenyl, which phenyl is optionally mono- or polysubstituted by substituents independently selected from the group U2.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6, 10 or 12 membered aromatic ring, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5, 6, 10 or 12 membered heteroaromatic ring system, or 5, 6, 10 or 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3, 5, or 6 membered saturated or partially saturated heterocyclic ring system, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; Z is C1-C4 alkyl; U is halogen; U2 is halogen, cyano, C1-C4 alkyl, C3- C6 cycloalkyl, C1-C4 haloalkyi or C1-C4 alkoxy and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, biphenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is pyridyl, pyrimidyl, phenylpyridyl, pyridylphenyl, thienyl or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group Lb; wherein n is 0 or 1 ; Z is Ci-C4 alkyl; U is halogen; U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or Ci-C4 alkoxy and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is each oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is Cs cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or R5 is C1-C4 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; U is halogen; U2 is halogen, cyano, C1-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl or cyanomethyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6, 10 or 12 membered aromatic ring, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5, 6, 10 or 12 membered heteroaromatic ring system, or 5, 6, 10 or 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3, 5, or 6 membered saturated or partially saturated heterocyclic ring system, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; Z is Ci- C4 alkyl; U is halogen; U2 is halogen, cyano, C1-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy; and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is 6, 10 or 12 membered aromatic ring, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 5, 6, 10 or 12 membered heteroaromatic ring system, or 5, 6, 10 or 12 membered saturated or partially saturated heterocyclic ring system, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is a 3, 5, or 6 membered saturated or partially saturated heterocyclic ring system, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; Z is Ci-C4 alkyl; U is halogen; U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or Ci-C4 alkoxy and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, biphenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is pyridyl, pyrimidyl, phenylpyridyl, pyridylphenyl, thienyl or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; U is halogen; U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy; and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is each oxygen; Rib, Ric and Rid are each hydrogen and Ria is methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is phenyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is C3 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; wherein n is 0 or 1 ; U is halogen; U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy; and U3 is halogen or phenyl.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is biphenyl or napthyl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; or R5 is pyrimidyl, phenylpyridyl, pyridylphenyl, or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; wherein n is 0 or 1 ; U is halogen; and U2 is halogen, cyano, C1-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy.
Preferred compounds of formula I are where V is oxygen; Rib, Ric and Rid are each hydrogen and Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12; and R5 is selected from the groups (i) to (iii): (i) benzyl, 3-CI-Phenyl, 3,5-diCI-Phenyl, 2-CI-Phenyl, 2-F-Phenyl, 4-F- Phenyl, 3-l-Phenyl, 2-methyl-Phenyl, 3,5-diBr-Phenyl, ,3-Br-5-CF3-Phenyl, 3-Br-5-OCF3-Phenyl, 3- OCF3-Phenyl, 3-SCH3-Phenyl, 4-methoxy-Phenyl, 3-methoxy-Phenyl, 3-Br-Phenyl, 4-F-Phenyl., 4- CF3-Phenyl, 3-CHF2-Phenyl, or 3,4,5-tri-fluroro-Phenyl; (ii) heptafluoropropyl, 2-CF3-cyclopropyl-, CH3CF2CH2-, or (CF3)2CH-; and (iii) biphenyl, napthyl, phenylpyridyl, pyridylphenyl, or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; wherein U2 is halogen, cyano, Ci-C4 alkyl, C3-C6 cycloalkyl, C1-C4 haloalkyl or Ci-C4 alkoxy.
Whenever a substiutent list (e.g. Z or Lh or U3) is used in more than one substiuent in the compound, the substituent list is independently selected for each substituent (e..g in the instance of Z, it can be used on the nitrogen atom of the ring Y29, and also on atom of the heteroatomic ring F¾; or in the instance of U2, it can be a substituent on the 5 to 12 membered aromatic ring Rs and also on a 5 or 6 membered aromatic ring R5; or in the instance of U3, it can be a substiuent on C3-C6 cycloalkyl R5 or Ci-Ce alkyl R5, etc),
The compounds according to the invention can be prepared by methods known to those skilled in the art, in particular, for example, see Canadian Journal of Chemistry (1971 ), 49(4), 668-71 or Journal of the Chemical Society (1959), 2865-71.
Scheme 1
Figure imgf000018_0001
The compounds of formula III, wherein Ria, Rib, Ric and Rid as described under formula I above and wherein R is a C1-C4 alkyl, can be prepared from compounds of formula 111 wherein Ria, Rib, Ric and Rid are as described in formula I, via alkylation of compound 111 with compound of formula IV1 wherein R is a C1-C4 alkyl, in presence of a base, such as lithium amide, in a appropriate solvent such as for example toluene, to generate a compound of formula III at temperatures between -20 and 150°C, preferably between 20°C and 130°C. . These methods are known to those skilled in the art and described in, for example, in JACS (1951 ), 5467-5469.
Alternatively, the compound of formula III, wherein Ria, Rib, Ric, Rid are as described under formula I above and wherein R is a C1-C4 alkyl, can be prepared from compounds of formula II2 via palladium coupling (Buchwald-Hartwig cross coupling), which involves for example, reacting compounds of formula II2, wherein Ria, Rib, Ric and Rid are as described in formula I and wherein X is a leaving group, for example, chlorine, bromine or iodine with, for example, compounds of formula IV2 wherein R is a C1-C4 alkyl. The reaction can be catalyzed by a palladium based catalyst, for example palladium acetate, in presence of a base, like cesium carbonate or sodium tert-butoxide, in a solvent or a solvent mixture, like, for example toluene, preferably under inert atmosphere and in presence of chelating phosphine such as BINAP or Xamtphos. The reaction temperature can preferentially range from ambient temperature to the boiling point of the reaction mixture. Such Buchwald-Hartwig cross coupling are well known to those skilled in the art, many variation are described in literature and have been reviewed, for example in Strategic Applications of Named Reactions in Organic Synthesis (Kurti, Laszlo, Czako, Barbara, Editors. Ed. ELSEVIER) 2005, p70 and cited references, Modern Tools for the Synthesis of Complex Bioactive Molecules (Chapter 3: Metal-catalyzed C-heteroatom cross-coupling reactions) 2012, p.77-109. See for example European Journal of Medicinal Chemistry, 109, 294-304, 2016.
Alternatively, compounds of formula III, wherein Ria, Rib, Ric and Rid are as defined in formula I above, and R is a C1-C4 alkyl) can be prepared by nucleophile substitution which involves for example, reaction of compounds of formula II2, wherein X is a leaving group, for example, fluorine with compounds of formula IV2 wherein R is a C1-C4 alkyl, under basic condition or not, with or without solvent, via heating or under microwave irradiation (see for example WO2016029146 or Journal of the Chemical Society, Perkin T 1 Organic and Bio-Organic Chemistry 1980, p 132).
Other alternatives are possible and well known to those skilled in the art and described in, see for example Tetrahedron 64 (2008) 10798-1080.
Scheme 2
Figure imgf000019_0001
The preparation of compounds of formula IV, wherein Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above and R is C1-C4 alkyl from compounds of formula III wherein Ria, Rib, Ric and Rid are as described under formula I above and R is C1-C4 alkyl, may involve (scheme 2) alkylation of compound III with R2R3R4C-XLG wherein R2, R3 and R4 are as described under formula I above and wherein XLG is a leaving group, such as a halogen, preferably iodine, bromine or chlorine, in presence of a base, such as butyllithium or sodium hydride, in a appropriate solvent such as for example tetrahydrofuran, N,N-dimethylformamide, Ν,Ν-dimethylacetamide or acetonitrile, at temperatures between -78°C and 150°C, preferably between -78°C and 50°C.
Scheme 3
Figure imgf000020_0001
The preparation of compounds of formula V wherein Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above, from compounds of formula IV wherein Ria, Rib, Ric and Rid are as described under formula I above and R is C1-C4 alkyl, may involve (scheme 3) cleavage of the acetal group to aldehyde in presence of an acid, such as hydrochloric acid or trifluoroacetic acid in a appropriate solvent such as for example water or acetone, at temperatures between -20 and 100°C, preferably between 0°C and 80°C. Such transformations are known from the literature and will be recognize to those skilled in the art, for example the conditions described in Protective groups in organic synthesis (third edition, Theodora W. Greene, Peter G. M. Wuts 1999) p299.
Scheme 4
Figure imgf000020_0002
Compounds of the formula V, wherein Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above, can be oxidized to their corresponding acid VI under standard conditions (scheme 4). For example, with sodium chlorite in presence of sodium dihydrogenphosphate and cyclohexene in mixture of terbutanol, water at temperatures between 0°C and refluxing conditions, or alternatively by using a suitable oxidizing agent, such oxidations are known from the literature and will be recognize to those skilled in the art, for example the conditions described in Comprehensive Organic
Transformations: A Guide to Functional Group Preparations. Edited by Richard C. Larock 1989 p 838, VCH publishers could be apply for this transformation.
Scheme 5
Figure imgf000021_0001
The preparation of compounds of formula la wherein Ria, Rib, Ric, Rid, R2, R3, R4 and R5 are as described under formula I above, from compounds of formula VI wherein Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above, may involve (scheme 5) cyclisation and acylation in presence of an anhydride Vila or a acid halide Vllb wherein X is halogen such as fluoride and R5 is as described under formula I above with or without solvent at temperatures between -20 and 140°C, preferably between 0°C and 80°C.
Scheme 6
Figure imgf000021_0002
la Compounds of formula Ic, wherein V is S, can be prepared (scheme 6) by reacting compounds of formula la wherein V is O with a reagent that could transfer a sulphur atom such as, for example, the Lawesson's reagent in a solvent such as, for example dimethylformamide or toluene, usually at temperature between 50 to 150°C. This type of transformation is known to a person skilled in the art and are, for example, described in Heteroatom Chem. 2014, 25:548-555, Science of Synthesis 2004, 27, 215-243.
Scheme 7
Figure imgf000022_0001
Compounds of formula Id, wherein and R is R7 or Re, V is S or O, Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above, can be prepared (scheme 7) by reacting compounds of formula VI with a compound of formula Vllc wherein V is S or O and N-R is defined as NHR7 or NHRs in formula I, in a solvent such as, for example acetonitrile, usually at temperature between -50 to 100°C, preferably between 20 to 100°C.
Compound of formula Vllc are known to the person skilled in the art and are commercialy available or could be made easely by the person skilled in the art, examples of theses type of preparation could be find in , for example, Chemical Reviews (Washington, DC, United States) (1948), 43, p 203-18, Chemical Reviews (Washington, DC, United States) (1957), 57, 47-76, Chem. Soc. Rev., 1974,3, 209- 230 or Green Chemistry Letters and Reviews 2011 , 4:1 , 1-34.
Scheme 8
Figure imgf000022_0002
Compounds of formula le, wherein V is S or O, Ria, Rib, Ric, Rid, R2, R3, R4, R7 and Re are as described under formula I above, can be prepared (scheme 8) by reacting compounds of formula Id, wherein and R is R7 or Re, V is S or O, Ria, Rib, Ric, Rid, R2, R3 and R4 are as described under formula I above, with a compound of formula R'-XLG, wherein R' is Re or R7 as described under formula I above and XLG a leaving group, such as halogen, preferably iodine, bromine or chlorine, in presence of a base, such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, in a appropriate solvent such as for example Ν,Ν-dimethylformamide, N,N-dimethylacetamide or acetonitrile, usually at temperature between -50 to 100°C, preferably between 20 to 100°C.
The reactants can be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert- butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine,
triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, Ν,Ν-diethylaniline, pyridine, 4- (N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1 ,8-diazabicyclo[5.4.0]undec-7-ene (DBU).
The reactants can be reacted with each other as such, i.e. without adding a solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture of these. If the reaction is carried out in the presence of a base, bases which are employed in excess, such as triethylamine, pyridine, N-methylmorpholine or Ν,Ν-diethylaniline, may also act as solvents or diluents.
The reaction is advantageously carried out in a temperature range from approximately -80°C to approximately +140°C, preferably from approximately -30°C to approximately +100°C, in many cases in the range between ambient temperature and approximately +80°C.
A compound of formula I can be converted in a manner known per se into another compound of formula I by replacing one or more substituents of the starting compound of formula I in the customary manner by (an)other substituent(s) according to the invention.
Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step.
Salts of compounds of formula I can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds of formula I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
Salts of compounds of formula I can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.
Salts of compounds of formula I can be converted in a manner known per se into other salts of compounds of formula I, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
Depending on the procedure or the reaction conditions, the compounds of formula I, which have salt-forming properties, can be obtained in free form or in the form of salts.
The compounds of formula I and, where appropriate, the tautomer's thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule, the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.
Diastereomer mixtures or racemate mixtures of compounds of formula I, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl cellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents.
Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.
Compounds of formula I wherein V is S can be prepared by reacting a compound of the formula I wherein V is O with a suitable agent, for example the Lawesson reagent or diphosphorus pentasulfide in presence of a solvent or not such as dimethylformamide. Such reactions are known to the person skilled in the art and are described, for example, Tetrahedron, 63(48), 1 1862-1 1877, 2007, Inorganic Chemistry, 43(21), 6534-6536, 2004 or Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, Fourth Edition by Jerry March, 1992 (Publisher Wiley New York, N. Y.) pages 1 184-1 185.
It is advantageous to isolate or synthesize in each case the biologically more effective isomer, for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity.
The compounds of formula I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
Certain intermediates used in the process are also novel.
Accordingly in a further aspect, the present invention provides a compound of formula IV
Figure imgf000025_0001
wherein Ria, Rib, Ric, Rid, R2, and R3 are as defined in formula l÷ and R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined in formula I; and R is Ci-C4 alkyl; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula IV. Preferably R is methyl or ethyl.
Accordingly in a further aspect, the present invention provides a compound of formula V
Figure imgf000025_0002
wherein Ria, Rib, Ric, Rid, R2, and R3 are as defined in formula I; and R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12, substituted with a substituent from the group U, wherein n and U are as defined in formula I; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula V.
Accordingly in a further aspect, the present invention provides a compound of formula VI
Figure imgf000026_0001
wherein-Ria, Ri b, Ric, Rid, R2 and R3 are as defined in formula I† and R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined in formula I; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula VI.
In a further aspect, the present invention makes available a process for preparing a compound of formula la, wherein (1 ) a compound of formula III is prepared from compound of formula 111 via alkylation with a compound of formula IV1 , in presence of a base to generate a compound of formula III; or the compound of formula III is prepared from a compound of formula II2 via palladium coupling with a compound of formula IV2; or a compound of formula III is prepared by nucleophile substitution, in presence of a base, with a compound of formula IV2;
Figure imgf000026_0002
(2) a compound of formula IV is prepared from a compound of formula III by alkylation with R2R3R4C-
Figure imgf000027_0001
(3) a compound of formula V is prepared from a compound of formula IV by cleavage of the acetal group to aldehyde in presence of an acid;
Figure imgf000027_0002
(4) a compound of the formula V is oxidized to its corres onding acid of formula VI; and
Figure imgf000027_0003
(5) a compound of formula la is prepared from a compound of formula VI by cyclisation and acylation in presence of an anhydride of formula Vila or acid halide of formula Vllb,
Figure imgf000028_0001
wherein R is C1-C4 alkyl; XLG and X are independently of each other a leaving group; and Ria, Ri b, Ric and Rid, R2, R3, R4 and R5 are as described for formula I herein.
The compounds according to the following Tables 1 , 2, 3 and 4 below can be prepared according to the methods described herein. The compounds which follow are intended to illustrate the invention and show particularly preferred compounds of formula I, IVa, Va, and Via. "Ph" represents the phenyl group.
Table 1 : This table discloses 139 com ounds of the formula I:
Figure imgf000028_0002
Table 1 :
Comp. No. Ria R2 R4 Rs
1.001 H H Phenyl
1.002 H H -CH2Ph
1.003 H H 3-CI-Phenyl
1.004 H H At ci 3,5-diCI-Phenyl Comp. No. Rla R2 R4 Rs
1.005 H H -CF3
1.006 H H -CF2CF3
1.007 H H CH3
1.008 H H 3-Br-Phenyl
1.009 H H 4-F-Phenyl
1.010 H H 4-CI-Phenyl
1.01 1 H H Thiophenyl-2
1.012 H H Thiophenyl-3
1.013 CH3 H Phenyl
1.014 CH3 H -CH2Ph
1.015 CH3 H 3-CI-Phenyl Comp. No. Rla R2 R4 Rs
1.016 CH3 H 3,5-diCI-Phenyl
1.017 CH3 H -CF3
1.018 CH3 H -CF2CF3
1.019 CH3 H CH3
1.020 CH3 H 3-Br-Phenyl
1.021 CH3 H 4-F-Phenyl
1.022 CH3 H 4-CI-Phenyl
1.023 CH3 H Thiophenyl-2
1.024 CH3 H Thiophenyl-3
Figure imgf000030_0001
1.025 H H Phenyl
1.026 H H -CH2Ph
Figure imgf000031_0001
Comp. No. Rla R2 R4 Rs
1.039 CH3 H 3-CI-Phenyl
1.040 CH3 H 3,5-diCI-Phenyl
1.041 CH3 H -CF3
1.042 CH3 H -CF2CF3
1.043 CH3 H CH3
1.044 CH3 H 3-Br-Phenyl
1.045 CH3 H 4-F-Phenyl
1.046 CH3 H 4-CI-Phenyl
1.047 CH3 H Thiophenyl-2
1.048 CH3 H Thiophenyl-3
1.049 H H Phenyl
1.050 H H -CH2Ph
Figure imgf000033_0001
Comp. No. Rla R2 R4 Rs
1.060 H H Thiophenyl-3
1.061 CH3 H Phenyl
1.062 CH3 H -CH2Ph
1.063 CH3 H 3-CI-Phenyl
1.064 CH3 H 3,5-diCI-Phenyl
1.065 CH3 H -CF3
1.066 CH3 H -CF2CF3
1.067 CH3 H CH3
1.068 CH3 H 3-Br-Phenyl
Figure imgf000035_0001
Figure imgf000036_0001
Figure imgf000037_0001
Figure imgf000038_0001
Figure imgf000039_0001
Figure imgf000040_0001
Figure imgf000041_0001
Comp. No. Rla R2 R4 Rs
1.111 H * * H 3-Br-Phenyl
1.112 H * * H 4-F-Phenyl
1.113 H H 4-CI-Phenyl
* *
1.114 H H Thiophenyl-2
* *
1.115 H * * H Thiophenyl-3
1.116 H * * H Phenyl
1.117 H * H -CH2Ph
*
1.118 H H 3-CI-Phenyl
* * Comp. No. Rla R2 R4 Rs
1.119 H * * H 3,5-diCI-Phenyl
1.120 CH3 * * H -CF3
1.121 CH3 * * H -CF2CF3
1.122 CH3 * * H CH3
1.123 CH3 * * H 3-Br-Phenyl
1.124 CH3 * * H 4-F-Phenyl
1.125 CH3 * * H 4-CI-Phenyl
1.126 CH3 * * H Thiophenyl-2
Figure imgf000044_0001
Figure imgf000045_0001
Figure imgf000046_0001
and the N-oxides of the compounds of Table 1.
Table 2: This table discloses 32 compounds of intermediates of formula IVa
Figure imgf000046_0002
Figure imgf000047_0001
Figure imgf000048_0001
Figure imgf000049_0001
and the N-oxides o the compounds of Table 2.
Table 3: This table discloses 32 compounds of intermediates of formula (Va):
Figure imgf000049_0002
Table 3:
Figure imgf000050_0001
Figure imgf000051_0001
Figure imgf000052_0001
and the N-oxides of the compounds of Table 3.
Table 4: This table discloses 32 compounds of intermediates of formula (Via):
Figure imgf000053_0001
Figure imgf000054_0001
Figure imgf000055_0001
Figure imgf000056_0001
and the N-oxides of the compounds of Table 4.
The compounds of formula I (including compounds of formula la and lb) according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warmblooded species, fish and plants. The compounds of formula I are safe towards non-target species, such as bees, and accordingly have a good toxicity profile. The active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate. Examples of the abovementioned animal pests are:
from the order Acarina, for example,
Acalitus spp, Aculus spp, Acaricalus spp, Aceria spp, Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp, Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp, Eotetranychus spp, Eriophyes spp., Hemitarsonemus spp,
Hyalomma spp., Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp, Polyphagotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.,
from the order Anoplura, for example,
Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp., from the order Coleoptera, for example, Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp, Astylus atromaculatus, Ataenius spp, Atomaria linearis, Chaetocnema tibialis, Cerotoma spp, Conoderus spp, Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp, Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp, Maecolaspis spp, Maladera castanea, Megascelis spp, Melighetes aeneus, Melolontha spp., Myochrous armatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp, Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp, Sphenophorus spp, Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp., from the order Diptera, for example,
Aedes spp., Anopheles spp, Antherigona soccata,Bactrocea oleae, Bibio hortulanus, Bradysia spp, Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp, Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp, Rivelia quadrifasciata, Scatella spp, Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.,
from the order Hemiptera, for example,
Acanthocoris scabrator, Acrosternum spp, Adelphocoris lineolatus, Amblypelta nitida, Bathycoelia thalassina, Blissus spp, Cimex spp., Clavigralla tomentosicollis, Creontiades spp, Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp, Euchistus spp., Eurydema pulchrum, Eurygaster spp., Euschistus spp. (stinkbugs), Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp, Margarodes spp, Murgantia histrionic, Neomegalotomus spp, Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis, Piesma spp., Piezodorus spp, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp. , Thyanta spp , Triatoma spp., Vatiga illudens,
Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicoryne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp, Cofana spectra, Cryptomyzus spp, Cicadulina spp, Coccus hesperidum, Dalbulus maidis, Dialeurodes spp, Diaphorina citri, Diuraphis noxia, Dysaphis spp, Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp, Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Lecanium corni, Lepidosaphes spp., Lopaphis erysimi, Lyogenys maidis,
Macrosiphum spp., Mahanarva spp, Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Sogatella furcifera, Spissistilus festinus, Tarophagus Proserpina, Toxoptera spp, Trialeurodes spp, Tridiscus sporoboli, Trionymus spp, Trioza erytreae , Unaspis citri, Zygina flammigera, Zyginidia scutellaris,
from the order Hymenoptera, for example,
Acromyrmex, Arge spp, Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp, Slenopsis invicta, Solenopsis spp. and Vespa spp.,
from the order Isoptera, for example,
Coptotermes spp, Corniternes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp., Solenopsis geminate
from the order Lepidoptera, for example,
Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp.,
Anticarsia gemmatalis, Archips spp., Argyresthia spp, Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella, Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Chrysoteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp, Crocidolomia binotalis, Cryptophlebia leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp., Eldana saccharina, Ephestia spp., Epinotia spp, Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Gra- pholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp, Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp, Noctua spp, Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Papaipema nebris, Pectinophora gossypi- ela, Perileucoptera coffeella, Pseudaletia unipuncta, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Pseudoplusia spp, Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni, Tuta absoluta, and Yponomeuta spp.,
from the order Mallophaga, for example,
Damalinea spp. and Trichodectes spp.,
from the order Orthoptera, for example,
Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp. , Scapteriscus spp, and Schistocerca spp.,
from the order Psocoptera, for example,
Liposcelis spp.,
from the order Siphonaptera, for example, Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis,
from the order Thysanoptera, for example,
Calliothrips phaseoli, Frankliniella spp., Heliothrips spp, Hercinothrips spp., Parthenothrips spp, Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp,
from the order Thysanura, for example, Lepisma saccharina.
The active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests.
Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum, beet, such as sugar or fodder beet, fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries, leguminous crops, such as beans, lentils, peas or soya, oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts, cucurbits, such as pumpkins, cucumbers or melons, fibre plants, such as cotton, flax, hemp or jute, citrus fruit, such as oranges, lemons, grapefruit or tangerines, vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers, Lauraceae, such as avocado, Cinnamonium or camphor, and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family, latex plants and ornamentals.
The active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Thrips tabaci, Euschistus heros, Heliothis virescens, Myzus persicae, Plutella xylostella and Spodoptera littoralis in cotton, vegetable, maize, rice and soya crops. The active ingredients according to the invention are further especially suitable for controlling Mamestra
(preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca(preferably in vegetables, vineyards), Leptinotarsa (preferably in potatos) and Chilo supressalis (preferably in rice).
In a further aspect, the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species, cyst-forming nematodes, Globodera rostochiensis and other Globodera species, Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species, Seed gall nematodes, Anguina species, Stem and foliar nematodes, Aphelenchoides species, Sting nematodes, Belonolaimus longicaudatus and other Belonolaimus species, Pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species, Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species, Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species, Awl nematodes, Dolichodorus species, Spiral nematodes, Heliocotylenchus multicinctus and other Helicotylenchus species, Sheath and sheathoid nematodes, Hemicycliophora species and Hemicriconemoides species, Hirshmanniella species, Lance nematodes, Hoploaimus species, false rootknot nematodes, Nacobbus species, Needle nematodes, Longidorus elongatus and other Longidorus species, Pin nematodes,
Pratylenchus species, Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans,
Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species, Burrowing nematodes, Radopholus similis and other Radopholus species, Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis and other Rotylenchus species, Scutellonema species, Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species, Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species, Citrus nematodes, Tylenchulus species, Dagger nematodes, Xiphinema species, and other plant parasitic nematode species, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp..
The compounds of the invention may also have activity against the molluscs. Examples of which include, for example, Ampullariidae, Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus),
Bradybaenidae (Bradybaena fruticum), Cepaea (C. hortensis, C. Nemoralis), ochlodina, Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum), Discus (D. rotundatus), Euomphalia, Galba (G. trunculata), Helicelia (H. itala, H. obvia), Helicidae Helicigona arbustorum), Helicodiscus, Helix (H. aperta), Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus), Lymnaea, Milax (M. gagates, M. marginatus, M. sowerbyi), Opeas, Pomacea (P. canaticulata), Vallonia and Zanitoides. The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from Bacillus cereus or Bacillus popilliae, or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, e.g. CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A, or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or
Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus, toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins, toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins, agglutinins, proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors, ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin, steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.
In the context of the present invention there are to be understood by δ-endotoxins, for example CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.
The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).
Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin), YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin), YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin), Starlink® (maize variety that expresses a Cry9C toxin), Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium), NuCOTN 33B® (cotton variety that expresses a Cry1 Ac toxin), Bollgard I® (cotton variety that expresses a Cry1 Ac toxin), Bollgard II® (cotton variety that expresses a Cry 1 Ac and a Cry2Ab toxin), VipCot® (cotton variety that expresses a Vip3A and a CrylAb toxin), NewLeaf® (potato variety that expresses a Cry3A toxin), NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer (CB) trait) and Protecta®.
Further examples of such transgenic crops are:
1. Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated CrylAb toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/ES/96/02.
6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1 160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cryl F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.
7. NK603 * MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 * MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain
Lepidoptera, include the European corn borer.
Transgenic crops of insect-resistant plants are also described in BATS (Zentrum fur Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003,
(https://bats.ch).
The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818 and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
Crops may also be modified for enhanced resistance to fungal (for example Fusarium,
Anthracnose, or Phytophthora), bacterial (for example Pseudomonas) or viral (for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus) pathogens.
Crops also include those that have enhanced resistance to nematodes, such as the soybean cyst nematode. Crops that are tolerance to abiotic stress include those that have enhanced tolerance to drought, high salt, high temperature, chill, frost, or light radiation, for example through expression of NF-YB or other proteins known in the art.
Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1 , KP4 or KP6 toxins, stilbene synthases, bibenzyl synthases, chitinases, glucanases, the so- called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225), antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called "plant disease resistance genes", as described in WO 03/000906).
Further areas of use of the compositions according to the invention are the protection of stored goods and store ambients and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.
The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors, see also https://www.who.int/malaria/vector_control/irs/en/). In one embodiment, the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In another embodiment, it is contemplated to apply such compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents. A further object of the invention is therefore a substrate selected from nonwoven and fabric material comprising a composition which contains a compound of formula I.
In one embodiment, the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.
Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are known, e.g. WO 2008/151984, WO 03/034823, US 5631072, WO 2005/64072, WO 2006/128870, EP 1724392, WO 20051 13886 or WO 2007/090739. Further areas of use of the compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.
In the field of tree injection/trunk treatment, the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following tables A and B:
Table A. Examples of exotic woodborers of economic importance.
Family Species Host or Crop Infested
Buprestidae Agrilus planipennis Ash
Cerambycidae Anoplura glabripennis Hardwoods
Xylosandrus crassiusculus Hardwoods
Scolytidae X. mutilatus Hardwoods
Tomicus piniperda Conifers
Table B. Examples of native woodborers of economic importance.
Family Species Host or Crop Infested
Agrilus anxius Birch
Agrilus politus Willow, Maple
Agrilus sayi Bayberry, Sweetfern
Agrilus vittaticolllis Apple, Pear, Cranberry,
Serviceberry, Hawthorn
Chrysobothris femorata Apple, Apricot, Beech, Boxelder,
Cherry, Chestnut, Currant, Elm,
Buprestidae Hawthorn, Hackberry, Hickory,
Horsechestnut, Linden, Maple,
Mountain-ash, Oak, Pecan, Pear, Peach, Persimmon, Plum, Poplar, Quince, Redbud, Serviceberry,
Sycamore, Walnut, Willow
Texania campestris Basswood, Beech, Maple, Oak,
Sycamore, Willow, Yellow-poplar
Goes pulverulentus Beech, Elm, Nuttall, Willow, Black oak, Cherrybark oak, Water oak, Sycamore
Goes tigrinus Oak
Cerambycidae
Neoclytus acuminatus Ash, Hickory, Oak, Walnut, Birch,
Beech, Maple, Eastern
hophornbeam, Dogwood,
Persimmon, Redbud, Holly, Family Species Host or Crop Infested
Hackberry, Black locust,
Honeylocust, Yellow-poplar, Chestnut, Osage-orange, Sassafras, Lilac, Mountain-mahogany, Pear, Cherry, Plum, Peach, Apple, Elm, Basswood, Sweetgum
Neoptychodes trilineatus Fig, Alder, Mulberry, Willow,
Netleaf hackberry
Oberea ocellata Sumac, Apple, Peach, Plum,
Pear, Currant, Blackberry
Oberea tripunctata Dogwood, Viburnum, Elm,
Sourwood, Blueberry,
Rhododendron, Azalea, Laurel, Poplar, Willow, Mulberry
Oncideres cingulata Hickory, Pecan, Persimmon, Elm,
Sourwood, Basswood, Honeylocust, Dogwood, Eucalyptus, Oak, Hackberry, Maple, Fruit trees
Saperda calcarata Poplar
Strophiona nitens Chestnut, Oak, Hickory, Walnut,
Beech, Maple
Corthylus columbianus Maple, Oak, Yellow-poplar,
Beech, Boxelder, Sycamore, Birch, Basswood, Chestnut, Elm
Dendroctonus frontalis Pine
Dryocoetes betulae Birch, Sweetgum, Wild cherry,
Beech, Pear
Monarthrum fasciatum Oak, Maple, Birch, Chestnut,
Scolytidae Sweetgum, Blackgum, Poplar,
Hickory, Mimosa, Apple, Peach, Pine
Phloeotribus liminaris Peach, Cherry, Plum, Black
cherry, Elm, Mulberry, Mountain-ash
Pseudopityophthorus pruinosus Oak, American beech, Black cherry, Chickasaw plum, Chestnut, Maple, Hickory, Hornbeam, Hophornbeam
Sesiidae Paranthrene simulans Oak, American chestnut Family Species Host or Crop Infested
Sannina uroceriformis Persimmon
Synanthedon exitiosa Peach, Plum, Nectarine, Cherry,
Apricot, Almond, Black cherry
Synanthedon pictipes Peach, Plum, Cherry, Beach,
Black Cherry
Synanthedon rubrofascia Tupelo
Synanthedon scitula Dogwood, Pecan, Hickory, Oak,
Chestnut, Beech, Birch, Black cherry, Elm, Mountain-ash, Viburnum,
Willow, Apple, Loquat, Ninebark,
Bayberry
Vitacea polistiformis Grape
The present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs. The present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults.
In particular, the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as Cyclocephala spp. (e.g. masked chafer, C. lurida),
Rhizotrogus spp. (e.g. European chafer, R. majalis), Cotinus spp. (e.g. Green June beetle, C. nitida), Popillia spp. (e.g. Japanese beetle, P. japonica), Phyllophaga spp. (e.g. May/June beetle), Ataenius spp. (e.g. Black turfgrass ataenius, A. spretulus), Maladera spp. (e.g. Asiatic garden beetle, M.
castanea) and Tomarus spp.), ground pearls (Margarodes spp.), mole crickets (tawny, southern, and short-winged, Scapteriscus spp., Gryllotalpa africana) and leatherjackets (European crane fly, Tipula spp.).
The present invention may also be used to control insect pests of turfgrass that are thatch dwelling, including armyworms (such as fall armyworm Spodoptera frugiperda, and common armyworm
Pseudaletia unipuncta), cutworms, billbugs (Sphenophorus spp. , such as S. venatus verstitus and S. parvulus), and sod webworms (such as Crambus spp. and the tropical sod webworm, Herpetogramma phaeopteralis).
The present invention may also be used to control insect pests of turfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), rhodesgrass mealybug (Antonina graminis), two-lined spittlebug (Propsapia bicincta), leafhoppers, cutworms (Noctuidae family), and greenbugs.
The present invention may also be used to control other pests of turfgrass such as red imported fire ants (Solenopsis invicta) that create ant mounds in turf. ln the hygiene sector, the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
Examples of such parasites are:
Of the order Anoplurida: Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.,
Of the order Mallophagida: Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp., Of the order Diptera and the suborders Nematocerina and Brachycerina, for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp.,
Of the order Siphonapterida, for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.,
Of the order Heteropterida, for example Cimex spp., Triatoma spp., Rhodnius spp.,
Panstrongylus spp.,
Of the order Blattarida, for example Blatta orientalis, Periplaneta americana,
Blattelagermanica and Supella spp.,
Of the subclass Acaria (Acarida) and the orders Meta- and Meso-stigmata, for example Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp.,
Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergatesspp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.. The compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings.
The compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium
rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec.,Tryptodendron spec, Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec, and Dinoderus minutus, and also hymenopterans such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus and Urocerus augur, and termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes,
Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis and Coptotermes formosanus, and bristletails such as Lepisma saccharina.
The compounds according to the invention can be used as pesticidal agents in unmodified form, but they are generally formulated into compositions in various ways using formulation adjuvants or addditives, such as carriers, solvents and surface-active substances. The formulations can be in various physical forms, e.g. in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo- emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic solvent as carrier), impregnated polymer films or in other forms known e.g. from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, First Edition, Second Revision (2010). Such formulations can either be used directly or diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers,
micronutrients, biological organisms, oil or solvents.
The formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.
The active ingredients can also be contained in very fine microcapsules. Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95 % by weight of the capsule weight. The active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art. Alternatively, very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the
microcapsules are not themselves encapsulated.
The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1 ,2-dichloropropane, diethanolamine, p- diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, A/,A/-dimethylformamide, dimethyl sulfoxide, 1 ,4- dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1 , 1 , 1-trichloroethane, 2- heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy- propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol, and alcohols of higher molecular weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, A/-methyl-2- pyrrolidone and the like.
Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances. A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use. Surface- active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate, salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate, alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate, alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate, soaps, such as sodium stearate, salts of alkylnaphthalenesulfonat.es, such as sodium dibutylnaphthalenesulfonate, dialkyl esters of sulfosuccinate salts, such as sodium di(2- ethylhexyl)sulfosuccinate, sorbitol esters, such as sorbitol oleate, quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate, block copolymers of ethylene oxide and propylene oxide, and salts of mono- and di- alkylphosphate esters, and also further substances described e.g. in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood New Jersey (1981 ).
Further adjuvants that can be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and liquid and solid fertilisers. The compositions according to the invention can include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10 %, based on the mixture to be applied. For example, the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. Preferred oil additives comprise alkyl esters of C8-C22 fatty acids, especially the methyl derivatives of C12-C18 fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10th Edition, Southern Illinois University, 2010.
The inventive compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to
95 % by weight, of compounds of the present invention and from 1 to 99.9 % by weight of a formula- tion adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance.
Whereas commercial products may preferably be formulated as concentrates, the end user will normally employ dilute formulations.
The rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. As a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to
1000 l/ha.
Preferred formulations can have the following compositions (weight %):
Emulsifiable concentrates:
active ingredient: 1 to 95 %, preferably 60 to 90 %
surface-active agent: 1 to 30 %, preferably 5 to 20 %
liquid carrier: 1 to 80 %, preferably 1 to 35 %
Dusts:
active ingredient: 0.1 to 10 %, preferably 0.1 to 5 %
solid carrier: 99.9 to 90 %, preferably 99.9 to 99 %
Suspension concentrates:
active ingredient: 5 to 75 %, preferably 10 to 50 %
water: 94 to 24 %, preferably 88 to 30 %
surface-active agent: 1 to 40 %, preferably 2 to 30 %
Wettable powders:
active ingredient: 0.5 to 90 %, preferably 1 to 80 % surface-active agent: 0.5 to 20 %, preferably 1 to 15 %
solid carrier: 5 to 95 %, preferably 15 to 90 %
Granules:
active ingredient: 0.1 to 30 %, preferably 0.1 to 15 %
solid carrier: 99.5 to 70 %, preferably 97 to 85 %
The following Examples further illustrate, but do not limit, the invention.
Figure imgf000071_0001
The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
Figure imgf000071_0002
The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
Emulsifiable concentrate active ingredients 10
%
octylphenol polyethylene glycol ether (4-5 mol of ethylene 3
oxide) %
calcium dodecylbenzenesulfonate 3
%
castor oil polyglycol ether (35 mol of ethylene oxide) 4
%
Cyclohexanone 30
%
xylene mixture 50
%
Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
Figure imgf000072_0001
Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
Figure imgf000072_0002
The combination is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.
Coated qranules
Active ingredients 8
% polyethylene glycol (mol. wt. 200) 3
%
Kaolin 89
%
The finely ground combination is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
Figure imgf000073_0001
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Figure imgf000073_0002
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Slow Release Capsule Suspension
28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8: 1 ). This mixture is emulsified in a mixture of 1 .2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51 .6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1 ,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo- emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.
In a further aspect, the present invention makes available a pesticidal composition comprising a compound of the first aspect, one or more formulation additives and a carrier.
The activity of the compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/or fungicidally active ingredients. The mixtures of the compounds of formula I with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use.
Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.
The following mixtures of the compounds of formula I with active ingredients are preferred (the abbreviation "TX" means "one compound selected from the group consisting of the compounds described in Tables 1 and A of the present invention"):
an adjuvant selected from the group of substances consisting of petroleum oils (628) + TX, an acaricide selected from the group of substances consisting of 1 , 1-bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881 ) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (lUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos [CCN] + TX, benzoximate (71 ) + TX, benzyl benzoate (lUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate + TX, bromocyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50'439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971 ) + TX, chlorfenvinphos (131 ) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel [CCN] + TX, coumaphos (174) + TX, crotamiton [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882-07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201 ) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-O (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX, dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071 ) + TX, dimefox (1081 ) + TX, dimethoate (262) + TX, dinactin (653) + TX, dinex (1089) + TX, dinex- diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1 102) + TX, diphenyl sulfone (lUPAC name) (1 103) + TX, disulfiram [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1 1 13) + TX, doramectin [CCN] + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, EPN (297) + TX, eprinomectin [CCN] + TX, ethion (309) + TX, ethoate-methyl (1 134) + TX, etoxazole (320) + TX, etrimfos (1 142) + TX, fenazaflor (1 147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad + TX, fenpyroximate (345) + TX, fenson (1 157) + TX, fentrifanil (1 161 ) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacry- pyrim (360) + TX, fluazuron (1 166) + TX, flubenzimine (1 167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1 174) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl cyclopropanecarboxylate (lUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441 ) + TX, iodomethane (lUPAC name) (542) + TX, isocarbophos (473) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, ivermectin [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261 ) + TX, mesulfen [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531 ) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX,
mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime [CCN] + TX, mipafox (1293) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, NC-512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (628) + TX, phenkapton (1330) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX, polychloroterpenes (traditional name) (1347) + TX, polynactins (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671 ) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (71 1 ) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos + TX, selamectin [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (development code) (1404) + TX, sulfiram [CCN] + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfur (754) + TX, SZI-121 (development code) (757) + TX, tau-fluvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam + TX, tetrachlorvinphos (777) + TX, tetradifon (786) + TX, tetranactin (653) + TX, tetrasul (1425) + TX, thiafenox + TX, thiocarboxime (1431 ) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thioquinox (1436) + TX, thuringiensin [CCN] + TX, triamiphos (1441 ) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,
an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hyd rated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,
an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin [CCN] + TX, ivermectin [CCN] + TX, milbemycin oxime [CCN] + TX, moxidectin [CCN] + TX, piperazine [CCN] + TX, selamectin [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,
an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1-hydroxy-1 /- -pyridine-2-thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + TX, fenaminosulf (1 144) + TX, formaldehyde (404) + TX, hydrargaphen [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (lUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1 ) + TX, potassium
hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX,
streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal [CCN] + TX, a biological agent selected from the group of substances consisting of Adoxophyes orana GV (12) + TX, Agrobacterium radiobacter (13) + TX, Amblyseius spp. (19) + TX, Anagrapha falcifera NPV (28) + TX, Anagrus atomus (29) + TX, Aphelinus abdominalis (33) + TX, Aphidius colemani (34) + TX, Aphidoletes aphidimyza (35) + TX, Autographa californica NPV (38) + TX, Bacillus firmus (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51 ) + TX, Beauveria bassiana (53) + TX, Beauveria brongniartii (54) + TX, Chrysoperla carnea (151 ) + TX, Cryptolaemus montrouzieri (178) + TX, Cydia pomonella GV (191 ) + TX, Dacnusa sibirica (212) + TX, Diglyphus isaea (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (300) + TX, Helicoverpa zea NPV (431 ) + TX, Heterorhabditis bacteriophora and H. megidis (433) + TX, Hippodamia convergens (442) + TX, Leptomastix dactylopii (488) + TX, Macrolophus caliginosus (491 ) + TX, Mamestra brassicae NPV (494) + TX, Metaphycus helvolus (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (575) + TX, Orius spp. (596) + TX, Paecilomyces fumosoroseus (613) + TX, Phytoseiulus persimilis (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinernema bibionis (742) + TX, Steinernema carpocapsae (742) + TX, Steinernema feltiae (742) + TX, Steinernema glaseri (742) + TX, Steinernema riobrave (742) + TX, Steinernema riobravis (742) + TX, Steinernema scapterisci (742) + TX,
Steinernema spp. (742) + TX, Trichogramma spp. (826) + TX, Typhlodromus occidentalis (844) and Verticillium lecanii (848) + TX, a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,
a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir [CCN] + TX, busulfan [CCN] + TX, diflubenzuron (250) + TX, dimatif [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron [CCN] + TX, tepa [CCN] + TX, thiohempa [CCN] + TX, thiotepa [CCN] + TX, tretamine [CCN] and uredepa [CCN] + TX,
an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (lUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (lUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (lUPAC name) (541 ) + TX, (E,Z)-tetradeca-4, 10-dien-1-yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (lUPAC name) (285) + TX, (Z)-hexadec-l 1- enal (lUPAC name) (436) + TX, (Z)-hexadec-l 1-en-1-yl acetate (lUPAC name) (437) + TX, (Z)- hexadec-13-en-1 1-yn-1-yl acetate (lUPAC name) (438) + TX, (Z)-icos-13-en-10-one (lUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (lUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (lUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (lUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (lUPAC name) (283) + TX, (9Z, 1 1 E)-tetradeca-9, 1 1-dien-1-yl acetate (lUPAC name) (780) + TX, (9Z, 12E)-tetradeca-9, 12-dien-1-yl acetate (lUPAC name) (781 ) + TX, 14-methyloctadec-1-ene (lUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (lUPAC name) (544) + TX, alpha-multistriatin [CCN] + TX, brevicomin [CCN] + TX, codlelure [CCN] + TX, codlemone (167) + TX, cuelure (179) + TX, disparlure (277) + TX, dodec-8-en-1-yl acetate (lUPAC name) (286) + TX, dodec-9-en-1-yl acetate (lUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1-yl acetate (lUPAC name) (284) + TX, dominicalure [CCN] + TX, ethyl 4-methyloctanoate (lUPAC name) (317) + TX, eugenol [CCN] + TX, frontalin [CCN] + TX, gossyplure (420) + TX, grandlure (421 ) + TX, grandlure I (421 ) + TX, grandlure II (421 ) + TX, grandlure III (421 ) + TX, grandlure IV (421 ) + TX, hexalure [CCN] + TX, ipsdienol [CCN] + TX, ipsenol [CCN] + TX, japonilure (481 ) + TX, lineatin [CCN] + TX, litlure [CCN] + TX, looplure [CCN] + TX, medlure [CCN] + TX, megatomoic acid [CCN] + TX, methyl eugenol (540) + TX, muscalure (563) + TX, octadeca-2, 13-dien-1-yl acetate (lUPAC name) (588) + TX, octadeca-3, 13-dien-1-yl acetate (lUPAC name) (589) + TX, orfralure [CCN] + TX, oryctalure (317) + TX, ostramone [CCN] + TX, siglure [CCN] + TX, sordidin (736) + TX, sulcatol [CCN] + TX, tetradec-1 1-en-1-yl acetate (lUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (839) + TX, trimedlure Bi (839) + TX, trimedlure B2 (839) + TX, trimedlure C (839) and trunc-call [CCN] + TX,
an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (lUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX, an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane (lUPAC/Chemical Abstracts name) (1058) + TX, 1 , 1-dichloro-2,2-bis(4-ethylphenyl)ethane (lUPAC name) (1056), + TX, 1 ,2-dichloropropane (lUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2- dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1-bromo-2-chloroethane (lUPAC/Chemical Abstracts name) (916) + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (lUPAC name) (1451 ) + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (lUPAC name) (1066) + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate (lUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2-butoxyethoxy)ethyl thiocyanate (lUPAC/Chemical Abstracts name) (935) + TX, 2- (4,5-dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate (lUPAC/ Chemical Abstracts name) (1084) + TX, 2-(4-chloro-3,5-xylyloxy)ethanol (lUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate
(lUPAC name) (984) + TX, 2-imidazolidone (lUPAC name) (1225) + TX, 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (lUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (lUPAC name) (1433) + TX, 3-bromo-1-chloroprop-1-ene (lUPAC name) (917) + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (lUPAC name) (1283) + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (lUPAC name) (1285) + TX, 5,5-dimethyl- 3-oxocyclohex-1-enyl dimethylcarbamate (lUPAC name) (1085) + TX, abamectin (1 ) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (lUPAC name) (861 ) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin [CCN] + TX, allyxycarb (866) + TX, alpha-cypermethrin (202) + TX, alpha-ecdysone [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (41 ) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (52) + TX, barium hexafluorosilicate [CCN] + TX, barium polysulfide (lUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta- cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (lUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX, butoxycarboxim (104) + TX, butylpyridaben + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbon disulfide (lUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (lUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (1 19) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131 ) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141 ) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin l (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin + TX, cismethrin (80) + TX, clocythrin + TX, cloethocarb (999) + TX, closantel [CCN] + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton [CCN] + TX, crotoxyphos (1010) + TX, crufomate (101 1 ) + TX, cryolite (177) + TX, CS 708 (development code) (1012) + TX, cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX, cycloprothrin (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201 ) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate [CCN] + TX, cf-limonene
[CCN] + TX, c/-tetramethrin (788) + TX, DAEP (1031 ) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S- methyl (224) + TX, demeton-S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051 ) + TX, dichlorvos (236) + TX, dicliphos + TX, dicresyl [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (lUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081 ) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX, dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271 ) + TX, diofenolan (1099) + TX, dioxabenzofos (1 100) + TX, dioxacarb (1 101 ) + TX, dioxathion (1 102) + TX, disulfoton (278) + TX, dithicrofos (1 108) + TX, DNOC (282) + TX, doramectin [CCN] + TX, DSP (1 1 15) + TX, ecdysterone [CCN] + TX, El 1642 (development code) (1 1 18) + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, EMPC (1 120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, endrin (1 122) + TX, EPBP (1 123) + TX, EPN (297) + TX, epofenonane (1 124) + TX, eprinomectin [CCN] + TX, esfenvalerate (302) + TX, etaphos [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate- methyl (1 134) + TX, ethoprophos (312) + TX, ethyl formate (lUPAC name) [CCN] + TX, ethyl-DDD (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1 136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1 142) + TX, EXD (1 143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1 147) + TX, fenchlorphos (1 148) + TX, fenethacarb (1 149) + TX, fenfluthrin (1 150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1 153) + TX, fenoxycarb (340) + TX, fenpirithrin (1 155) + TX, fenpropathrin (342) + TX, fenpyrad + TX, fensulfothion (1 158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flubendiamide (CAS. Reg. No.: 272451-65-7) + TX, flucofuron (1 168) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171 ) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191 ) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (121 1 ) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX, iodomethane (lUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231 ) + TX, isobenzan (1232) + TX,
isocarbophos (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I [CCN] + TX, juvenile hormone II [CCN] + TX, juvenile hormone III [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251 ) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m-cumenyl methylcarbamate (lUPAC name) (1014) + TX, magnesium phosphide (lUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261 ) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam-potassium (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (lUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531 ) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin [CCN] + TX, naftalofos [CCN] + TX, naled (567) + TX, naphthalene (lUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluridide (1309) + TX, nitenpyram (579) + TX, nithiazine (131 1 ) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (lUPAC name) (1057) + TX, 0,0-diethyl 0-4-methyl-2-oxo-2A -chromen-7-yl phosphorothioate (lUPAC name) (1074) + TX, Ο,Ο-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (lUPAC name) (1075) + TX, 0,0, 0',Ο'-tetrapropyl dithiopyrophosphate (lUPAC name) (1424) + TX, oleic acid (lUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfluron [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (lUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor (1339) + TX, phosphamidon (639) + TX, phosphine (lUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651 ) + TX, pirimiphos-ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (lUPAC name) (1346) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I [CCN] + TX, precocene II [CCN] + TX, precocene III [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia [CCN] + TX, quinalphos (71 1 ) + TX, quinalphos-methyl (1376) + TX, quinothion
(1380) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, rafoxanide [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (725) + TX, schradan (1389) + TX, sebufos + TX, selamectin [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride
(lUPAC/Chemical Abstracts name) (1399) + TX, sodium hexafluorosilicate (1400) + TX, sodium pentachlorophenoxide (623) + TX, sodium selenate (lUPAC name) (1401 ) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spiropidion (CCN) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta-cypermethrin (204) + TX, thiacloprid (791 ) + TX, thiafenox + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431 ) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441 ) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron + TX, trichlorfon (824) + TX, trichlormetaphos-3 [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (725) + TX, veratrine (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, YI-5302 (compound code) + TX, zeta- cypermethrin (205) + TX, zetamethrin + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19 + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121-52-0] + TX, cyflumetofen [400882-07-7] + TX,
pyrifluquinazon [337458-27-2] + TX, spinetoram [187166-40-1 + 187166-15-0] + TX, spirotetramat [203313-25-1] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin
[915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX, triflumezopyrim (disclosed in WO
2012/0921 15) + TX,
a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX, pyriprole [394730-71-3] + TX,
a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2- dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3- dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4- dichlorotetrahydrothiophene 1 ,1-dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4- chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3- ylacetic acid (lUPAC name) (1286) + TX, 6-isopentenylaminopurine (210) + TX, abamectin (1 ) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben + TX, cadusafos (109) + TX, carbofuran (1 18) + TX, carbon disulfide (945) + TX, carbosulfan (1 19) + TX, chloropicrin (141 ) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051 ) + TX, dicliphos + TX, dimethoate (262) + TX, doramectin [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad + TX,
fensulfothion (1 158) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furfural [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (lUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231 ) + TX, ivermectin [CCN] + TX, kinetin (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam-potassium (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime
[CCN] + TX, moxidectin [CCN] + TX, Myrothecium verrucaria composition (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos + TX, selamectin [CCN] + TX, spinosad (737) + TX, terbam + TX, terbufos (773) + TX, tetrachlorothiophene (lUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (210) + TX, fluensulfone [318290-98-1] + TX,
a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,
a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (720) + TX, a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione
(lUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, alpha-chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891 ) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91 ) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301 ) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1 183) + TX, flupropadine hydrochloride (1 183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (lUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (lUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (lUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341 ) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371 ) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851 ) and zinc phosphide (640) + TX,
a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (lUPAC name) (903) + TX, farnesol with nerolidol (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,
an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,
a virucide selected from the group of substances consisting of imanin [CCN] and ribavirin
[CCN] + TX,
a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX, and biologically active compounds selected from the group consisting of azaconazole (60207-31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [1 16255-48-2] + TX, cyproconazole [94361-06- 5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-24-3] + TX, epoxiconazole
[106325-08-0] + TX, fenbuconazole [1 14369-43-6] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674-21-0] + TX, hexaconazole [79983-71-4] + TX, imazalil [35554-44-0] + TX, imibenconazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, metconazole [1251 16-23-6] + TX, myclobutanil [88671-89-0] + TX, pefurazoate [101903-30-4] + TX, penconazole [66246-88-6] + TX, prothioconazole [178928-70-6] + TX, pyrifenox [88283-41-4] + TX, prochloraz [67747-09-5] + TX, propiconazole [60207-90-1] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534-96-3] + TX, tetraconazole [1 12281-77-3] + TX, triadimefon [43121-43-3] + TX, triad imenol [55219-65-3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771-68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71-9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221-53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidine [67306-00-7] + TX, fenpropimorph [67564-91-4] + TX, spiroxamine [1 18134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61-2] + TX, mepanipyrim [1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [131341-86-1] + TX, benalaxyl [71626-1 1-4] + TX, furalaxyl [57646-30-7] + TX, meta- laxyl [57837-19-1] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21-7] + TX, debacarb
[62732-91-6] + TX, fuberidazole [3878-19-1] + TX, thiabendazole [148-79-8] + TX, chlozolinate [84332-86-5] + TX, dichlozoline [24201-58-9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61-8] + TX, procymidone [32809-16-8] + TX, vinclozoline [50471-44-8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68-4] + TX, fenfuram [24691-80-3] + TX, flutolanil [66332-96- 5] + TX, mepronil [55814-41-0] + TX, oxycarboxin [5259-88-1] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine [108173-90-6] + TX, dodine [2439-10-3] [1 12-65- 2] (free base) + TX, iminoctadine [13516-27-3] + TX, azoxystrobin [131860-33-8] + TX, dimoxystrobin [149961-52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1 , 93} + TX, fluoxastrobin [361377-29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1] + TX, trifloxystrobin [141517-21-7] + TX, orysastrobin [248593-16-0] + TX, picoxystrobin [1 17428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, ferbam [14484-64-1] + TX, mancozeb [8018-01-7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071-83-9] + TX, thiram [137-26-8] + TX, zineb [12122-67-7] + TX, ziram [137-30-4] + TX, captafol [2425-06-1] + TX, captan [133-06-2] + TX, dichlofluanid [1085-98-9] + TX, fluoroimide [41205-21-4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731-27-1] + TX, bordeaux mixture [801 1- 63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758-98-7] + TX, copperoxid [1317-39-1] + TX, mancopper [53988-93-5] + TX, oxine-copper [10380-28-6] + TX, dinocap [131-72-6] + TX, nitrothal-isopropyl [10552-74-6] + TX, edifenphos
[17109-49-8] + TX, iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1] + TX, phosdiphen [36519-00-3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl [57018-04-9] + TX, acibenzo- lar-S-methyl [135158-54-2] + TX, anilazine [101-05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-01-2] + TX, chloroneb [2675-77-6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid [180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [117-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20-9] + TX, dimethomorph [110488-70-5] + TX, SYP-LI90 (Flumorph) [211867-47-9] + TX, dithianon [3347-22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] + TX, famoxadone [131807-57-3] + TX, fenamidone [161326-34-7] + TX, fenoxanil [115852-48-7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64-7] + TX, fluazinam
[79622-59-6] + TX, fluopicolide [2391 10-15-7] + TX, flusulfamide [106917-52-6] + TX, fenhexamid [126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004-44-1] + TX, iprovalicarb [140923-17-7] + TX, IKF-916 (Cyazofamid) [120116-88-3] + TX, kasugamycin [6980-18- 3] + TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899-03-6] + TX, pencycuron [66063- 05-67 + TX, phthalide [27355-22-2] + TX, polyoxins [1 1 1 13-80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41-1] + TX, proquinazid [189278-12-4] + TX, pyroquilon [57369-32-1] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, tiadinil [223580-51-6] + TX, triazoxide [72459-58-6] + TX, tricyclazole [41814-78-2] + TX, triforine [26644- 46-2] + TX, validamycin [37248-47-8] + TX, zoxamide (RH7281 ) [156052-68-5] + TX,
mandipropamid [374726-62-2] + TX, isopyrazam [881685-58-1] + TX, sedaxane [874967-67-6] + TX, 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4-tetrahydro-1 ,4- methano-naphthalen-5-yl)-amide (dislosed in WO 2007/048556) + TX, 3-difluoromethyl-1-methyl-1 H- pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343) + TX, [(3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-3-[(cyclopropylcarbonyl)oxy]- 1 ,3,4,4a,5,6,6a, 12,12a, 12b- decahydro-6, 12-dihydroxy-4,6a,12b-trimethyl-^
e]pyran-4-yl]methyl-cyclopropanecarboxylate [915972-17-7] + TX and 1 ,3,5-trimethyl-N-(2-methyl-1- oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro^
pyrazole-4-carboxamide [926914-55-8] + TX, lancotrione [1486617-21-3] + TX, florpyrauxifen [943832- 81-3] ] + TX, ipfentrifluconazole[1417782-08-1] + TX, mefentrifluconazole [1417782-03-6] + TX, quinofumelin [861647-84-9] + TX, chloroprallethrin [399572-87-3] + TX, cyhalodiamide [1262605-53- 7] ] + TX, fluazaindolizine [1254304-22-7] + TX, fluxametamide [928783-29-3] + TX, epsilon- metofluthrin [240494-71-7] + TX, epsilon-momfluorothrin [1065124-65-3] + TX, pydiflumetofen
[1228284-64-7] + TX, kappa-bifenthrin [439680-76-9] + TX, broflanilide [1207727-04-5] + TX, dicloromezotiaz [1263629-39-5] + TX, dipymetitrone [161 14-35-5] + TX, pyraziflumid [942515-63-1] + TX, kappa-tefluthrin [391634-71-2] + TX, fenpicoxamid [517875-34-2] + TX, fluindapyr [1383809-87-7] + TX, alpha-bromadiolone [28772-56-7] + TX, flupyrimin [1689566-03-7] + TX, benzpyrimoxan
[1449021-97-9] + TX, acynonapyr [1332838-17-1] + TX, inpyrfluxam [1352994-67-2] + TX, isoflucypram [1255734-28-1] + TX, rescalure [64309-03-1] + TX, fluxametamide [928783-29-3] + TX, tetraniliprole [1229654-66-3] + TX, guadipyr (described in WO2010/060231 ) + TX, cycloxaprid
(described in WO 2005/077934) + TX, Afidopyropen + TX, kappa-bifenthrin + TX, kappa-tefluthrin + TX, Tetrachloraniliprole + TX, aminopyrifen [1531626-08-0] + TX, tyclopyrazoflor [1477919-27-9] + TX, Dichloromezotiaz + TX, Momfluorothrin + TX, Fluopyram + TX, Terpenoid blend + TX, Fluhexafon + TX, Cyclaniliprole + TX, and spiropidion [1229023-00-0] + TX; and
microbials including: Acinetobacter Iwoffii + TX, Acremonium alternatum + TX + TX, Acremonium cephalosporium + TX + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter strain K84 (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX,
Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp. + TX, Aureobasidium pullulans + TX, Azospirillum + TX, (MicroAZ® + TX, TAZO B®) + TX, Azotobacter + TX, Azotobacter chroocuccum (Azotomeal®) + TX, Azotobacter cysts (Bionatural Blooming Blossoms®) + TX, Bacillus amyloliquefaciens + TX, Bacillus cereus + TX, Bacillus chitinosporus strain CM-1 + TX, Bacillus chitinosporus strain AQ746 + TX, Bacillus licheniformis strain HB-2 (Biostart™ Rhizoboost®) + TX, Bacillus licheniformis strain 3086 (EcoGuard® + TX, Green Releaf®) + TX, Bacillus circulans + TX, Bacillus firmus (BioSafe®, BioNem- WP®, VOTiVO®) + TX, Bacillus firmus strain 1-1582 + TX, Bacillus macerans + TX, Bacillus marismortui + TX, Bacillus megaterium + TX, Bacillus mycoides strain AQ726 + TX, Bacillus papillae (Milky Spore Powder®) + TX, Bacillus pumilus spp. + TX, Bacillus pumilus strain GB34 (Yield Shield®) + TX, Bacillus pumilus strain AQ717 + TX, Bacillus pumilus strain QST 2808 (Sonata® + TX, Ballad Plus®) + TX, Bacillus spahericus (VectoLex®) + TX, Bacillus spp. + TX, Bacillus spp. strain AQ175 + TX, Bacillus spp. strain AQ177 + TX, Bacillus spp. strain AQ178 + TX, Bacillus subtilis strain QST 713 (CEASE® + TX, Serenade® + TX, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 (Taegro® + TX, Rhizopro®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis CrylAb + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis israelensis (BMP123® + TX, Aquabac® + TX, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin® + TX, Deliver® + TX, CryMax® + TX, Bonide® + TX, Scutella WP® + TX, Turilav WP ® + TX, Astuto® + TX, Dipel WP® + TX, Biobit® + TX, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF / 3P®) + TX, Bacillus thuringiensis strain BD#32 + TX, Bacillus thuringiensis strain AQ52 + TX, Bacillus thuringiensis var. aizawai (XenTari® + TX, DiPel®) + TX, bacteria spp. (GROWMEND® + TX, GROWSWEET® + TX, Shootup®) + TX, bacteriophage of Clavipacter michiganensis (AgriPhage®) + TX, Bakflor® + TX, Beauveria bassiana (Beaugenic® + TX, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES® + TX, Mycotrol O® + TX, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz® + TX, Schweizer Beauveria® + TX, Melocont®) + TX, Beauveria spp. + TX, Botrytis cineria + TX, Bradyrhizobium japonicum
(TerraMax®) + TX, Brevibacillus brevis + TX, Bacillus thuringiensis tenebrionis (Novodor®) + TX, BtBooster + TX, Burkholderia cepacia (Deny® + TX, Intercept® + TX, Blue Circle®) + TX,
Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp. + TX, Canadian thistle fungus (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reukaufii + TX, Candida saitoana (Bio-Coat® + TX, Biocure®) + TX, Candida sake + TX, Candida spp. + TX, Candida tenius + TX, Cedecea dravisae + TX, Cellulomonas flavigena + TX, Chaetomium cochliodes (Nova-Cide®) + TX, Chaetomium globosum (Nova-Cide®) + TX,
Chromobacterium subtsugae strain PRAA4-1T (Grandevo®) + TX, Cladosporium cladosporioides + TX, Cladosporium oxysporum + TX, Cladosporium chlorocephalum + TX, Cladosporium spp. + TX, Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp. + TX, Cryptococcus albidus (YIELDPLUS®) + TX, Cryptococcus humicola + TX, Cryptococcus infirmo-miniatus + TX,
Cryptococcus laurentii + TX, Cryptophlebia leucotreta granulovirus (Cryptex®) + TX, Cupriavidus campinensis + TX, Cydia pomonella granulovirus (CYD-X®) + TX, Cydia pomonella granulovirus (Madex® + TX, Madex Plus® + TX, Madex Max/ Carpovirusine®) + TX, Cylindrobasidium laeve (Stumpout®) + TX, Cylindrocladium + TX, Debaryomyces hansenii + TX, Drechslera hawaiinensis + TX, Enterobacter cloacae + TX, Enterobacteriaceae + TX, Entomophtora virulenta (Vektor®) + TX, Epicoccum nigrum + TX, Epicoccum purpurascens + TX, Epicoccum spp. + TX, Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean® / Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop® + TX, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp. (SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus
(Granupom®) + TX, Halobacillus halophilus + TX, Halobacillus litoralis + TX, Halobacillus trueperi + TX, Halomonas spp. + TX, Halomonas subglaciescola + TX, Halovibrio variabilis + TX, Hanseniaspora uvarum + TX, Helicoverpa armigera nucleopolyhedrovirus (Helicovex®) + TX, Helicoverpa zea nuclear polyhedrosis virus (Gemstar®) + TX, Isoflavone - formononetin (Myconate®) + TX, Kloeckera apiculata + TX, Kloeckera spp. + TX, Lagenidium giganteum (Laginex®) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Met52®) + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX, Micromonospora coerulea + TX, Microsphaeropsis ochracea + TX, Muscodor albus 620 (Muscudor®) + TX, Muscodor roseus strain A3-5 + TX, Mycorrhizae spp. (AMykor® + TX, Root Maximizer®) + TX, Myrothecium verrucaria strain AARC-0255 (DiTera®) + TX, BROS PLUS® + TX, Ophiostoma piliferum strain D97 (Sylvanex®) + TX, Paecilomyces farinosus + TX, Paecilomyces fumosoroseus (PFR-97® + TX, PreFeRal®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, Paecilomyces lilacinus strain 251 (MeloCon WG®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1®) + TX, Pantoea spp. + TX, Pasteuria spp. (Econem®) + TX, Pasteuria nishizawae + TX, Penicillium aurantiogriseum + TX, Penicillium billai (Jumpstart® + TX, TagTeam®) + TX, Penicillium
brevicompactum + TX, Penicillium frequentans + TX, Penicillium griseofulvum + TX, Penicillium purpurogenum + TX, Penicillium spp. + TX, Penicillium viridicatum + TX, Phlebiopsis gigantean (Rotstop®) + TX, phosphate solubilizing bacteria (Phosphomeal®) + TX, Phytophthora cryptogea + TX, Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX,
Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp. + TX, Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudomons fluorescens (Zequanox®) + TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex L®) + TX, Puccinia canaliculata + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium
paroecandrum + TX, Pythium oligandrum (Polygandron® + TX, Polyversum®) + TX, Pythium periplocum + TX, Rhanella aquatilis + TX, Rhanella spp. + TX, Rhizobia (Dormal® + TX, Vault®) + TX, Rhizoctonia + TX, Rhodococcus globerulus strain AQ719 + TX, Rhodosporidium diobovatum + TX, Rhodosporidium toruloides + TX, Rhodotorula spp. + TX, Rhodotorula glutinis + TX, Rhodotorula graminis + TX, Rhodotorula mucilagnosa + TX, Rhodotorula rubra + TX, Saccharomyces cerevisiae + TX, Salinococcus roseus + TX, Sclerotinia minor + TX, Sclerotinia minor (SARRITOR®) + TX, Scytalidium spp. + TX, Scytalidium uredinicola + TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X® + TX, Spexit®) + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, Spodoptera littoralis nucleopolyhedrovirus (Littovir®) + TX,
Sporobolomyces roseus + TX, Stenotrophomonas maltophilia + TX, Streptomyces ahygroscopicus + TX, Streptomyces albaduncus + TX, Streptomyces exfoliates + TX, Streptomyces galbus + TX, Streptomyces griseoplanus + TX, Streptomyces griseoviridis (Mycostop®) + TX, Streptomyces lydicus (Actinovate®) + TX, Streptomyces lydicus WYEC-108 (ActinoGrow®) + TX, Streptomyces violaceus + TX, Tilletiopsis minor + TX, Tilletiopsis spp. + TX, Trichoderma asperellum (T34 Biocontrol®) + TX, Trichoderma gamsii (Tenet®) + TX, Trichoderma atroviride (Plantmate®) + TX, Trichoderma hamatum TH 382 + TX, Trichoderma harzianum rifai (Mycostar®) + TX, Trichoderma harzianum T-22 (Trianum- P® + TX, PlantShield HC® + TX, RootShield® + TX, Trianum-G®) + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma spp. LC 52 (Sentinel®) + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma taxi + TX, Trichoderma virens + TX, Trichoderma virens (formerly Gliocladium virens GL-21 ) (SoilGuard®) + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX,
Trichothecium spp. + TX, Trichothecium roseum + TX, Typhula phacorrhiza strain 94670 + TX, Typhula phacorrhiza strain 94671 + TX, Ulocladium atrum + TX, Ulocladium oudemansii (Botry-Zen®) + TX, Ustilago maydis + TX, various bacteria and supplementary micronutrients (Natural II®) + TX, various fungi (Millennium Microbes®) + TX, Verticillium chlamydosporium + TX, Verticillium lecanii (Mycotal® + TX, Vertalec®) + TX, Vip3Aa20 (VIPtera®) + TX, Virgibaclillus marismortui + TX, Xanthomonas campestris pv. Poae (Camperico®) + TX, Xenorhabdus bovienii + TX, Xenorhabdus nematophilus, and
Plant extracts including: pine oil (Retenol®) + TX, azadirachtin (Plasma Neem Oil® + TX,
AzaGuard® + TX, MeemAzal® + TX, Molt-X® + TX, Botanical IGR (Neemazad®, Neemix®) + TX, canola oil (Lilly Miller Vegol®) + TX, Chenopodium ambrosioides near ambrosioides (Requiem®) + TX, Chrysanthemum extract (Crisant®) + TX, extract of neem oil (Trilogy®) + TX, essentials oils of Labiatae (Botania®) + TX, extracts of clove rosemary peppermint and thyme oil (Garden insect killer®) + TX, Glycinebetaine (Greenstim®) + TX, garlic + TX, lemongrass oil (GreenMatch®) + TX, neem oil + TX, Nepeta cataria (Catnip oil) + TX, Nepeta catarina + TX, nicotine + TX, oregano oil (MossBuster®) + TX, Pedaliaceae oil (Nematon®) + TX, pyrethrum + TX, Quillaja saponaria (NemaQ®) + TX, Reynoutria sachalinensis (Regalia® + TX, Sakalia®) + TX, rotenone (Eco Roten®) + TX, Rutaceae plant extract (Soleo®) + TX, soybean oil (Ortho ecosense®) + TX, tea tree oil (Timorex Gold®) + TX, thymus oil + TX, AGNIQUE® MMF + TX, BugOil® + TX, mixture of rosemary sesame pepermint thyme and cinnamon extracts (EF 300®) + TX, mixture of clove rosemary and peppermint extract (EF 400®) + TX, mixture of clove pepermint garlic oil and mint (Soil Shot®) + TX, kaolin (Screen®) + TX, storage glucam of brown algae (Laminarin®) + TX, and
pheromones including: blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Codling Moth Pheromone (Paramount dispenser-(CM)/ Isomate C-Plus®) + TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Leafroller pheromone (3M MEC - LR Sprayable Pheromone®) + TX, Muscamone (Snip7 Fly Bait® + TX, Starbar Premium Fly Bait®) + TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable pheromone®) + TX, Peachtree Borer Pheromone (Isomate-P®) + TX, Tomato Pinworm Pheromone (3M Sprayable pheromone®) + TX, Entostat powder (extract from palm tree) (Exosex CM®) + TX, Tetradecatrienyl acetate + TX, 13-Hexadecatrienal + TX, (E + TX,Z)-7 + TX,9-Dodecadien-1-yl acetate + TX, 2-Methyl- 1-butanol + TX, Calcium acetate + TX, Scenturion® + TX, Biolure® + TX, Check-Mate® + TX, Lavandulyl senecioate, and
Macrobials including: Aphelinus abdominalis + TX, Aphidius ervi (Aphelinus-System®) + TX,
Acerophagus papaya + TX, Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline® + TX, Andersoni-System®) + TX, Amblyseius californicus
(Amblyline® + TX, Spical®) + TX, Amblyseius cucumeris (Thripex® + TX, Bugline cucumeris®) + TX, Amblyseius fallacis (Fallacis®) + TX, Amblyseius swirskii (Bugline swirskii® + TX, Swirskii-Mite®) + TX, Amblyseius womersleyi (WomerMite®) + TX, Amitus hesperidum + TX, Anagrus atomus + TX, Anagyrus fusciventris + TX, Anagyrus kamali + TX, Anagyrus loecki + TX, Anagyrus pseudococci (Citripar®) + TX, Anicetus benefices + TX, Anisopteromalus calandrae + TX, Anthocoris nemoralis (Anthocoris-System®) + TX, Aphelinus abdominalis (Apheline® + TX, Aphiline®) + TX, Aphelinus asychis + TX, Aphidius colemani (Aphipar®) + TX, Aphidius ervi (Ervipar®) + TX, Aphidius gifuensis + TX, Aphidius matricariae (Aphipar-M®) + TX, Aphidoletes aphidimyza (Aphidend®) + TX, Aphidoletes aphidimyza (Aphidoline®) + TX, Aphytis lingnanensis + TX, Aphytis melinus + TX, Aprostocetus hagenowii + TX, Atheta coriaria (Staphyline®) + TX, Bombus spp. + TX, Bombus terrestris (Natupol Beehive®) + TX, Bombus terrestris (Beeline® + TX, Tripol®) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chrysoperla carnea (Chrysoline®) + TX, Chrysoperla carnea
(Chrysopa®) + TX, Chrysoperla rufilabris + TX, Cirrospilus ingenuus + TX, Cirrospilus quadristriatus + TX, Citrostichus phyllocnistoides + TX, Closterocerus chamaeleon + TX, Closterocerus spp. + TX, Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug® + TX, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica + TX, Dacnusa sibirica
(Minusa®) + TX, Diglyphus isaea (Diminex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea + TX, Diglyphus isaea (Miglyphus® + TX, Digline®) + TX, Dacnusa sibirica (DacDigline® + TX, Minex®) + TX, Diversinervus spp. + TX, Encarsia citrina + TX, Encarsia formosa (Encarsia max® + TX, Encarline® + TX, En- Strip®) + TX, Eretmocerus eremicus (Enermix®) + TX, Encarsia guadeloupae + TX, Encarsia haitiensis + TX, Episyrphus balteatus (Syrphidend®) + TX, Eretmoceris siphonini + TX, Eretmocerus californicus + TX, Eretmocerus eremicus (Ercal® + TX, Eretline e®) + TX, Eretmocerus eremicus (Bemimix®) + TX, Eretmocerus hayati + TX, Eretmocerus mundus (Bemipar® + TX, Eretline m®) + TX, Eretmocerus siphonini + TX, Exochomus quadripustulatus + TX, Feltiella acarisuga (Spidend®) + TX, Feltiella acarisuga (Feltiline®) + TX, Fopius arisanus + TX, Fopius ceratitivorus + TX,
Formononetin (Wirless Beehome®) + TX, Franklinothrips vespiformis (Vespop®) + TX, Galendromus occidentalis + TX, Goniozus legneri + TX, Habrobracon hebetor + TX, Harmonia axyridis
(HarmoBeetle®) + TX, Heterorhabditis spp. (Lawn Patrol®) + TX, Heterorhabditis bacteriophora
(NemaShield HB® + TX, Nemaseek® + TX, Terranem-Nam® + TX, Terranem® + TX, Larvanem® + TX, B-Green® + TX, NemAttack ® + TX, Nematop®) + TX, Heterorhabditis megidis (Nemasys H® + TX, BioNem H® + TX, Exhibitline hm® + TX, Larvanem-M®) + TX, Hippodamia convergens + TX, Hypoaspis aculeifer (Aculeifer-System® + TX, Entomite-A®) + TX, Hypoaspis miles (Hypoline m® + TX, Entomite-M®) + TX, Lbalia leucospoides + TX, Lecanoideus floccissimus + TX, Lemophagus errabundus + TX, Leptomastidea abnormis + TX, Leptomastix dactylopii (Leptopar®) + TX,
Leptomastix epona + TX, Lindorus lophanthae + TX, Lipolexis oregmae + TX, Lucilia caesar
(Natufly®) + TX, Lysiphlebus testaceipes + TX, Macrolophus caliginosus (Mirical-N® + TX, Macroline c® + TX, Mirical®) + TX, Mesoseiulus longipes + TX, Metaphycus flavus + TX, Metaphycus lounsburyi + TX, Micromus angulatus (Milacewing®) + TX, Microterys flavus + TX, Muscidifurax raptorellus and Spalangia cameroni (Biopar®) + TX, Neodryinus typhlocybae + TX, Neoseiulus californicus + TX, Neoseiulus cucumeris (THRYPEX®) + TX, Neoseiulus fallacis + TX, Nesideocoris tenuis
(NesidioBug® + TX, Nesibug®) + TX, Ophyra aenescens (Biofly®) + TX, Onus insidiosus (Thripor-I® + TX, Oriline i®) + TX, Onus laevigatus (Thripor-L® + TX, Oriline I®) + TX, Orius majusculus (Oriline m®) + TX, Orius strigicollis (Thripor-S®) + TX, Pauesia juniperorum + TX, Pediobius foveolatus + TX, Phasmarhabditis hermaphrodita (Nemaslug®) + TX, Phymastichus coffea + TX, Phytoseiulus macropilus + TX, Phytoseiulus persimilis (Spidex® + TX, Phytoline p®) + TX, Podisus maculiventris (Podisus®) + TX, Pseudacteon curvatus + TX, Pseudacteon obtusus + TX, Pseudacteon tricuspis + TX, Pseudaphycus maculipennis + TX, Pseudleptomastix mexicana + TX, Psyllaephagus pilosus +
TX, Psyttalia concolor (complex) + TX, Quadrastichus spp. + TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinemema carpocapsae (Nematac C® + TX, Millenium® + TX, BioNem C® + TX, NemAttack® + TX, Nemastar® + TX, Capsanem®) + TX, Steinemema feltiae (NemaShield® + TX, Nemasys F® + TX, BioNem F® + TX, Steinernema-System® + TX, NemAttack® + TX, Nemaplus® + TX, Exhibitline sf® + TX, Scia-rid® + TX, Entonem®) + TX, Steinemema kraussei (Nemasys L® + TX, BioNem L® + TX, Exhibitline srb®) + TX, Steinemema riobrave (BioVector® + TX, BioVektor®) + TX, Steinemema scapterisci (Nematac S®) + TX, Steinemema spp. + TX, Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator, and
other biologicals including: abscisic acid + TX, bioSea® + TX, Chondrostereum purpureum
(Chontrol Paste®) + TX, Colletotrichum gloeosporioides (Collego®) + TX, Copper Octanoate
(Cueva®) + TX, Delta traps (Trapline d®) + TX, Erwinia amylovora (Harpin) (ProAct® + TX, Ni-HIBIT Gold CST®) + TX, Ferri-phosphate (Ferramol®) + TX, Funnel traps (Trapline y®) + TX, Gallex® + TX, Grower's Secret® + TX, Homo-brassonolide + TX, Iron Phosphate (Lilly Miller Worry Free Ferramol Slug & Snail Bait®) + TX, MCP hail trap (Trapline f®) + TX, Microctonus hyperodae + TX,
Mycoleptodiscus terrestris (Des-X®) + TX, BioGain® + TX, Aminomite® + TX, Zenox® + TX,
Pheromone trap (Thripline ams®) + TX, potassium bicarbonate (MilStop®) + TX, potassium salts of fatty acids (Sanova®) + TX, potassium silicate solution (Sil-Matrix®) + TX, potassium iodide + potassiumthiocyanate (Enzicur®) + TX, SuffOil-X® + TX, Spider venom + TX, Nosema locustae (Semaspore Organic Grasshopper Control®) + TX, Sticky traps (Trapline YF® + TX, Rebell Amarillo®) + TX and Traps (Takitrapline y + b®) + TX.
The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium, Thirteenth Edition, Editor: C. D. S. TomLin, The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound, for example, the compound "abamectin" is described under entry number (1 ). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood, Compendium of Pesticide Common Names, Copyright © 1995-2004], for example, the compound "acetoprole" is described under the internet address https://www.alanwood.net/pesticides/acetoprole.html.
Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound, in that case, the lUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "development code" is used. "CAS Reg. No" means the Chemical Abstracts Registry Number.
The ratio (by weight) of active ingredient mixture of the compounds of formula I selected from Tables 1 and A with active ingredients described above is from 100: 1 to 1 :6000, especially from 50: 1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10: 1 to 1 : 10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2: 1 to 1 :2, and a ratio of from 4: 1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 : 150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750.
The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
The mixtures comprising a compound of formula I selected from Tables 1 and A and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula I selected from Tables 1 and A and the active ingredients as described above is not essential for working the present invention.
In a further aspect, the present invention provides a combination of active ingredients comprising a compound defined in the first aspect, and one or more further active ingredients (whether chemical or biological).
The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides. The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also a subject of the invention.
The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha.
A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.
The compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing. Alternatively, the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.
The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.
The present invention also comprises seeds coated or treated with or containing a compound of formula I. The term "coated or treated with and/or containing" generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application. When the said seed product is (re)planted, it may absorb the active ingredient. In an embodiment, the present invention makes available a plant propagation material adhered thereto with a compound of formula I . Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound of formula I .
Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The seed treatment application of the compound formula I can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds.
The compounds of the invention can be distinguished from other similar compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples below, using lower concentrations if necessary, for example 10 ppm, 5 ppm, 2 ppm, 1 ppm or 0.2 ppm; or lower application rates, such as 300, 200 or 100, mg of Al per m2.
An aspect of the present invention is a method of controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula I defined the first aspect, or a composition containing a compound of formula I defined the first aspect, to a pest, a locus of pest, preferably a plant, to a plant susceptible to attack by a pest or to plant propagation material thereof, such as a seed, provided if the the control were on a human or animal body, then it is non-therapeutical.
A further aspect is a plant propagation material comprising by way of treatment or coating one or more compounds of formula I defined the first aspect, optionally also comprising a colour pigment.
In each aspect and embodiment of the invention, "consisting essentially" and inflections thereof are a preferred embodiment of "comprising" and its inflections, and "consisting of and inflections thereof are a preferred embodiment of "consisting essentially of" and its inflections.
The disclosure in the present application makes available each and every combination of embodiments disclosed herein.
The following Examples serve to illustrate the invention. They do not limit the invention. Temperatures are given in degrees Celsius; mixing ratios of solvents are given in parts by volume.
PREPARATORY EXAMPLES:
"Mp" means melting point in °C. Free radicals represent methyl groups. H and 9F NMR measurements were recorded on Brucker 400MHz or 300MHz spectrometers, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated. Either one of the LCMS methods below was used to characterize the compounds. The characteristic LCMS values obtained for each compound were the retention time ("Rt", recorded in minutes) and the measured molecular ion (M+H)+ and/or (M-H)~.
LCMS Methods:
Method A - Standard: (SQD-ZDQ-ZCQ)
Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150°C, Desolvation Temperature: 350°C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μηη, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH:
gradient: gradient: 0 min 0% B, 100%A, 1.2-1.5min 100% B, Flow (ml/min) 0.85.
Method B - MobilePhase:A:water(0.1 %HCOOH) B:ACN(0.08%HCOOH), Gradient :10%B increase to 95%B with 4min,95%B for 10min , Flow rate: 0.6ml/min. column :porpshell 120 C18 4.6*50mm,2.7um a) Synthesis of intermediates:
Example 11 : Preparation of 2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)aminolacetic acid (compound B2 in table B)
Figure imgf000096_0001
Step 11 -A: Synthesis of N-(2,2-dimethoxyethyl)pyridin-2-amine
Figure imgf000096_0002
To a suspension of lithium amide (L1NH2) (2.77 g) in anhydrous toluene (41 ml), under dry argon atmosphere, was added 2-aminopyridine (10.00 g), portion wise, while stirring. Once the evolution of ammonia has slowed down, the suspension is heated up to 1 10°C and stirred for 4 more hours. To the resulting purple-gray suspension was added 2-chloro-1 , 1-dimethoxyethane (13.24 g) within a few minutes, at the same temperature. The heating was continued for 14 hours, leading to a dark brown suspension.
After cooling down to 20°C the suspension was filtered through a pad of celite®. The residue was washed with diethyl ether and the filtrate was evaporated under reduced pressure to yield a dark brown oily residue. The crude product was submitted to flash chromatography over silica gel, eluting with a mixture of ethyl acetate-cyclohexane (60/40) to yield the title compound as a brown oil.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.10 (m, 1 H), 7.41 (m, 1 H), 6.59 (m, 1 H), 6.43 (d, 1 H), 4.68 (br s, 1 H), 4.56 (t, 1 H), 3.49 (t, 2H), 3.43 (s, 6H).
Step 11-B: Synthesis of N-[(2-chlorothiazol-5-yl)methyll-N-(2,2-dimethoxyethyl)pyridin-2-amine (compound B5 in table B)
Figure imgf000097_0001
To a solution of N-(2,2-dimethoxyethyl)pyridin-2-amine (described above) (9.36 g) in anhydrous tetrahydrofuran (77 ml) stirred at 0°C, under inert atmosphere, was slowly added a solution of n-butyl lithium (1.6 M in hexanes) (32 ml), while keeping the temperature. After the addition, the mixture was further stirred at 0°C for 1 hour. At this point, 2-chloro-5-(chloromethyl)thiazole (preparation described in the literature) (8.63 g) was added. The reaction mixture was stirred at 0°C for 4 hours, then the cooling bath was removed and the reaction mixture was stirred at 20°C for 1 1 hours. Water (a few drops) was added carefully and the reaction mixture was evaporated. The residue was submitted to flash chromatography over silica gel, eluting with a mixture of ethyl acetate and cyclohexane.
Evaporation of the selected fractions yielded the title compound as a light orange oil.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.22 (d, 1 H), 7.49 (m, 1 H), 7.45 (s, 1 H), 6.67 (m, 1 H), 6.62 (d, 1 H), 4.88 (s, 2H), 4.54 (t, 1 H), 3.52 (d, 2H), 3.43 (s, 6H).
Step 11-C: Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)aminolacetaldehyde (compound B1 in table B)
Figure imgf000097_0002
N-[(2-chlorothiazol-5-yl)methyl]-N-(2,2-dimethoxyethyl)pyridin-2-amine (preparation described here above) (5.33 g) was treated with hydrochloric acid (2.0 M in water, 85 ml) under argon atmosphere. The mixture was stirred at 80°C for 20 minutes. The reaction mixture was then cooled to 0°C, diluted with dichloromethane (130 ml) and the pH was adjusted to pH = 9 by adding saturated aqueous sodium carbonate solution. The phases were separated and the aqueous phase was extracted twice with dichloromethane. The organic extracts were unified and dried over anhydrous sodium sulfate. After removal of the solvent under reduced pressure, the aldehyde was used without purification in the following step. A sample of the crude 2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)amino]acetaldehyde was characterized by H-NMR.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 9.58 (br s, 1 H), 8.24 (d, 1 H), 7.55 (m, 1 H), 7.46 (s, 1 H), 6.75
(dd, 1 H), 6.55 (d, 1 H), 4.87 (s, 2H), 4.20 (s, 2H). Step 11-D: Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)aminolacetic acid (compound B2 in table B)
Figure imgf000098_0001
The crude product of the deprotection step (3.96 g) was dissolved in a mixture of tert-butyl alcohol (195 ml) and cyclohexene (37.5 ml) under argon atmosphere. To this solution was added at 20°C, under vigorous stirring, a freshly prepared solution of sodium chlorite (2.36 g) and sodium dihydrogen phosphate (2.40 g) in water (58 ml). After completion of the addition, it was stirred for 1.5 hour more, at which time the LC-MS analysis of a sample of the reaction mixture showed that the starting material was consumed. Diethyl ether was added and the phases were separated. The aqueous phase was extracted with ether and the combined organic phases were washed with brine and dried over sodium sulfate. Removal of the solvent under reduced pressure left a residue that was purified by
chromatography over silica gel, eluting first with dichloromethane, then with a mixture of methanol and dichloromethane. The selected fraction were evaporated to leave the title compound characterized by Ή-NMR.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.21 (d, 1 H), 7.58 (m, 1 H), 7.47 (s, 1 H), 6.78 (dd, 1 H), 6.64 (d, 1 H), 4.85 (s, 2H), 4.21 (s, 2H).
Example I2: Preparation of 2-[(2-chlorothiazol-5-yl)methyl-(3-methyl-2-pyridyl)aminolacetic acid (compound B4 in table B)
Figure imgf000098_0002
Step I2-A: Synthesis of N-(2,2-dimethoxyethyl)-3-methyl-pyridin-2-amine
Figure imgf000098_0003
In an analogous way as for N-(2,2-dimethoxyethyl)pyridin-2-amine described in step A of example 11 , starting with 3-methylpyridine-2-amine instead of 2-aminopyridine, the title compound was obtained as an oil. Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.02 (d, 1 H), 7.23 (d, 1 H), 6.55 (dd, 1 H), 4.58 (t, 1 H), 4.39 (br s, 1 H), 3.68 (t, 2H), 3.45 (s, 6H), 2.1 1 (s, 3H).
Step I2-B: Synthesis of N-[(2-chlorothiazol-5-yl)methyll-N-(2,2-dimethoxyethyl)-3-methyl-pyridin-2- amine
Figure imgf000099_0001
In an analogous way as for N-[(2-chlorothiazol-5-yl)methyl]-N-(2,2-dimethoxyethyl)pyridin-2-anriine described in step B of example 11 , starting with N-(2,2-dimethoxyethyl)-3-methyl-pyridin-2-amine instead of N-(2,2-dimethoxyethyl)pyridin-2-amine, the title compound was obtained as an oil.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.18 (d, 1 H), 7.43 (d, 1 H), 7.42 (s, 1 H), 6.89 (dd, 1 H), 4.68
(s, 2H), 4.52 (t, 1 H), 3.35 (s, 6H), 3.28 (d, 2H), 2.32 (s, 3H).
Step I2-C: Synthesis of 2-[(2-chlorothiazol-5-vnmethyl-(3-methyl-2-pyridvnaminolacetaldehyde (compound B3 in table B)
Figure imgf000099_0002
The title compound was obtained in an similar way as for the preparation of 2-[(2-chlorothiazol-5- yl)methyl-(2-pyridyl)amino]acetic acid described in step C of example 11.
A sample of the crude 2-[(2-chlorothiazol-5-yl)methyl-(3-methyl-2-pyridyl)amino]acetaldehyde was characterized by Ή-NMR: Ή-NMR (CDCI3, 400 MHz, δ in ppm): 9.50 (br s, 1 H), 8.20 (d, 1 H), 7.48 (d, 1 H), 7.43 (s, 1 H), 6.94 (dd, 1 H), 4.64 (s, 2H), 3.93 (s, 2H), 2.34 (s, 3H).
Step I2-D: Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-(3-methyl-2-pyridyl)aminolacetic acid (compound B4 in table B
Figure imgf000099_0003
The crude product of the deprotection step was oxidized, as described in Step D of example 11 , to the title compound, which was purified by chromatography over silica gel.
H-NMR (CDCI3, 400 MHz, δ in ppm): 8.16 (d, 1 H), 7.67 (d, 1 H), 7.54 (s, 1 H), 7.13 (dd, 1 H), 4.46 (s, 2H), 4.00 (s, 2H), 2.42 (s, 3H). Example 13: Preparation of 2-[(2-chlorothiazol-5-vnmethyl-[3-(trifluoromethvn-2-pyridyllaminolacetic acid (compound B10 in table B)
Figure imgf000100_0001
Step I3-A: Synthesi -[(2-chlorothiazol-5-vnmethyll-3- trifluoromethvnpyridin-2-amine
Figure imgf000100_0002
Step I3-B: Synthesis of N-allyl-N-[(2-chlorothiazol-5-vnmethyll-3-(trifluoromethyl)pyridin-2-amine (compound B8 in table B)
Figure imgf000100_0003
Sodium hydride (313 mg, 7.83 mmol, 1.15 equiv.) was added to a solution of N-[(2-chlorothiazol-5- yl)methyl]-3-(trifluoromethyl)pyridin-2-amine (2.00 g, 6.81 mmol) in N,N-dimethylformamide (22 mL) was at 0°C. After stirring the mixture for 1 hour, 3-bromoprop-1-ene (0.68 mL, 7.83 mmol, 1.15 equiv.) was added dropwise, and the reaction was warmed up to room temperature and stirred overnight. The mixture was quenched by addition of water, the aqueous phase was extracted three times with ethyl acetate, the combined organic layers were washed with brine, dried over magnesium sulfate, filtered and concentrated. Purification by flash chromatography over silica gel (ethyl acetate in cyclohexane) afforded the desired compound as a yellowish oil. LCMS (method ): 334 (M+H)+, retention time: 1.21 min. 1 H NMR (400 MHz, CDCI3) 5 ppm 8.45 - 8.49 (m, 1 H) 7.90 - 7.94 (m, 1 H) 7.39 - 7.41 (m, 1 H) 7.01 - 7.07 (m, 1 H) 5.87 - 5.99 (m, 1 H) 5.24 - 5.31 (m, 2 H) 4.59 - 4.64 (m, 2 H) 3.79 - 3.83 (m, 2 H).
Step I3-C: Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2- pyridyllaminolacetaldehyde (compound B9 in table B)
Figure imgf000101_0001
A 2.5% osmium tetroxide in tert-butanol (1.10 mL, 910 mg, 0.09 mmol, 0.03 equiv.) was added to a solution of N-allyl-N-[(2-chlorothiazol-5-yl)methyl]-3-(trifluoromethyl)pyridin-2-amine (compound B8 prepared as described above) (1.00 g, 3.00 mmol) in tetrahydrofuran (37.5 mL) and water (5.2 mL). After stirring overnight at room temperature, the reaction mixture was diluted with ethyl acetate, and the organic phase was wahed with a saturated ammonium chloride aqueous solution, brine, dried over sodium sulfate, filtered and concentrated. The crude 3-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)- 2-pyridyl]amino]propane-1 ,2-diol was used directly without purification.
Sodium periodate (640 mg, 3.00 mmol, 1.00 equiv.) was added to a 0 °C cooled solution of crude 3-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2-pyridyl]amino]propane-1 ,2-diol (1.10 g, 3.00 mmol, 1.00 equiv.) in water (16 mL) and methanol (16 mL). After stirring at 0 °C for 30 min and at room temperature for 1 hour, more sodium periodate (640 mg, 3.00 mmol, 1.00 equiv.) was added the mixture again at 0°C. After stirring at 0 °C for 30 min and at room temperature for 1 hour, a third portion of sodium periodate (640 mg, 3.00 mmol, 1.00 equiv.) was added the mixture again at 0°C, and the reaction was stirred at room temperature for 3 hours. The reaction mixture was diluted with ethyl acetate, the organic layer was washed with a saturated ammonium chloride aqueous solution, brine, dried over sodium sulfate, filtered and concentrated. The crude must be kept in the freezer and can be used directly without purification. LC-MS (method A): 336 (M+H)+, retention time: 0.57 min.
Step I3-D: Synthesis of 2-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2-pyridyllaminolacetic
Figure imgf000101_0002
A freshly prepared colorless solution of sodium chlorite (189 mg, 1.50 equiv.) and sodium dihydrogen phosphate (193 mg, 1.25 equiv.) in water (4.70 mL) was added dropwise to a solution of crude freshly prepared 2-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2-pyridyl]amino]acetaldehyde (750 mg, 1.00 equiv.) in tert-butanol (15.6 mL) and cyclohexene (3.02 mL) under argon at room temperature. After stirring for 2 hours, an additional freshly prepared solution of sodium chlorite (189 mg, 1.50 equiv.) and sodium dihydrogen phosphate (193 mg, 1.25 equiv.) in water (4.70 mL) was added dropwise. After stirring for 1 hour more at room temperature, diethyl ether was added and the phases were separated. The organic layer was washed with brine, dried over sodium sulfate, filtered and evaporated under vacuum. The crude material was purified by flash chromatography over silica gel (methanol in dichloromethane) to afford the desired compound (40mg, 10% yield) as a yellowish oil. . LC-MS (method A): 351 (M+H)+, retention time: 0.93 min.
Example I4: Preparation of2-[2-pyridyl(pyrimidin-5-ylmethyl)aminolacetic acid
Figure imgf000102_0001
Step I3-A: Synthesis of 5-(chloromethyl)pyrimidine
I
Figure imgf000102_0002
To a stirred solution of pyrimidin-5-ylmethanol (5.00 g, 45.4 mmol) in dichloromethane (125 mL) was added thionyl chloride (9.88 mL, 136 mmol) drop wise at 0 °C, and allowed to stirred at room temperature for 2 h. The reaction mixture was analyzed by TLC (50% EtOAc/hexanes) and it showed no starting material. The reaction mixture was concentrated under reduced pressure to afford title compound (4.2 g, 69.3%) as a light brown solid. Ή NMR (400 MHz, DMSO-c/6): δ 9.17 (s, 1 H), 8.91 (s, 2H), 4.85 (s, 2H).
Step I3-B: Synthesis of tert-butyl N-(2-pyridyl Carbamate
Figure imgf000102_0003
To a stirred solution of 2-aminopyridine (6.00 g, 63.8 mmol) in THF (120.0 mL) was added NaHMDS (2.00 M, 63.8 mL, 128 mmol) drop wise at 0 °C and stirred at room temperature for 30 min. followed by addition of (Boc)20 (17.6 mL, 76.5 mmol) and stirred at room temperature for 30min. Reaction mixture was analyzed by TLC (50% EtOAc/hexanes) and it showed no starting material. Reaction mixture was diluted with H2O (50 mL) and extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with brine (50 mL), dried over Na2S04 and concentrated under reduced pressure to afford crude reaction mixture. The crude was purified by combiflash chromatography [eluent: EtOAc (50%) in hexanes] to afford title compound (8.3 g, 60.7%) as an off white solid.
Ή NMR (300 MHz, DMSO-c/6): δ 9.71 (s, 1 H), 8.22 (d, 1 H), 7.78 - 7.67 (m, 2 H), 6.99 (t, 1 H), 1 .45 (s, 9H).
Step I3-C: Synthesis of tert-butyl N-(2-pyridyl)-N-(pyrimidin-5-ylmethyl)carbamate
Figure imgf000103_0001
To a stirred solution of tert-butyl N-(2-pyridyl)carbamate (3.60 g, 16.7 mmol) in DMF (150.0ml_) was added sodium hydride (60.0 %, 2.00 g, 50.0 mmol), followed by 5-(chloromethyl)pyrimidine (2.80 g, 21.8 mmol) at 0 °C and stirred at room temperature for 3 h. Reaction mixture was analyzed by TLC (50% EtOAc/hexanes) and it showed no starting material. The reaction mixture was diluted with H2O (50 mL) and extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with brine (50 mL), dried over Na2S04 and concentrated under reduced pressure to afford crude reaction mixture. The crude was purified by combiflash chromatography [eluent: EtOAc (50%) in hexanes] to afford the title compound (4.5 g, 89.5%).
Ή NMR (300 MHz, DMSO-c/6): δ 9.08 (s, 1 H), 8.75 (s, 2H), 8.40 (d, 1 H), 7.82 (t, 1 H), 7.68 (d, 1 H), 7.19 - 7.15 (m, 1 H), 5.08 (s, 2H), 1 .38 (s, 9H).
Figure imgf000103_0002
To a stirred solution of tert-butyl N-(2-pyridyl)-N-(pyrimidin-5-ylmethyl)carbamate (8.00 g, 20.6 mmol) in dichloromethane (100.0 mL) was added trifluoro acetic acid (15.7 mL, 206 mmol) at 0 °C and stirred at room temperature for 3 h. The reaction mixture was analyzed by TLC (50% EtOAc/hexanes) and it showed no starting material. The reaction mixture was diluted with saturated aqueous NaHCO3(150 mL) and extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with brine (150 mL), dried over Na2S04 and concentrated under reduced pressure to afford the title compound (4.5 g, 82.3%). Ή NMR (400 MHz, DMSO-c/6): δ 9.12 (s, 1 H), 8.76 (s, 2H), 8.10 (d, 1 H), 7.45 - 7.40 (m, 1 H), 6.66 - 6.63 (m, 1 H), 6.42 (d, 1 H), 4.87 (s, 1 H), 4.61 (d, 2H).
Step I3-E: Synthesis of tert-butyl 2-[2-pyridyl(pyrimidin-5-ylmethyl)aminolacetate
Figure imgf000103_0003
To a stirred solution of N-(pyrimidin-5-ylmethyl)pyridin-2-amine (2.50 g, 12.6 mmol) in THF (50.0 mL) was added NaHMDS (2.00 M, 18.9 mL, 37.9 mmol) at 0 °C and stirred for 1 h, followed by tert- butyl 2-bromoacetate (2.95 g, 15.1 mmol) was added at 0 °C, and allowed to stirred at room temperature for 4 h. Reaction mixture was analyzed by TLC (80% EtOAc/hexanes) and it showed no starting material. The reaction mixture was diluted with H2O (100 mL) and extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with brine (50 mL), dried over Na2S04 and concentrated under reduced pressure to afford crude reaction mixture. The crude was purified by combiflash chromatography [eluent: EtOAc (80%) in hexanes] to afford the title compound (1.5 g, 38.1 %).
Ή NMR (400 MHz, DMSO-c/6): δ 9.13 (s, 1 H), 8.73 (s, 2H), 8.18 - 8.16 (m, 1 H), 7.49 - 7.45 (m, 1 H), 6.69 - 6.66 (m, 1 H), 6.45 (d, 1 H), 4.87 (s, 2H), 4.10 (s, 2H), 1 .42 (s, 9 H).
Figure imgf000104_0001
To a stirred solution of tert-butyl 2-[2-pyridyl(pyrimidin-5-ylmethyl)amino]acetate (1.20 g, 3.80 mmol) in dichloromethane (100.0 mL) was added trifluoro acetic acid (2.90 mL, 38.0 mmol) at 0 °C and stirred at room temperature for 3 h. The reaction mixture was analyzed by TLC (80% EtOAc/hexanes) and it showed no starting material. The reaction mixture was concentrated under reduced pressure to afford crude reaction mixture. The crude was purified by combiflash chromatography [eluent: EtOAc (90%) in hexanes] to afford the title compound (0.4 g, 45.6%).
Ή NMR (300 MHz, DMSO-c/6): δ 12.58 (s, 1 H), 9.05 (s, 1 H), 8.77 (s, 2H), 8.09 - 8.07 (m, 1 H), 7.50 (d, 1 H), 6.66 - 6.57 (m, 2H), 4.79 (s, 2H), 4.33 (s, 2H).
Example I: Preparation of 2-benzoyl-1-[(2-chlorothiazol-5-yl)methyllimidazo[1 ,2-alpyridin-1-ium-3- olate (example A1 in table A)
Figure imgf000104_0002
2-[(2-chlorothiazol-5-yl)methyl-(2-pyridyl)amino]acetic acid (preparation describe above) (0.056 g) and benzoic anhydride (0.55 g) were mixed in a vial under inert atmosphere and the mixture was heated to 60°C and stirred for 20 hours at that temperature. After cooling down, the mixture was submitted to flash chromatography over silica gel, eluting with a mixture of methanol in
dichloromethane (5:95). The selected fractions yielded, after evaporation, the title compound showing the following NMR spectrum.
H-NMR (CDCI3, 400 MHz, δ in ppm): 8.42 (d, 1 H), 7.92 (d, 2H), 7.71 (dd, 1 H), 7.66 (s, 1 H), 7.58- 7.40 (m, 4H), 7.02 (t, 1 H), 5.92 (s, 2H).
Example 2: 1-[(2-chlorothiazol-5-yl)methyll-8-methyl-2-(2,2,2-trifluoroacetyl)imidazo[1 ,2-alpyridin-1- ium-3-olate (example A2 in table A)
Figure imgf000105_0001
2-[(2-chlorothiazol-5-yl)methyl-(3-methyl-2-pyridyl)amino]acetic acid (preparation describe above) (0.100 g) was treated with trifluoroacetic anhydride (0.356 g) under argon atmosphere. The mixture was stirred at 40°C for 6 days. The reaction mixture was then evaporated under reduced pressure and the residue submitted to chromatography on reverse phase, eluting with mixtures of acetonitrile and water. Evaporation of the selected fractions yielded the title compound with the following NMR-data.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.43 (d, 1 H), 7.61 (d, 1 H), 7.44 (s, 1 H), 7.05 (t, 1 H), 6.17 (br. s, 2H), 2.81 (s, 3H).
Example 3: 1-[(2-chlorothiazol-5-vnmethyll-2-(2,2,2-trifluoroacetvn-8-(trifluoromethvnimidazo[1 ,2- alpyridin-1-ium-3-olate (example A16 in table A)
Figure imgf000105_0002
A solution of 2-[(2-chlorothiazol-5-yl)methyl-[3-(trifluoromethyl)-2-pyridyl]amino]acetic acid
(compound B10 prepared as described above) (25 mg, 0.071 mmol) and trifluoroacetic anhydride (19.8 μΙ_, 0.142 mmol, 2.00 equiv.) in acetonitrile (0.852 ml_.) was heated at 80°C for 1 hour. After cooling down to room temperature, the reaction mixture was evaporated and the crude residue directly purified by flash chromatography over silica gel (methanol in dichloromethane) to afford a yellow oil containing a mixture of desired compound contaminated by trifluoroacetic acid. The product was dissolved in dichloromethane, the organic layer was washed with a saturated sodium
hydrogenocarbonate aqueous solution, dried over magnesium sulfate, filtered and concentrated to obtain the pure material as a yellow solid. (31 mg, quant.) with the following LC-MS and NMR-data. LC-MS (method A): 430 (M+H)+, retention time: 0.94 min. 1 H NMR (400 MHz, CDCI3) δ ppm 8.75 - 8.79 (m, 1 H) 8.27 - 8.33 (m, 1 H) 7.45 - 7.49 (m, 1 H) 7.23 - 7.28 (m, 1 H) 5.98 - 6.33 (m, 2 H).
Example 4: 2-benzoyl-1-(pyrimidin-5-ylmethyl)imidazo[1 ,2-alpyridin-1-ium-3-olate (example A18 in table A)
Figure imgf000106_0001
A 100 mL flask was charged with 2-[2-pyridyl(pyrimidin-5-ylmethyl)amino]acetic acid (0.40 g, 1.563 mmol), trifluoroacetic anhydride (1.03 g, 4.95 mmol) and stirred at 60 °C for 24 h. Reaction mixture was analyzed by TLC (100% EtOAc) and it showed no starting material. The reaction mixture was concentrated under reduced pressure to afford crude reaction mixture. The crude was purified by combiflash chromatography [eluent: EtOAc (100%)] to afford the title compound (0.05 g, 10.1 %) as a light yellow solid.
Ή NMR (300 MHz, DMSO-c/6): δ 9.10 (s, 1 H), 8.71 (s, 2H), 8.43 (d, J = 5.7 Hz, 1 H), 7.97 (s, 2H), 7.16 (s, 1 H), 5.74 (s, 2H).
Example 5: 2-benzoyl-1-(pyrimidin-5-ylmethyl)imidazo[1 ,2-alpyridin-1-ium-3-olate (example A17 in table A)
Figure imgf000106_0002
A 100 mL flask was charged with 2-[2-pyridyl(pyrimidin-5-ylmethyl)amino]acetic acid (0.20 g, 0.778 mmol), benzoic anhydride (2.1 1 g, 9.33 mmol) and stirred at 60°C for 24 h. The reaction mixture was analyzed by TLC (100% EtOAc) and it showed no starting material. The reaction mixture was concentrated under reduced pressure to afford crude reaction mixture. The crude was purified by combiflash chromatography [eluent: EtOAc (100%)] to afford the title compound (0.07 g, 26.2%).
Example I6: Preparation of 1-[(2-chlorothiazol-5-yl)methyl1-8-methyl-2-(2,2,2- trifluoroethylcarbamoyl)imidazo[1 ,2-a1pyridin-1-ium-3-olate (example A92 in table A)
Figure imgf000106_0003
ln a tube closed with a septum, under an argon atmosphere, 2-[(2-chlorothiazol-5-yl)methyl-(3- methyl-2-pyridyl)amino]acetic acid (preparation describe above) (0.050 g) was mixed in acetonitrile (0.13 g) at 20°C and 1 ,1 ,1-trifluoro-2-isocyanato-ethane (0.064 g) was added. The reaction mixture was stirred at 70°C. The conversion was checked by LC-MS analysis. After 3 hours, the reaction mixture was evaporated under reduced pressure and the residue was chromatographed on a silica gel column, eluting with a gradient of MeOH (0-5%) in dichloromethane. Evaporation of the selected fractions gave the title compound as a yellow solid.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 9.04 (t, 1 H), 8.35 (d, 1 H), 7.44 (s, 1 H), 7.38 (d, 1 H), 6.99 (t, 1 H), 4.10 (quint. 2 H), 2.79 (s, 3H).
Example 7: 1-[(2-chlorothiazol-5-yl)methyll-8-methyl-2-[methyl(2,2,2-trifluoroethyl)carbamoyll- imidazo[1 ,2-alpyridin-1-ium-3-olate (example A91 in table A)
Figure imgf000107_0001
1-[(2-chlorothiazol-5-yl)methyl]-8-methyl-2-(2,2,2-trifluoroethylcarbamoyl)imidazo[1 ,2-a]pyridin-1- ium-3-olate (preparation describe above) (0.042 g) dissolved in acetonitrile (1 ml) was treated with a suspension of sodium hydride (60% in oil) (3.0 equiv.) at 20°C under argon atmosphere and stirring. After the gas evolution stopped, iodomethane (0.020 ml) was added and the mixture was stirred for 2 hours. The starting material was fully converted (LC-MS analysis). A few drops of water were carefully added and the reaction mixture was concentrated under reduced pressure. The crude product was chromatographed on a silica gel column, eluting with a gradient of MeOH (0-10%) in dichloromethane. Evaporation of the selected fractions gave the title compound as a yellow solid.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 8.38 (d, 1 H), 7.40-7.33 (m, 2 H), 6.99 (t, 1 H), 6.03 (s, 2 H), 4.60-4.10 (broad signal, 2 H), 3.50-3.10 (broad signal, 3 H), 2.75 (s, 3H).
Example 8: Preparation of 2-[[3,5-bis(trifluoromethyl)phenyllcarbamothioyll-1-[(2-chlorothiazol-5- yl)methyllimidazo[1 ,2-alpyridin-1-ium-3-olate (example A123 in table A3)
Figure imgf000107_0002
ln a tube closed with a septum, under an argon atmosphere, 2-[(2-chlorothiazol-5-yl)methyl-(2- pyridyl)amino]acetic acid (preparation describe above) (0.050 g) was mixed with 1-isothiocyanato-3,5- bis(trifluoromethyl)benzene (0.244 g). The reaction mixture was stirred at 70°C for 24 hours. The conversion was checked by LC-MS analysis. After cooling to 20°C, the reaction mixture was submitted to chromatography on a silica gel, eluting with a mixture of 65% ethyl acetate in cyclohexane.
Evaporation of the selected fractions gave the title compound as a brown solid.
Ή-NMR (CDCI3, 400 MHz, δ in ppm): 13.01 (s, 1 H), 8.44 (s, 2 H), 7.88 (dd, 1 H), 7.72 (s, 1 H), 7.69 (s, 1 H), 7.56 (d, 1 H), 7.38 (d, 1 H), 7.19 (t, 1 H), 6.71 (s, 2 H).
Table A: This table discloses compounds of the formula lb
Figure imgf000108_0001
Figure imgf000108_0002
Figure imgf000109_0001
Figure imgf000110_0001
Figure imgf000111_0001
Figure imgf000112_0001
Figure imgf000113_0001
Figure imgf000114_0001
Figure imgf000115_0001
Figure imgf000116_0001
Figure imgf000117_0001
Figure imgf000118_0001
Figure imgf000119_0001
Figure imgf000120_0001
Figure imgf000121_0001
Figure imgf000122_0001
Figure imgf000123_0001
Table A2: This table discloses compounds of the formula la
Figure imgf000123_0002
Figure imgf000123_0003
Figure imgf000124_0001
Figure imgf000125_0001
Figure imgf000126_0001
Table A3: This table discloses compounds of the formula Id :
Figure imgf000126_0002
Wherein Ria, Rib, Ric, and Rid are each Hydrogen, V is S and: .
Comp. Analytical
R4 N-R
No. data
See experimental
A123
part
V— N (Example
F3C 8) Table A4: This table discloses compounds of the formula I :
Figure imgf000127_0001
Wherein Rib, Ric, id, R3, R4 are each Hydrogen, V is O, and:
Figure imgf000127_0003
Table B: Examples of intermediates of formulae (IV), (V) and (VI)
Figure imgf000127_0002
time
Figure imgf000128_0001
Figure imgf000129_0001
Figure imgf000130_0001
Figure imgf000131_0001
Figure imgf000132_0001
(s,
(s,
(d, (d, -
Figure imgf000133_0001
1H),
(s, 1H), 1H),
Figure imgf000134_0001
(s,
(d, (s,
1H),
(t, (d, (s,
Figure imgf000135_0001
(s,
1H),
(d, (s, (s,
Figure imgf000136_0001
Figure imgf000137_0001
(d,
(s, (d, (s,
Figure imgf000138_0001
(d,
(s, (s,
Figure imgf000139_0001
Figure imgf000140_0001
Figure imgf000141_0001
Figure imgf000142_0001
BIOLOGICAL EXAMPLES:
Diabrotica balteata (Corn root worm)
Maize sprouts placed onto an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation.
The following compounds gave an effect of at least 80% in at least one of the two categories (i.e. mortality and growth inhibition) at an application rate of 200 ppm:
A1 , A2, A3, A5, A6, A7, A9, A11 , A12, A13, A14, A15, A20, A23, A24, A25, A28, A32, A33, A34, A35, A36, A41 , A47, A51 , A52, A53, A55, A60, A64, A65, A67, A68, A74, A75, A76, A77, A78, A83, A86, A88, A89, A92, A97, A110, A111 , A114, A118, A122, A124, A127, A128, A130, A131
Euschistus fteros(Neotropical Brown Stink Bug)
Soybean leaves on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaves were infested with N2 nymphs. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
The following compounds gave an effect of at least 80% in at least one of the two categories (i.e mortality and growth inhibition) at an application rate of 200 ppm:
A2, A39, A53, A61 , A64, A67, A70, A80, A101 , A119, A135 Plutella xylostella (Diamond back moth)
24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions by pipetting. After drying, Plutella eggs were pipetted through a plastic stencil onto a gel blotting paper and the plate was closed with it. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 8 days after infestation. The following compounds gave an effect of at least 80% in at least one of the two categories (i.e mortality and growth inhibition) at an application rate of 200 ppm:
A16, A19, A23, A25, A26, A65, A66, A67, A68, A69, A70, A71 , A72, A74, A75, A76, A77, A78, A79, A80, A81 , A83, A84, A86, A89, A90, A1 14, A122
Myzus persicae (Green peach aphid):Feeding/Contact activity
Sunflower leaf discs were placed onto agar in a 24-well microtiter plate and sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying, the leaf discs were infested with an aphid population of mixed ages. The samples were assessed for mortality 6 days after infestation.
The following compounds resulted in at least 80% mortality at an application rate of 200 ppm:
A3 , A5 , A9 , A17 , A127 , A128
Plutella xylostella (Diamond back moth)
24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
The following compounds gave an effect of at least 80% in at least one of the two categories (i.e. mortality and growth inhibition) at an application rate of 200 ppm:
A1 , A2, A5, A7, A8, A9, A10, A1 1 , A12, A13, A14, A24, A32, A33, A34, A36, A41 , A52, A62, A63, A64, A92, A127, A128
Spodoptera littoral is (Egyptian cotton leaf worm)
Cotton leaf discs were placed onto agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf discs were infested with five L1 larvae. The samples were assessed for mortality, anti-feeding effect, and growth inhibition in comparison to untreated samples 3 days after infestation. Control of Spodoptera littoralis by a test sample is given when at least one of the categories of mortality, anti-feedant effect, and growth inhibition is higher than the untreated sample.
The following compounds resulted in at least 80% control at an application rate of 200 ppm:
A2, A3, A5, A9, A1 1 , A12, A13, A14, A20, A21 , A22, A23, A24, A25, A33, A34, A35, A36, A41 , A51 , A52, A53, A57, A62, A64, A67, A68, A71 , A76, A77, A83, A86, A88, A89, A107, A127, A128, A130

Claims

CLAIMS:
1. A compound of formula I ,
Figure imgf000144_0001
wherein
V is S or O;
Ria, Rib, Ric and Rid are independently selected from hydrogen, halogen, amino, hydroxyl, Ci-C6 alkyl, Ci-C6 haloalkyi, C1-C6 haloalkoxy, Ci-C6 alkoxy, C3-C6 cycloalkyl, C3-C6 halocycloalkyl and cyano; R2 is hydrogen, halogen, hydroxyl, amino, cyano, Ci-C6 alkyl, mono- or poly-substituted Ci-C6 alkyl (where the substituents are independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, Ci-C6 alkoxy, Ci-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, Ci-C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl and Ci-C6 haloalkylsulfonyl), C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, triazole, pyrazole, imidazole, or tetrazole, wherein said triazole, pyrazole, imidazole and tetrazole can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, Ci-C4 alkyl, Ci-C4 alkoxy, C1-C4 haloalkyi and cyano;
R3 is hydrogen or Ci-C6 alkyl;
R4 is hydrogen or a 5 or 6 membered heteroaromatic ring Y, optionally independently substituted with a substituent from the group U, wherein Y is a ring selected from Y1 to Y29
Figure imgf000145_0001
wherein Z is hydrogen, cyano, nitro, hydroxyl, Ci-C4alkyl, C1-C4 haloalkyi, Ci-C4alkoxy, C1-C4 haloalkoxy, C1-C4 haloalkoxy-Ci-C4alkyl or Ci-C4alkoxy-Ci-C4alkyl;
n is 0, 1, 2, or 3;
U is independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, amino, C1-C4 alkyl, C1-C4 haloalkyi, Ci-C4alkoxy, C1-C4 haloalkoxy, C1-C4 haloalkoxy-Ci-C4alkyl, Ci-C4alkoxy-Ci-C4 alkyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, Ci-C4 aloalkylsulfonyl, formyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C1-C6 alkylcarbonyl and C3-C6 cycloalkylcarbonyl; and
Rs is hydrogen, -OR6, -NR8R/, -N(R8)N(R8R7); or
Rs is a 5 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can be mono- or polysubstituted by substituents independently selected from the group U2; or
Rs is a 3 to 12 membered heteroaromatic ring, or a 3 to 12 membered saturated or partially saturated heterocyclic ring, each of which can be monocyclic or polycyclic, which ring system can contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said 3 to 12-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2; or
Rs is C3-C6 cycloalkyi, which can be mono- or poly-substituted by substituents independently selected from the group U3; or
Rs is C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or
Rs is C2-C4 alkenyl which can optionally be mono- or poly-substituted by substituents independently selected from the group U3; or
Rs is C2-C4 alkynyl which can optionally be mono- or poly-substituted by substituents independently selected from the group U3;
U2 is selected from the group consisting of halogen, nitro, cyano, amino, hydroxyl, -SCN, -CO2H, C1-C6 alkyl, C3-C6 cycloalkyi, C3-C6 halocycloalkyl, C3-C6 cycloalkyl-Ci-C4 alkyl, C3-C6 halocycloalkyl-Ci-C4 alkyl, C1-C6 haloalkyl, Ci-C6 alkoxy, Ci-C4alkoxy-Ci-C4 alkyl, Ci-C4 alkoxy-Ci-C4 alkoxy, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6alkylsulfanyl, C1-C6 alkylsulfinyl, Ci-C6 alkylsulfonyl, Ci- C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, Ci-C6 haloalkylcarbonyl, C1-C6 haloalkoxycarbonyl, (Ci-C6 alkyl)NH, (Ci-C6 alkyl)2N, (C3-C6 cycloalkyi )NH, (C3-C6 cycloalkyl)2N, C1-C6 alkylcarbonylamino, C3-C6 cycloalkylcarbonylamino, C1-C6 haloalkylcarbonylamino, C3-C6 halocycloalkylcarbonylamino, Ci-C6 alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, C1-C6 haloalkylaminocarbonyl, C3-C6 halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs and -C(0)NH2;
U3 is selected from the group consisting of halogen, nitro, cyano, amino, hydroxyl, -SCN, -CO2H, C1-C6 alkyl, C3-C6 cycloalkyi, C3-C6 halocycloalkyl, C3-C6 cycloalkyl-Ci-C4 alkyl, C3-C6 halocycloalkyl-Ci-C4 alkyl, C1-C6 haloalkyl, Ci-C6 alkoxy, Ci-C4alkoxy-Ci-C4 alkyl, Ci-C4 alkoxy-Ci-C4 alkoxy, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6alkylsulfanyl, C1-C6 alkylsulfinyl, Ci-C6 alkylsulfonyl, Ci- C6 haloalkylsulfanyl, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, Ci-C6 haloalkylcarbonyl, C1-C6 haloalkoxycarbonyl, (Ci-C6 alkyl)NH, (Ci-C6 alkyl)2N, (C3-C6 cycloalkyi )NH, (C3-C6 cycloalkyl)2N, C1-C6 alkylcarbonylamino, C3-C6 cycloalkylcarbonylamino, C1-C6 haloalkylcarbonylamino, C3-C6 halocycloalkylcarbonylamino, Ci-C6 alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, C1-C6 haloalkylaminocarbonyl, C3-C6 halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs and -C(0)NH2; or
U3 is a 5 to 6 membered aromatic ring, 5 to 6 membered heteroaromatic ring, or 5 to 6 membered saturated or partially saturated carbocyclic or heterocyclic ring system, wherein heteroaromatic or heterocyclic ring can contain 1 to 4 hetero atoms selected from the group consisting of nitrogen substituted or not, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, said 5 to 6-membered ring system can be mono- or polysubstituted by substituents independently selected from the group U2;
R6 is selected from the group consisting of hydrogen, amino, Ci-C6 alkyl, Ci-C6 haloalkyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, Ci-C4 alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C6 cycloalkyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl and C3-C6 halocycloalkyl;
Re is selected from the group consisting of hydrogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 haloalkyl, Ci- C6 haloalkoxy, Ci-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6 alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, Ci-C4alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl, pyridyl and pyrimidyl, wherein said phenyl, pyridyl or pyrimidyl ring system can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, and Ci-C4 alkoxy; and
R7 is selected from the group consisting of hydrogen, cyano, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C4 haloalkoxy-Ci-C4 alkyl, Ci-C6alkoxy-Ci-C6 alkyl, Ci-C6 alkoxy, Ci-C4 alkylsulfanyl, Ci-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, C2-C6alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, cyano-Ci-C4 alkyl, cyano-Ci-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl, pyridyl and pyrimidyl, wherein said phenyl, pyridyl or pyrimidyl ring system can be mono- or polysubstituted by substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, and Ci-C4 alkoxy; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide of the compound of formula I, wherein in the instance the moiety -NCR2R3R4 is - NCH2CH3, R5 is not phenyl, methyl or ethyl.
2. The compound according to either claim 1 , wherein Ria, Rib, Ric and Rid are independently selected from hydrogen, Ci-C6alkyl, Ci-C6 alkoxy, or C1-C6 haloalkyl.
3. The compound according to either claim 1 or claim 2, wherein n is 0 or 1.
4. The compound according to any one of claims 1 to 3, wherein R2 is hydrogen, C1-C6 alkyl, or mono- or poly-substituted C1-C6 alkyl independently selected from the group consisting of halogen, hydroxyl, amino, cyano, nitro, C1-C6 haloalkoxy, Ci-C6 alkoxy, Ci-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfanyl, Ci-C6 aloalkylsulfinyl and C1-C6 haloalkylsulfonyl.
5. The compound according to any one of claims 1 to 4, wherein R3 is hydrogen or Ci-C4 alkyl.
6. The compound according to any one of claims 1 to 5, wherein R4 is heteroaromatic ring Y selected from Y1 to Y29 independently substituted with a substituent from the group U, wherein n, Z and U are as defined claim 1. 7. The compound according to any one of claims 1 to 6, wherein R5 is 6 to 12 membered aromatic ring, which can be monocyclic or polycyclic, which ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2, wherein group U2 is as defined in claim 1. 8. The compound according to any one of claims 1 to 6, wherein R5 is 5 to 12 membered heteroaromatic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2, or R5 is 3 to 6 membered saturated or partially saturated heterocyclic ring system, which can be monocyclic or polycyclic, which ring system can contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, with the proviso that each ring cannot contain more than 2 oxygen atoms or more than 2 sulfur atoms, wherein the nitrogen heteroatom can be substituted by Z and said ring system can optionally be mono- or polysubstituted by substituents independently selected from the group U2; wherein Z and U2 are as defined in claim 1.
9. The compound according to any one of claims 1 to 6, wherein R5 is a C3-C6 cycloalkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wherein U3 is as defined in claim 1.
10. The compound according to any one of claims 1 to 6, wherein R5 is a C1-C6 alkyl, which can optionally be mono- or poly-substituted by substituents independently selected from the group U3, wheerein U3 is as defined in claim 1.
1 1. A compound of formula la
Figure imgf000149_0001
la
wherein Ria is hydrogen, methyl, methoxy, or trifluoromethyl; R2 is hydrogen, or methyl; R3 is hydrogen, or methyl; R4 is heteroaromatic ring Y selected from selected from Y4, Y9 and Y12 (as defined in claim 1 ); and R5 is selected from the groups (i) to (iii): (i) benzyl, 3-CI-Phenyl, 3,5-diCI- Phenyl, 2-CI-Phenyl, 2-F-Phenyl, 4-F-Phenyl, 3-l-Phenyl, 2-methyl-Phenyl, 3,5-diBr-Phenyl, ,3-Br-5- CF3-Phenyl, 3-Br-5-OCF3-Phenyl, 3-OCF3-Phenyl, 3-SCH3-Phenyl, 4-methoxy-Phenyl, 3-methoxy- Phenyl, 3-Br-Phenyl, 4-F-Phenyl., 4-CF3-Phenyl, 3-CHF2-Phenyl, or 3,4,5-tri-fluroro-Phenyl; (ii) heptafluoropropyl, 2-CF3-cyclopropyl-, CH3CF2CH2-, or (CF3)2CH-; and (iii) biphenyl, napthyl, phenylpyridyl, pyridylphenyl, or tetrahydrofuryl, which can optionally be mono- or polysubstituted by substituents independently selected from the group U2; wherein U2 is halogen, cyano, Ci-C4 alkyl, C3- C6 cycloalkyl, C1-C4 haloalkyl or C1-C4 alkoxy; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide of the compound of formula la.
Figure imgf000149_0002
Figure imgf000150_0001
wherein Ria, Rib, Ric and Rid, R2, R3 are as defined in any one of claims 1 , 2, 4, and 5; R4 is a heteroaromatic ring Y selected from Y4, Y9 and Y12 substituted with a substituent from the group U, wherein n and U are as defined in claim 1 ; and R (for formila (IV)) is Ci-C4 alkyl; and acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formulae IV, V and Vi respectively.
13. A process for preparing a compound of formula la, wherein
(1 ) a compound of formula III is prepared from compound of formula 111 via alkylation with a compound of formula IV1 , in presence of a base to generate a compound of formula III; or the compound of formula III is prepared from a compound of formula II2 via palladium coupling with a compound of formula IV2; or a compound of formula III is prepared by nucleophile substitution, in presence of a base, with a compound of formula IV2;
Figure imgf000151_0001
(2) a compound of formula IV is prepared from a compound of formula III by alkylation with R2R3R4C-
Figure imgf000151_0002
(3) a compound of formula V is prepared from a compound of formula IV by cleavage of the acetal group to aldehyde in presence of an acid;
Figure imgf000152_0001
(4) a compound of the formula V is oxidized to its corresponding acid of formula VI; and
Figure imgf000152_0002
(5) a compound of formula la is prepared from a compound of formula VI by cyclisation and acylation in presence of an anhydride of formula Vila or acid halide of formula Vllb,
Figure imgf000152_0003
wherein R is C1-C4 alkyl; XLG and X are independently of each other a leaving group; and Ria, Rib, Ric, Rid, R2, R3, R4 and R5 are as described for formula I in any one of claims 1 to 8.
14. A pesticidal composition comprising a compound of formula I as defined in any one of claims 1 to 1 1 and one or more formulation additives and a carrier.
15. A combination of active ingredients comprising a compound of formula I as defined in any one of claims 1 to 1 1 , and one or more further active ingredients.
16. A method of controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula I as defined in any one or claims 1 to 1 , or a composition containing a compound of formula I as defined in any one or claims 1 to 11 , to a pest, a locus of pest, preferably a plant, to a plant susceptible to attack by a pest or to plant propagation material thereof, such as a seed, provided if the control were on a human or animal body, then it is non-therapeutical.
17. A plant propagation material comprising by way of treatment or coating one or more compounds of formula I defined in any one of claims 1 to 11 , optionally also comprising a colour pigment.
PCT/EP2018/079743 2017-10-31 2018-10-30 Pesticidally active mesoionics heterocyclic compounds WO2019086474A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17199389 2017-10-31
EP17199389.2 2017-10-31

Publications (1)

Publication Number Publication Date
WO2019086474A1 true WO2019086474A1 (en) 2019-05-09

Family

ID=60201440

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/079743 WO2019086474A1 (en) 2017-10-31 2018-10-30 Pesticidally active mesoionics heterocyclic compounds

Country Status (1)

Country Link
WO (1) WO2019086474A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200093133A1 (en) * 2017-05-09 2020-03-26 Fmc Corporation Mesoionic insecticides
WO2020239517A1 (en) 2019-05-29 2020-12-03 Basf Se Mesoionic imidazolium compounds and derivatives for combating animal pests
EP3769623A1 (en) 2019-07-22 2021-01-27 Basf Se Mesoionic imidazolium compounds and derivatives for combating animal pests
CN112442026A (en) * 2019-08-27 2021-03-05 东莞市东阳光农药研发有限公司 Mesoionic derivative and preparation method and application thereof
US10993439B2 (en) * 2017-04-21 2021-05-04 Bayer Aktiengesellschaft Mesoionic imidazopyridines as insecticides
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Citations (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003034823A1 (en) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Treatment of fabric materials with an insecticide
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2005064072A2 (en) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2005077934A1 (en) 2004-02-18 2005-08-25 Ishihara Sangyo Kaisha, Ltd. Anthranilamides, process for the production thereof, and pest controllers containing the same
WO2005113886A1 (en) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Method for the treatment of flexible substrates
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
EP1724392A2 (en) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Process for the microbicidal finishing of textile surfaces
WO2006128870A2 (en) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007090739A1 (en) 2006-02-03 2007-08-16 Basf Se Process for treating substrates
WO2008151984A1 (en) 2007-06-12 2008-12-18 Basf Se Aqueous formulation and process for the impregnation of non-living-materials imparting a protective activity against pests
WO2009099929A1 (en) 2008-02-06 2009-08-13 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2010060231A1 (en) 2008-11-25 2010-06-03 Qin Zhaohai Condensed amino nitroguanidine compounds, synthesis and use as botanical insecticides thereof
WO2011017347A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2011017342A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2011017334A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2012106495A1 (en) 2011-02-03 2012-08-09 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2012136724A1 (en) 2011-04-06 2012-10-11 Basf Se Substituted pyrimidinium compounds for combating animal pests
WO2014033244A2 (en) 2012-09-03 2014-03-06 Basf Se Substituted mesoionic imine compounds for combating animal pests
WO2014167084A1 (en) 2013-04-11 2014-10-16 Basf Se Substituted pyrimidinium compounds and derivatives for combating animal pests
WO2014202582A1 (en) 2013-06-17 2014-12-24 Basf Se Substituted pyrimidinium compounds and derivatives for combating animal pests
WO2016029146A1 (en) 2014-08-22 2016-02-25 University Of Washington Specific inhibitors of methionyl-trna synthetase
WO2016055431A1 (en) 2014-10-06 2016-04-14 Basf Se Substituted pyrimidinium compounds for combating animal pests
WO2016171053A1 (en) 2015-04-21 2016-10-27 日本化薬株式会社 Mesoionic compound
WO2017093214A1 (en) 2015-12-03 2017-06-08 Bayer Cropscience Aktiengesellschaft Mesoionic halogenated 3-(acetyl)-1-[(1,3-thiazol-5-yl)methyl]-1h-imidazo[1,2-a]pyridin-4-ium-2-olate derivatives and related compounds as insecticides

Patent Citations (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003034823A1 (en) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Treatment of fabric materials with an insecticide
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2005064072A2 (en) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2005077934A1 (en) 2004-02-18 2005-08-25 Ishihara Sangyo Kaisha, Ltd. Anthranilamides, process for the production thereof, and pest controllers containing the same
WO2005113886A1 (en) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Method for the treatment of flexible substrates
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
EP1724392A2 (en) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Process for the microbicidal finishing of textile surfaces
WO2006128870A2 (en) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007090739A1 (en) 2006-02-03 2007-08-16 Basf Se Process for treating substrates
WO2008151984A1 (en) 2007-06-12 2008-12-18 Basf Se Aqueous formulation and process for the impregnation of non-living-materials imparting a protective activity against pests
WO2009099929A1 (en) 2008-02-06 2009-08-13 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2010060231A1 (en) 2008-11-25 2010-06-03 Qin Zhaohai Condensed amino nitroguanidine compounds, synthesis and use as botanical insecticides thereof
WO2011017347A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2011017342A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2011017334A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2012106495A1 (en) 2011-02-03 2012-08-09 E. I. Du Pont De Nemours And Company Mesoionic pesticides
WO2012136724A1 (en) 2011-04-06 2012-10-11 Basf Se Substituted pyrimidinium compounds for combating animal pests
WO2014033244A2 (en) 2012-09-03 2014-03-06 Basf Se Substituted mesoionic imine compounds for combating animal pests
WO2014167084A1 (en) 2013-04-11 2014-10-16 Basf Se Substituted pyrimidinium compounds and derivatives for combating animal pests
WO2014202582A1 (en) 2013-06-17 2014-12-24 Basf Se Substituted pyrimidinium compounds and derivatives for combating animal pests
WO2016029146A1 (en) 2014-08-22 2016-02-25 University Of Washington Specific inhibitors of methionyl-trna synthetase
WO2016055431A1 (en) 2014-10-06 2016-04-14 Basf Se Substituted pyrimidinium compounds for combating animal pests
WO2016171053A1 (en) 2015-04-21 2016-10-27 日本化薬株式会社 Mesoionic compound
WO2017093214A1 (en) 2015-12-03 2017-06-08 Bayer Cropscience Aktiengesellschaft Mesoionic halogenated 3-(acetyl)-1-[(1,3-thiazol-5-yl)methyl]-1h-imidazo[1,2-a]pyridin-4-ium-2-olate derivatives and related compounds as insecticides

Non-Patent Citations (28)

* Cited by examiner, † Cited by third party
Title
"Compendium of Herbicide Adjuvants, 10th ed.", 2010, SOUTHERN ILLINOIS UNIVERSITY
"Manual on Development and Use of FAO and WHO Specifications for Pesticides", 2010, UNITED NATIONS
"McCutcheon's Detergents and Emulsifiers Annual", 1981, PUBLISHING CORP.
"Modern Tools for the Synthesis of Complex Bioactive Molecules", 2012, article "Chapter 3: Metal-catalyzed C-heteroatom cross-coupling reactions", pages: 77 - 109
A. WOOD: "Compendium of Pesticide Common Names", 1995, COPYRIGHT
C. D. S. TOMLIN: "The Pesticide Manual - A World Compendium, 13th ed.", THE BRITISH CROP PROTECTION COUNCIL
CANADIAN JOURNAL OF CHEMISTRY, vol. 49, no. 4, 1971, pages 668 - 71
CHEM. SOC. REV., vol. 3, 1974, pages 209 - 230
CHEMICAL REVIEWS, vol. 43, 1948, pages 203 - 18
CHEMICAL REVIEWS, vol. 57, 1957, pages 47 - 76
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 109, 2016, pages 294 - 304
GREEN CHEMISTRY LETTERS AND REVIEWS, vol. 4, no. 1, 2011, pages 1 - 34
HETEROATOM CHEM., vol. 25, 2014, pages 548 - 555
INORGANIC CHEMISTRY, vol. 43, no. 21, 2004, pages 6534 - 6536
JACS, 1951, pages 5467 - 5469
JERRY MARCH: "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 4th ed.", 1992, PUBLISHER WILEY, pages: 1184 - 1185
JOURNAL OF THE CHEMICAL SOCIETY, 1959, pages 2865 - 71
JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL SOCIETY, LETCHWORTH; GB, 1 January 1959 (1959-01-01), pages 2865 - 2871, XP009504229, ISSN: 0368-1769 *
JOURNAL OF THE CHEMICAL SOCIETY, PERKIN T 1 ORGANIC AND BIO-ORGANIC CHEMISTRY, 1980, pages 132
KURTI, LASZLO, CZAKO, BARBARA: "Strategic Applications of Named Reactions in Organic Synthesis", 2005, pages: 70
PROC. BCPC, INT. CONGR., vol. 1, 2003, pages 93
RICHARD C. LAROCK: "Comprehensive Organic Transformations: A Guide to Functional Group Preparations", 1989, VCH PUBLISHERS COULD, pages: 838
SCIENCE OF SYNTHESIS, vol. 27, 2004, pages 215 - 243
TETRAHEDRON, vol. 41, no. 12, 1985, pages 2239 - 329
TETRAHEDRON, vol. 63, no. 48, 2007, pages 11862 - 11877
TETRAHEDRON, vol. 64, 2008, pages 10798 - 1080
TETRAHEDRON, vol. 69, 2013, pages 4146 - 4159
THEODORA W. GREENE, PETER G. M. WUTS: "Protective groups in organic synthesis, 3rd ed.", 1999, pages: 299

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10993439B2 (en) * 2017-04-21 2021-05-04 Bayer Aktiengesellschaft Mesoionic imidazopyridines as insecticides
US20200093133A1 (en) * 2017-05-09 2020-03-26 Fmc Corporation Mesoionic insecticides
US11044910B2 (en) * 2017-05-09 2021-06-29 Fmc Corporation Mesoionic insecticides
WO2020239517A1 (en) 2019-05-29 2020-12-03 Basf Se Mesoionic imidazolium compounds and derivatives for combating animal pests
EP3769623A1 (en) 2019-07-22 2021-01-27 Basf Se Mesoionic imidazolium compounds and derivatives for combating animal pests
CN112442026A (en) * 2019-08-27 2021-03-05 东莞市东阳光农药研发有限公司 Mesoionic derivative and preparation method and application thereof
CN112442026B (en) * 2019-08-27 2023-08-08 东莞市东阳光农药研发有限公司 Mesoionic derivative and preparation method and application thereof
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
US11452711B2 (en) 2020-09-03 2022-09-27 Pfizer Inc. Nitrile-containing antiviral compounds
US11541034B2 (en) 2020-09-03 2023-01-03 Pfizer Inc. Nitrile-containing antiviral compounds

Similar Documents

Publication Publication Date Title
US10308650B2 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
EP3268365B1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
EP3532471B1 (en) Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents
EP3585770B1 (en) Pesticidally active heterocyclic derivatives with sulfur containing substituents
EP3317275B1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016116338A1 (en) Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016107742A1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
EP3180341A2 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016046071A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016058928A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2017133994A1 (en) Pesticidally active derivatives with sulfur and cyclopropyl containing substituents
EP3353173B1 (en) Pesticidally active polycyclic derivatives with 5-membered sulfur containing heterocyclic ring systems
WO2016113155A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
US10894792B2 (en) Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2019086474A1 (en) Pesticidally active mesoionics heterocyclic compounds
WO2019076778A1 (en) Pesticidally active heterocyclic derivatives with sulfur and sulfonimidamides containing substituents
WO2016012395A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2019115404A1 (en) Pesticidally active mesoionic heterocyclic compounds
WO2016120182A1 (en) Pesticidally active amide heterocyclic derivatives with sulphur containing substituents
WO2020025658A1 (en) Pesticidally-active bicyclic heteroaromatic compounds
WO2020120694A1 (en) Pesticidally-active bicyclic heteroaromatic compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18806977

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18806977

Country of ref document: EP

Kind code of ref document: A1